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ABSTRACT  
In contrast with the wealth of information on the folding of soluble, cytosolic proteins, 
little is known about the folding of integral membrane proteins.  The outer membrane 
proteins (OMPs) of Gram-negative bacteria have a β-barrel structure and are essential 
for cell survival.  The mechanisms of OMP transport across the periplasm and how 
these proteins subsequently fold and insert into the outer membrane remain to be 
elucidated.   
The work presented herein examines the folding and membrane insertion of four 
different OMP constructs.  Two homologous bacterial OMPs, OmpT and OmpP, were 
cloned, over-expressed and purified before biochemical and biophysical methods were 
employed to examine their folding properties.  This work demonstrates that small 
differences in primary sequence can have large effects on folding efficiency and 
stability.   
In spite of both OmpT and OmpP being able to fold under a variety of conditions, it was 
not possible to establish conditions under which folding was completely reversible.  
Examination of the origins of irreversible OMP folding was carried out using OmpT, as 
well as both hexa-histidine tagged and untagged constructs of the outer membrane 
acyltransferase enzyme, PagP.  This study revealed evidence that lipid adhesion of the 
protein in the unfolded state may be important in preventing aggregation and promoting 
reversibility. 
Finally, conditions were established to promote the folding of untagged PagP in low 
urea concentrations to allow the study of OMPs in the presence of the periplasmic 
chaperones, SurA and Skp.  SurA was shown to have little effect on the folding of PagP 
into liposomes with zwitterionic or negatively charged membrane surfaces, while Skp 
was shown to exhibit holdase activity and to modulate PagP folding rate, dependent on 
the lipid composition.  The results present the first detailed insights into the mechanism 
by which Skp and SurA act to facilitate PagP folding in vitro. 
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LIST OF ABBREVIATIONS 
Amino acids are abbreviated according to their standard three-letter or single-letter 
codes.  Other abbreviations are as follows: 
 
Abz   ortho-aminobenzoic acid 
AFM   Atomic force microscopy 
ANS   8-Anilinonaphthalene-1-sulfonic acid 
Apol   Amphipol or amphipathic polymer 
ATP   Adenosine triphosphate 
BAM   β-barrel assembly machine 
BMP   bis(monoacylglycero)phosphate  
bO   Bacterioopsin 
bR   Bacteriorhodopsin 
BSA   Bovine serum albumin 
CD   Circular dichroism 
CHAPS 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate 
CL   Cardiolipin 
diCx:yPZ  A phospholipid with two identical acyl chains: 
   x indicates the number of carbon atoms in the acyl chain 
   y indicates the number of double bonds per acyl chain 
Z represents the head-group moiety; choline (C), ethanolamine 
(E), glycerol (G), inositol (I) or serine (S) 
Dansyl   5-(dimethylamino)naphthalene-1-sulfonyl 
DDM   n-dodecyl-β-D-maltopyranoside 
dH2O   Deionised water (greater than 15 MΩ resistance) 
DNA   Deoxyribonucleic acid 
dNTP   deoxyribonucleotide triphosphate 
dsDNA  Double stranded deoxyribonucleic acid 
E. coli   Escherichia coli 
EDTA   Ethylenediaminetetraacetic acid 
En-HD   Engrailed homeodomain 
ESI   Electrospray ionisation 
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EtOH   Ethanol 
fnIII   Fibronectin type III 
FRET   Förster resonance energy transfer 
GPI   Glycophosphatidylinositol 
GTP   Guanosine triphosphate  
GuHCl   Guanidine hydrochloride 
HT   His-tagged 
hVDAC  Human voltage-dependent anion-selective channel 
Ig   Immunoglobulin 
IM   Inner membrane  
IMS   Ion mobility spectrometry  
IPTG   Isopropyl-β-D-thiogalactoside 
LB   Lysogeny broth  
LDAO   N-lauryl-N,N-dimethylammonium-N-oxide 
LPR   Lipid to protein ratio 
LPS   Lipopolysaccharide 
LUV   Large unilamellar vesicle 
MALDI  Matrix-assisted laser desorption ionisation 
MD   Molecular dynamics 
MS   Mass spectrometry 
MWCO  Molecular weight cut-off  
NaCl   Sodium chloride 
NBF   Nucleotide binding fold 
N. meningitides Neisseria meningitides 
NMR   Nuclear magnetic resonance 
OM   Outer membrane 
OMP   Outer membrane protein 
PA   Phosphatidic acid 
PAGE   Polyacrylamide gel electrophoresis 
PBS    Phosphate-buffered saline 
PC   Phosphocholine 
PCR   Polymerase chain reaction 
PDB   Protein Data Bank 
PDZ   PSD-95, Discs-large, ZO-1 
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PE   Phosphoethanolamine 
PG   Phosphoglycerol 
pI   Isoelectric point 
PI   Phosphoinositol 
PMSF   Phenylmethanesulfonylfluoride 
POTRA  Polypeptide-transport-associated  
PPIase   Peptidyl-prolyl isomerise 
PS   Phosphoserine 
PVDF   Polyvinylidene fluoride 
RMSD   Root mean squared deviation 
SDS   Sodium dodecyl sulphate 
SDS-PAGE  Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SEM   Standard error of the mean 
SM   Sphingomyelin 
SOB   Super optimal broth 
SOC   Super optimal broth with catabolite repression 
SRP   Signal recognition particle 
SUV   Small unilamellar vesicle 
TAE   Tris-acetate-EDTA 
TBS   Tris-buffered saline 
TCA   Trichloroacetic acid 
TEMED  Tetramethylethylenediamine 
TEVp   Tobacco etch virus protease 
TPR   Tetratricopeptide repeat 
Tris   Tris (hydroxymethyl)-aminomethane 
UV   Ultra violet 
X-Gal   5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside
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1 INTRODUCTION 
1.1 PRINCIPLES OF PROTEIN FOLDING 
1.1.1 HOW WATER-SOLUBLE PROTEINS FOLD 
The biological activity of many proteins is reliant on their ability to adopt a specific, 
three-dimensional structure.  Failure to achieve this functional, or native, state can have 
serious consequences, as evidenced by the prevalence of diseases caused by protein 
misfolding and aggregation
1; 2; 3
.  The information required for a polypeptide chain to 
assume its native structure was shown to be contained within its primary sequence of 
amino acids by Anfinsen’s experiments on ribonuclease A4; 5.  Ribonuclease A was 
demonstrated to regain its native conformation when dialysis was carried out following 
complete denaturation of this small, globular protein with urea and reduction of the 
disulphide bonds using dithiothreitol
4
.  This seemingly simple conclusion has led to 
decades of scientific research on what remains one of the key questions in the study of 
protein folding: how does the amino acid sequence of a protein confer its native 
structure
6
?   
If folding were to occur by random sampling of all possible conformations of the 
polypeptide chain, finding the native state would take an astronomically long time, 
however, proteins are able to fold on biologically relevant timescales
7
.  Levinthal 
suggested that this apparent paradox could be resolved if proteins fold via defined 
pathways
8
.  Following this conclusion, several mechanisms were proposed to describe 
the pathways traversed by a folding protein en route to the native state.  Analysis of the 
refolding kinetics of ribonuclease A revealed two distinct phases
9
 and led to the 
suggestion of a “framework” mechanism of folding wherein the secondary structure is 
formed prior to docking together to form the tertiary structure
6; 10
.  Further investigation 
of the refolding of ribonuclease A revealed that one of the phases observed was not, in 
fact, due to the presence of an observable folding intermediate, but to proline cis-trans 
isomerisation
11
.  This realisation, alongside the characterisation of the folding of 
chymotrypsin inhibitor 2 which revealed a simple two-state folding system
12
, saw the 
framework mechanism become disfavoured due to its implication that folding 
intermediates should be present
6; 10
.  To explain folding in the absence of detectable 
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intermediates, the nucleation condensation mechanism was proposed.  This mechanism 
involves the formation of a small nucleus of structure stabilised by weak, long-range 
contacts and the subsequent rapid collapse around this folding nucleus to yield the 
native state
6; 10
.  A combination of simulation and experimental data on members of the 
homeodomain-like super-family of proteins revealed that these two seemingly 
contrasting folding mechanisms could be considered as two extremes of a single folding 
mechanism, with the relative stability of the secondary and tertiary structure 
determining if these elements are formed in series or in parallel
13
. 
More recently it has been realised that proteins fold via a collection of parallel pathways 
which make up a funnel shaped energy landscape
14
.  At the top of the funnel, the 
unfolded state represents a large ensemble of high-entropy conformations of the 
polypeptide chain, which may be biased by weak, residual interactions
15
.  Indeed, an 
unfolded variant of the bacterial immunity protein Im7 has been studied recently under 
non-denaturing conditions, revealing conformational restriction in the regions of the 
protein which ultimately form the native helices and demonstrating the importance of 
such interactions in the initiation of folding
16
.  By undergoing many reorganisations, the 
polypeptide chain forms stabilising interactions between side chains, the protein 
backbone and the solvent as the protein approaches the native state
14
.  The landscape 
view is an attractive one as it does not place restrictions on whether secondary structure 
must form before, or at the same time, as the tertiary structure
14
.  Additionally, the 
funnel-shaped landscape predicts the robustness of the folding process to destabilising 
mutations: so long as the final fold remains the most stable state relative to the unfolded 
ensemble, a mutation may block some of the pathways to the native state but alternative 
folding pathways can be utilised
14
. 
For proteins in which only the native and unfolded states are populated, known as a 
two-state folding mechanism, the energy landscape to be traversed by the folding 
polypeptide is relatively smooth (Figure 1.1A)
17
.  This simple folding scenario is rarely 
observed even for small proteins, however, and the folding landscape is often rugged 
with local energy minima representing the population of one or more folding 
intermediates en route to the native state (Figure 1.1B)
17; 18
.   
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Figure 1.1 A schematic representation of funnel shaped folding landscapes.  Examples 
of (A) a smooth folding landscape expected for a two-state folding mechanism where 
only the native and unfolded states are populated and (B) a rugged landscape wherein 
the polypeptide chain populates one or more intermediate structures which represent 
local energy minima.  This figure was taken from Bartlett and Radford, 2009
17
.  
 
Rugged folding landscapes are a consequence of the need to form the thousands of 
weak, stabilising interactions which are present in the native state
17
.  During the 
structural reorganisations required for the protein to traverse the folding pathway, it is 
not always possible to minimise the energy of all of these interactions simultaneously, 
leading to “frustration” in the landscape19; 20.   Theory predicts that a rough landscape 
will lead to slower folding by limiting the rate at which the protein can find the native 
state
19
.  Recently the effects of solvent viscosity on the folding kinetics of homologous 
domains of α-spectrin were studied, revealing the first explicit experimental evidence 
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that differences in landscape ruggedness can indeed influence folding kinetics of 
structurally homologous proteins
21
.  It has been suggested previously that frustration, 
and hence ruggedness in energy landscapes, arises due to conflicting pressures on 
proteins to evolve sequences which can reliably fold to a stable native structure that is 
also capable of carrying out a defined biological role
19; 20
.  While this may be true in 
some cases, the differences in landscape ruggedness of structurally and functionally 
similar spectrin domains suggest that increased frustration in some domains may act to 
deliberately slow unfolding in this protein which has an unusually long half-life in 
vivo
21
.  Furthermore, folding of the Trp-cage mini protein was shown to be slowed 
when the folding intermediate was destabilised by the presence of chemical denaturant 
or a helix-breaking mutation
22
 suggesting that in this case local energetic minima in the 
folding landscape act to separate the conformational search into multiple, smaller 
problems (reviewed in Brockwell and Radford, 2007
18
).  Whether folding intermediates, 
in general, act to disrupt or promote the folding process is still under debate.  The utility 
of intermediate species in providing insights into the structural regulation of biological 
function, however, as well as their role in initiation of protein aggregation, makes them 
valuable targets of study
23
. 
The landscape theory of protein folding also predicts the existence of “downhill 
folding”, that is, folding in the absence of significant energy barriers14.  In such a 
folding scenario, non-exponential folding kinetics would be observed due to the lack of 
a bottleneck in the pathway and the overall folding time would be expected to approach 
the folding “speed limit” predicted by theory14; 24.  Downhill folding would, in principle, 
allow the direct study of all the intermediate conformations adopted by the polypeptide 
chain en route to the native state, providing a wealth of information about these 
transiently populated species
17
.  Even with the most powerful single molecule 
techniques available, however, unequivocal identification of barrier-less folding is still 
difficult experimentally
25.  Analysis of the folding rates of known “fast-folding” 
proteins suggested that even these extreme examples could still be engineered to fold up 
to ten times faster
24
, in contrast with the expected results for a truly downhill folding 
system
14
.  Use of simulation methods to probe the folding of such fast-folding proteins 
suggested that although, in some cases, no barrier could be identified, many do 
experience energy barriers to folding
26
.  While it is clear that many fundamental 
questions remain to be answered about the folding of globular proteins, recent advances 
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in experimental and computational techniques have provided significant progress 
towards understanding this complex and important biological process. 
 
1.1.2 THE MEMBRANE PROTEIN FOLDING PROBLEM 
In contrast with the wealth of information available on the folding of water-soluble 
proteins, progress in the field of membrane protein folding has lagged significantly
27
.  
In water-soluble proteins, folding is driven by the need to bury hydrophobic side chains, 
in order to prevent aggregation, and facilitate formation of the most stable structure
28
.  
Conversely, the folding of integral membrane proteins is complicated by the need to 
insert the polypeptide chain into a lipid membrane, as well as to fold to the native 
state
27
.  Following insertion, most of the surface of the protein is in contact with the 
hydrophobic membrane interior, with hydrophilic residues restricted to regions which 
contact the polar head-groups of the membrane lipids or being exposed to the aqueous 
environment on either side of the membrane
27
.  Additionally, the membrane 
environment in vivo is highly dynamic and heterogeneous with regions of varying lipid 
composition
29
.  Recreating this environment in vitro has proved more difficult than the 
simple aqueous environment needed to fold water-soluble proteins, and this has greatly 
limited studies on the folding of integral membrane proteins
27; 29
.  Recently, however, 
more research is being focused on understanding the folding, stability and function of 
integral membrane proteins as these proteins represent 60 % of current drug targets and 
have many roles in the cell, including signalling, transport and biogenesis
30; 31
.  In spite 
of recent advances in this field, understanding of membrane protein folding and 
membrane protein structure databases still lag behind those of water-soluble proteins
29
.  
This illustrates the need for research into the underlying principles which govern the 
folding of membrane embedded proteins. 
 
1.2 CLASSES OF MEMBRANE PROTEINS 
The proteins present in biological membranes can be categorised by two distinct 
families: the lipid-anchored proteins, which have a covalently attached fatty-acid moiety 
to associate them with the membrane, and the integral membrane proteins, which 
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contain membrane-spanning regions.  Bacterial lipid-anchored proteins, or lipoproteins, 
are anchored to the membrane via an N-terminal N-acyl-diacylglycerylcysteine
32
 
moiety.  The type and location of these linkers vary in eukaryotic organisms, with 
examples including prenylation, found in the Rab family of monomeric G-proteins
33
, 
and glycophosphatidylinositol (GPI) linkers
34
.   
In contrast with the myriad of lipid linkages available to lipid-associated proteins, the 
integral membrane proteins are constrained by the need to compensate for the energetic 
cost of burying a peptide bond in the lipid bilayer
35
, estimated to be 1.2 kcal/mol
36
.  As 
a consequence of this, it was predicted that membrane spanning regions would form 
regular secondary structural elements in order to maximise the hydrogen bonding 
potential of the peptide backbone
35
.  Formation of secondary structure reduces the 
energetic cost of incorporation of peptide bonds into a bilayer by 0.4 kcal/mol per 
peptide bond for α-helical structure and 0.5 kcal/mol per peptide bond for β-sheet 
structure
36
.  The first α-helical membrane protein structure was solved in 1975 by 
Henderson and Unwin using electron microscopy to generate a three-dimensional image 
of the purple membrane of Halobacterium salinarum
37
.  The resulting 7 Å resolution 
image revealed the structure of bacteriorhodopsin (bR) to be a transmembrane seven 
helical bundle
37
.  The structural resolution has since been increased using X-ray 
crystallography and the most detailed structural information on bR available in the 
Protein Data Bank (PDB) is currently at a resolution of 1.43 Å
38
.  Since the structure of 
bR was elucidated, a wide variety of helical transmembrane structures have been solved 
and deposited in the Membrane Protein Data Bank
39
 showing a diverse range of sizes 
and functions across all organisms.  Some examples are depicted in Figure 1.2. 
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Figure 1.2 Example structures of α-helical integral membrane proteins.  Structures of 
(a) the transmembrane segment of a glycophorin A monomer from human erythrocyte 
membranes solved by NMR spectroscopy (1AFO
40
); (b) bacteriorhodopsin, a 
seven-helical bundle from the purple membrane of Halobacterium salinarum solved by 
X-ray crystallography (1C3W
41
) and (c) calcium ATPase 1 from the sarcoplasmic 
reticulum membrane of Oryctolagus cuniculus, a ten-helical bundle with large 
cytoplasmic domain solved by X-ray crystallography (1IWO
42
).  Proteins are coloured 
rainbow: violet (N-terminus) to red (C-terminus).  The approximate position of the 
membrane is indicated with grey shading with the cytoplasmic side of the membrane 
being represented by the bottom edge of the shaded area.  All images were generated 
from the Protein Data Bank
43
 files from the accession numbers given in brackets using 
UCSF Chimera molecular visualisation application
44
.  
 
In contrast with the ubiquitous distribution of α-helical transmembrane proteins, 
membrane proteins containing β-sheet secondary structure are found only in the outer 
membrane (OM) of Gram-negative bacteria, mitochondria and chloroplasts
45; 46
.  In 
order to satisfy all of the possible hydrogen bonds in the peptide backbone, each β-
strand associates laterally with its neighbours resulting in an overall cylindrical 
topology, known as a β-barrel45.  With predominantly non-polar side chains exposed to 
the hydrophobic membrane interior and each of the backbone hydrogen bonds satisfied, 
the resulting structure has a very high thermodynamic stability
36; 47
. The size of the β-
barrel is highly variable, with known structures containing between 8 and 24 β-strands, 
and the protein may contain periplasmic or extracellular domains
45; 46
.  The regions 
between β-strands often alternate between tight turns on the periplasmic side of the 
membrane and longer, more flexible loops on the outer surface, which are exposed to 
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the external environment
45
.  One almost entirely conserved structural feature is an even 
number of β-strands, with only one known exception to this rule discovered thus far: the 
human mitochondrial voltage-dependent anion-selective channel (hVDAC)
46; 48
.  Some 
examples of β-barrel membrane protein structures are depicted in Figure 1.3. 
 
 
Figure 1.3 Example structures of β-barrel integral membrane proteins.  Structures of (a) 
PagP, an 8-stranded palmitoyl transferase enzyme from Escherichia coli (1THQ
49
); (b) 
the 8-stranded transmembrane domain of OmpA, an ion channel from Escherichia coli 
(1BXW
50
); (c) the 10-stranded OM protease, OmpT, from Escherichia coli (1I78
51
); (d)  
the 12-stranded, colicin-secreting phospholipase A, OmpLa, from Escherichia coli 
(1QD5
52
); (e) the 19-stranded voltage-dependent anion-selective channel (hVDAC) 
from human mitochondria (2JK4
53
) and (f) the 24-stranded translocation domain of 
PapC from Escherichia coli (3FIP
54
).  All structures shown were solved by X-ray 
crystallography.  Proteins are coloured rainbow: violet (N-terminus) to red 
(C-terminus).  The approximate position of the membrane is indicated with grey 
shading with the extracellular face (or cytoplasmic face for hVDAC) represented by the 
top edge of the shaded area.  All images were generated from the Protein Data Bank
43
 
files from the accession numbers given in brackets using UCSF Chimera molecular 
visualisation application
44
.  
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As more and more research is focused on the determination of membrane protein 
structure, a total of almost 400 unique structures have now been reported with both 
α-helical and β-barrel proteins represented55.  Structure determination has been most 
successful using X-ray diffraction of crystallised proteins, although 100 of the reported 
structures were solved by nuclear magnetic resonance (NMR) spectroscopy, 
demonstrating the utility of both techniques in the membrane protein tool box
56
.  While 
integral membrane proteins still account for only 1 % of the protein structures in the 
PBD almost 30 years after the first membrane protein structure was reported, significant 
progress is now being made in this area with more structures being determined every 
year
57
.   
 
1.3 BIOLOGICAL MEMBRANES 
Lipids in cells have three main functions: energy storage, signal transduction and 
forming the matrix of biological membranes – the approximately 30 Å thick layer which 
encloses organelles within the cell, and the cell itself
58
.  The fulfilment of these 
functions depends on the ability of the cell to synthesise a variety of lipid structures (for 
examples, see Figure 1.4), demonstrated by the fact that approximately 5 % of the 
eukaryotic genome is dedicated solely to lipid synthesis
58
.  Cellular membranes are 
composed of polar lipids, which self associate into bilayers to shield the hydrophobic 
regions from the aqueous environment in a process entropically driven by water 
molecules
58
.  The first evidence for the bilayer structure of membranes came in 1925 
when Gorter and Grendel solubilised the lipid components of erythrocytes and 
measured the area covered when the lipids were deposited in a monolayer
59
.  This basic 
model was replaced with the fluid mosaic model of membrane structure in which 
globular proteins can freely diffuse through the two-dimensional membrane in which 
they are embedded
60
.  These simple models view the membrane as being predominantly 
homogeneous, and fail to predict the relatively slow diffusion constants of both lipids 
and proteins within the bilayer
61
.  This observation can be explained using the picket 
and fence model, which suggests that transmembrane proteins anchored to the 
membrane skeleton act to compartmentalise the membrane
62; 63
.  As a result, membrane 
components undergo “hop diffusion” where they are temporarily confined within a 
membrane compartment and undergo infrequent hops to adjacent compartments
62
. 
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The structure and composition of bilayers vary greatly even within an organism, as 
shown in Figure 1.5, allowing variation in the properties of different membranes.  For 
example, the plasma membrane of a eukaryotic cell is enriched with lipids such as 
sphingomyelin and cholesterol (for structures, see Figure 1.4) in order to decrease 
fluidity and resist mechanical stress, while late endosomes contain 
bis(monoacylglycero)phosphate (BMP) to aid in membrane fusion processes
58
. The 
mitochondrial membrane is much more reflective of bacterial membranes, being the 
only eukaryotic membrane to contain cardiolipin
58
.  Modulation of lipid composition to 
adapt to different functional requirements implies the evolutionary advantage of an 
extensive and complex lipid repertoire
58
. 
 
 
Figure 1.4 Example structures of structural lipids found in biological membranes.  
(a) phosphocholine (PC); (b) phosphoethanolamine (PE); (c) phosphoserine (PS); 
(d) phosphogylcerol (PG); (e) phosphatidic acid (PA); (f) phosphoinositol (PI); 
(g) sphingomyelin (SM); (h) cholesterol; (i) bis(monoacylglycero)phosphate (BMP); 
and (j) cardiolipin.  Example chain lengths and saturation are depicted. 
 
In addition to varying lipid compositions, membranes can have either a symmetrical or 
asymmetrical distribution of lipids between the two leaflets of the bilayer.  Examples of 
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symmetrical membranes include the eukaryotic endoplasmic reticulum membrane and 
the inner membrane (IM) of Gram-negative bacteria, while asymmetrical membranes 
include the eukaryotic plasma membrane, endosomal membranes and the OM of Gram 
negative bacteria
32; 53; 64
.  Within a leaflet, favourable interactions between some of the 
lipid components can generate domains of specific lipid compositions, known as lipid 
rafts, which are thought to be involved in localising membrane proteins
58
.  These 
variable properties of biological membranes demonstrate the highly dynamic and 
heterogeneous nature of the lipid environment in which integral membrane proteins 
must insert, fold and function. 
 
Figure 1.5 Lipid composition of different eukaryotic membranes.  The lipid 
composition data (in graphs) are expressed as a percentage of the total phospholipid 
(PL) in mammals (dark blue) and yeast (light blue). As a measure of sterol content, the 
molar ratio of cholesterol (CHOL; in mammals) and ergosterol (ERG; in yeast) to 
phospholipid is also included.  Lipid abbreviations are as follows: phosphocholine (PC), 
phosphoethanolamine (PE), phosphoinositol (PI), phosphoserine (PS), sphingomyelin 
(SM), yeast inositol sphingolipid (ISL), cardiolipin (CL), 
bis(monoacylglycero)phosphate (BMP) and all remaining lipids (R).  Example lipid 
structures are depicted in Figure 1.4.  This figure was adapted from van Meer et al, 
2008
58
.  
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1.4 THE CELL ENVELOPE OF GRAM-NEGATIVE BACTERIA 
The hallmark of Gram-negative bacteria, such as Escherichia coli (E. coli), is the cell 
envelope, which is composed of two lipid membranes enclosing an aqueous 
compartment called the periplasm (Figure 1.6)
64; 65
.  The IM is a symmetric 
phospholipid bilayer composed of approximately 70 % PE, 25 % phosphoglycerol (PG) 
and 5 % or less cardiolipin and forms the barrier between the cytoplasm and the 
periplasm
64; 65; 66
.  There are two types of protein associated with the IM; lipoproteins 
which undergo lipid modifications of the N-terminal cysteine to anchor them to the 
periplasmic face of the IM and the α-helical integral membrane proteins64.  IM proteins 
are responsible for many cellular processes, including lipid synthesis and small 
molecule transport
64
. 
 
 
Figure 1.6 The cell envelope of Gram-negative bacteria.  The cytoplasm of E. coli is 
surrounded by the inner membrane (IM), the periplasm and the outer membrane (OM). 
The IM is a symmetric phospholipid (PL) bilayer containing α-helical membrane 
proteins.  The OM is an asymmetric bilayer of PL and lipopolysaccharide (LPS) and 
contains β-barrel integral membrane proteins.  The periplasm is the aqueous 
compartment between the two membranes where the peptidoglycan cell wall is found.  
Both membranes have associated lipoproteins on their periplasmic faces.  This figure 
was taken from Ruiz et al (2006)
64
.  
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The periplasm is the compartment between the IM and the OM, which comprises 
around 10 % of the total cell volume and contains soluble proteins, as well as a 
peptidoglycan cell wall
64
.  The peptidoglycan layer plays an important role in 
maintaining the shape of the cell and preventing lysis, while the periplasmic proteins are 
involved in maintaining the integrity of the cell envelope
64
.  All of the processes which 
take place in the periplasm are independent of nucleotide hydrolysis, since no adenosine 
triphosphate (ATP) is present in this compartment
64; 67
.  When energy is required, the 
cell relies on complex coupling mechanisms which often use the proton-motive force of 
the IM as the primary energy source
64
. 
In contrast with the IM, the OM is an asymmetric bilayer.  The inner leaflet of the OM 
is comprised of phospholipids and is similar in composition to the IM, however, the PE 
content is enriched compared with the IM
64; 66
.  The outer leaflet of the OM consists of 
lipopolysaccharide (LPS), a glycolipid typically consisting of lipid A, a core 
oligosaccharide and an O-antigen (Figure 1.7)
65; 68
.  The structure of the O-antigen is 
highly variable even within species, with approximately 170 variants being recorded in 
E. coli
69
.  The high number of fatty acid chains on LPS compared with phospholipids, 
and the fact that these chains are saturated, facilitates tight packing of the LPS 
molecules in the OM
68
.  This confers low fluidity to the membrane and it is this 
property that is responsible for the low permeability of the OM
68
.  As a consequence, 
the OM prevents the rapid diffusion of small, hydrophobic molecules and thus 
Gram-negative bacteria tend to be less susceptible to hydrophobic antibiotics than 
Gram-positive bacteria
68
.  As with the IM, integral membrane proteins and lipoproteins 
are associated with the OM but in contrast, the integral outer membrane proteins 
(OMPs) usually have a β-barrel structure45; 64.  The barrel is formed by membrane 
spanning β-strands which are held together by a lateral hydrogen bond network45.  The 
structure of OMPs is discussed in more detail in Section 1.2 and several examples of 
integral membrane protein structures of both classes can be found in Figure 1.2 and 
Figure 1.3. 
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Figure 1.7 Structure of lipopolysaccharide in E. coli.  The structure of the core region 
from K-12 strains is shown.  Abbreviations: EtN, ethanolamine; Gal, D-galactose; Glu, 
D-glucose; Hep, L-glycero-D-manno-heptose; KDO, 3-deoxy-D-manno-oct-2-ulosonic 
acid; P, phosphate.  Taken from Ruiz et al, (2009)
68
.  
 
1.5 MEMBRANE PROTEIN BIOGENESIS IN VIVO 
1.5.1 SYNTHESIS AND TRANSLOCATION 
Approximately 30 % of bacterial proteins function either as secreted proteins or in the 
cell envelope and as such they must be translocated across the IM following their 
synthesis in the cytosol
70
.  The major translocation route in E. coli is the general 
secretion, or Sec, pathway
71
.  The Sec translocase is comprised of a proteinaceous, 
heterotrimeric membrane protein complex, SecYEG, which forms a passive channel 
through the membrane, and a peripherally bound ATPase or ribosome
71
.  The functional 
oligomeric state of the SecYEG complex has been debated due to the failure to detect 
oligomers using chemical cross-linking
71
.  It has since been shown, however, that the 
cross-linking process itself actually interferes with the oligomerisation process
71
.  
Recent data demonstrate that SecYEG dimerisation in a back-to-back manner is 
required for activation of the translocation partner, the SecA ATPase, providing strong 
35 
 
evidence that the SecYEG dimer is the functional state, at least for SecA-dependent 
translocation
71
. 
There are two main targeting pathways to the Sec translocon, the first of which is used 
by IM proteins and occurs co-translationally
70
.  As the nascent chain emerges from the 
ribosome, the hydrophobic transmembrane regions are recognised by the signal 
recognition particle (SRP)
70; 72
.  The SRP interacts with its receptor, which is embedded 
in the cytosolic membrane and through the interaction of the SRP receptor with the 
SecYEG complex, the ribosome-associated nascent chain is targeted to the translocation 
pore
72
.  The nascent chain diffuses through the channel in a manner independent of 
SecA (and hence nucleotide hydrolysis); however, it is coupled to chain elongation by 
the ribosome
72
.  Transmembrane segments insert directly into the membrane via 
opening of a lateral gate in the SecYEG pore
72; 73; 74
, while cytoplasmic domains emerge 
from the ribosome directly into the cytosol without entering the channel
72
. 
The second targeting pathway to the Sec translocon is utilised by secretory proteins and 
many OMPs after completion of translation (Figure 1.8)
71
.  These proteins have an 
N-terminal signal sequence which causes them to be trafficked to the secretion-
dedicated chaperone, SecB
70
.  SecB is a homotetrameric protein which binds to 
unfolded proteins prior to their translocation to prevent aggregation in the cytosol
70
.  
Binding of SecB to the dimeric form of SecA can then occur and allows the transfer of 
the unfolded polypeptide to SecA, which is peripherally bound to the translocation 
channel
70
.  Hydrolysis of ATP by the two nucleotide binding fold (NBF) domains in 
SecA provides the energy required to transfer the polypeptide into the SecYEG channel 
and translocation then occurs by a “pushing” mechanism, although the precise details of 
this mechanism remain unresolved
72
.  A membrane-bound signal peptidase enzyme on 
the periplasmic face of the IM cleaves the signal sequence from translocating 
polypeptides as they emerge into the periplasm
70; 75
. 
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Figure 1.8 A model of post-translational translocation in bacteria.  The protein to be 
translocated is maintained in an unfolded form by the SecB chaperone and is then 
targeted to the SecA ATPase.  SecA is bound to the SecYEG complex and uses ATP 
hydrolysis to provide the pushing force for translocation through the SecYEG pore and 
into the periplasm.  NBF1 is an abbreviation of nucleotide binding fold 1.  This figure 
was taken from Rapoport (2007)
72
.  
 
1.5.2 TRAVERSING THE PERIPLASM 
Following translocation into the periplasm, unfolded OMPs must be protected from 
aggregation, successfully traverse the periplasm including the peptidoglycan layer, and 
then correctly fold and insert into the OM
76
.  These observations suggest that transport 
across the periplasm and membrane insertion are facilitated processes and, indeed, a 
number of periplasmic and OM proteins have been implicated in the OMP assembly 
pathway
76
.  These proteins can be roughly grouped into three categories: proteases, 
chaperones which stabilise unfolded and non-native conformations of their client 
proteins, and folding catalysts, which catalyse rate-limiting steps in folding (Figure 
1.9)
76
.   
Given the range of essential functions carried out by OMPs
46
, it is unsurprising that the 
presence of unfolded OMPs in the periplasm is a strong inducer of the envelope stress 
response
76
.  Exposed C-terminal residues of misfolded OMPs are recognised by the 
PDZ domain of the inner membrane-associated protease, DegS, and cause activation of 
the DegS protease domain
77
.  PDZ is an acronym created from the first letter of three 
proteins which were first identified to contain such domains (post synaptic density 
protein (PSD-95), disc-large tumour suppressor and zonula occludens-1)
78
.  PDZ 
domains share a common structural motif, are commonly found in signalling proteins in 
most organisms and bind to C-terminal regions of client proteins
79
.  Activated DegS 
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triggers cleavage of the transmembrane regulator, RseA, which in turn causes 
transcriptional upregulation of genes of the σE-regulon (Figure 1.10)76; 77.  Using the 
assumption that depletion of periplasmic chaperones will cause an increase is misfolded 
OMPs, identification of many of the known periplasmic folding factors arose by the 
genetic study of bacterial strains showing high σE activity67.   To date, many of the 
studies of the roles of periplasmic chaperones have utilised in vivo depletion of the 
protein of interest. In order to fully understand the interactions of the OMP folding 
factors with their clients, however, more biochemical and biophysical studies are being 
conducted. 
 
 
Figure 1.9 Overview of known folding factors in E. coli OMP biogenesis.  Folding 
factors involved in OMP folding can be divided into OM associated proteins and 
periplasmic proteins.  Periplasmic chaperones have been grouped into proteases, folding 
chaperones and folding catalysts, but some of the proteins have dual functions as 
indicated.  Adapted from Mogensen and Otzen (2005)
76
.  
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Figure 1.10 Activation of the σE stress response by unfolded OMPs.  Under normal 
growth conditions (left), the σE transcription factor is sequestered in a complex with the 
cytoplasmic domain of the inactive protease, RseA.  The membrane-associated 
periplasmic protease DegS is inactive.  Under stress conditions (right), the exposed C-
terminal residues of denatured OMPs activate DegS, which cleaves RseA.  The IM 
protease YaeL (now known as RseP) then cleaves RseA again to release its cytoplasmic 
domain.  Degradation of this RseA fragment by cytosolic proteases such as ClpXP 
releases σE for binding to RNA polymerase and initiates transcription of periplasmic 
chaperones and proteases.  Abbreviations: IM, inner membrane; OM, outer membrane.  
This figure was taken from Mogensen and Otzen (2005)
76
.  
 
1.5.2.1 SurA 
SurA was first identified in 1990 when it was shown to be required for the survival of E. 
coli in the stationary phase
80
.  Initial characterisation described SurA as a parvulin-like 
peptidyl-prolyl isomerase (PPIase) involved in the proper assembly of major OMPs
67; 81; 
82
.  Trypsin digestion of OMPs in surA mutants showed that not all OMPs showed 
increased trypsin sensitivity in the absence of SurA, leading to the conclusion that SurA 
is not an essential folding factor
81
.  However, the amounts of FadL, LamB, OmpA, 
OmpC, OmpF, OmpX and LptD were all found to be lower in surA mutants
83
 and this is 
often a consequence of SurA depletion causing reduced mRNA levels as a result of σE 
induction
83; 84
.  Similar results were obtained using proteomic analysis of surA mutants, 
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which also showed decreased levels of FadL, LamB, OmpA, OmpF, OmpX and LptD 
and an upregulation of proteins under the control of the σE regulon85. 
Crystallisation of SurA revealed a four-domain protein with two PPIase domains (P1 
and P2) sandwiched between the N- and C-terminal domains (Figure 1.11)
86
.  Of the 
two PPIase domains, P1 is packed against the core structure of the N- and C-terminal 
domains and does not show significant activity, while the more active P2 domain 
extends away from the core structure
82; 86; 87
.  Deletion of both PPIase domains did not 
cause a significant loss of SurA function in vivo and the isolated PPIase domains failed 
to complement activity in surA mutants
87
.  This led to the conclusion that the main 
function of SurA is as a chaperone
87
.  Interestingly, mutations which would be expected 
to cause a loss of PPIase function in the P1 domain destabilised SurA in vitro, but 
increased chaperone activity in vivo
88
.  This result suggests a regulatory function of the 
P1 domain and provides an explanation of the lack of PPIase activity displayed by this 
domain
88
. 
 
 
Figure 1.11 Crystallographic structure of SurA from E. coli.  (a) Schematic of the 
domains of SurA: Signal sequence (white), N-terminal domain (blue), PPIase domain 
P1 (green), PPIase domain P2 (yellow) and C-terminal domain (red).  Amino acid 
numbers shown below the schematic correspond to the N-terminal residue of each 
domain.  (b) Ribbon diagram of SurA using the same colour coding as in (a) from PDB 
file 1M5Y
86
 created in UCSF Chimera molecular visualisation application
44
. 
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Binding studies using peptide sequences have been carried out on SurA in vitro, 
revealing a preference for aromatic-rich sequences with an Ar-X-Ar motif
89; 90
.  
Sequences containing this motif bind strongly to SurA with dissociation constants in the 
micromolar range
89
, suggesting that SurA binds preferentially to OMPs due to the above 
average frequency of this motif in OMP sequences, particularly in the C-terminal 
region
83; 91
.  Interestingly, this C-terminal motif is also responsible for activating DegS 
and triggering the σE stress response76; 83.  In contrast with the peptide binding data, very 
few studies have reported binding of full length OMPs to SurA
92; 93
.  The available data, 
however, suggest that unfolded OMPs are bound by SurA in preference to unfolded 
soluble proteins, while folded proteins do not bind
93
.  While the polypeptide binding site 
of SurA has not been identified conclusively, an extended crevice, located in the core 
region, was observed in the crystal structure of SurA and is thought to be the site 
through which SurA:client interaction occurs
86
. 
The work of Sklar and co-workers demonstrated that depletion of SurA caused a loss of 
OM density that was not seen when other periplasmic folding factors, Skp and DegP, 
were depleted
94
.  Additionally, SurA has been shown to be localised at the OM
89
 and is 
the only periplasmic folding factor to have been successfully cross-linked to BamA of 
the β-barrel assembly machine (BAM) complex in vivo94.  It is not yet known, however, 
if SurA binds directly to BamA, or if this interaction is through SurA-bound 
substrates
91
.  Together, these observations have led to the hypothesis that SurA is the 
main chaperone for OMP transport in vivo
94; 95
. 
 
1.5.2.2 Skp 
Although Skp was originally misidentified as a DNA-binding protein, an OMP and an 
LPS binding protein, it is now known that Skp is a periplasmic protein, as evidenced by 
the N-terminal signal sequence which targets Skp for translocation across the inner 
membrane
76
.  Depletion of Skp in vivo led to a moderate reduction of OmpC, OmpF, 
OmpA and LamB in the OM fraction, however, these cells were still viable 
demonstrating that Skp is non-essential
96
.  Further genetic studies revealed that the skp 
surA double mutant is bacteriostatic and that the degP surA double mutant results in a 
synthetic lethal phenotype
95
.  Synthetic lethality describes the situation where a 
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combination of mutations leads to cell death, but single mutations of the same genes 
produce a viable phenotype
97
.  This led to the prevailing hypothesis that the periplasmic 
chaperones Skp and DegP act on a separate, redundant pathway to SurA
95
.  Proteomic 
analysis of the OMPs in a skp mutant suggested that none of the OMPs identified were 
significantly affected by this mutant; however, depletion of SurA in the skp strain 
reduced the levels of almost all OMPs consistent with the parallel pathways 
hypothesis
98
.  While this hypothesis explains many of the observations above, the 
accumulation of protein aggregates in the periplasm of skp degP double mutants 
suggests that Skp may have an important role in maintaining the solubility of OMPs 
prior to folding
99
.  Additionally, skp fkpA double mutants showed defects in the 
assembly of the essential OMP LptD, which could not be compensated by over-
expression of SurA
100
, suggesting that the chaperone pathways in the periplasm may not 
be completely redundant. 
The chaperone activity of Skp was confirmed by the fact Skp can bind readily to 
unfolded OMPs
96; 101; 102
, forming tight complexes with dissociation constants in the 
nanomolar range
101
.  Furthermore, binding to OmpA was shown to occur only within 
the transmembrane domain of OmpA, and not the C-terminal periplasmic domain
96
.  
Analysis of the Skp:OmpA complex by NMR spectroscopy confirmed that the 
transmembrane domain of OmpA is Skp bound, while the periplasmic domain is free in 
solution and can fold independently
102
.  Interaction of unfolded OMPs with Skp is 
thought to occur early after translocation, as evidenced by the cross-linking of Skp to 
PhoE at the periplasmic side of the IM in spheroplasts
103
.  Furthermore, Skp has been 
shown to be required for the release of newly-translocated OmpA from the periplasmic 
side of the IM in spheroplasts
99
, suggesting that the N-terminal residues of the client 
protein may interact with Skp first as they emerge from the translocon.  This hypothesis 
has been confirmed using Förster resonance energy transfer (FRET) experiments which 
showed that the N-terminal residues of OmpC enter the Skp cavity first
104
.  Molecular 
dynamics (MD) simulations also suggested that N-terminal OMP fragments enter the 
Skp cavity while C-terminal OMP fragments do not
104
. 
In solution, Skp is a trimeric protein with a structure that has been described as 
“jellyfish-like” (Figure 1.12a, b)105; 106.  A β-barrel domain forms the body of the 
jellyfish, with long α-helical “tentacles” protruding outwards from the β-barrel105; 106.  
Skp is a basic protein, with a theoretical isoelectric point (pI) around 9.5, a property 
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which has been attributed to its tendency to mislocalise in cell fractionation 
experiments
76
.  The charge distribution of Skp is notable, with many basic residues 
clustered around the tips of the α-helices resulting in a large macrodipole moment 
(Figure 1.12c, d)
105; 106
, suggesting a role of Skp in substrate delivery to the OM.  The 
α-helical domains define a central cavity enriched with hydrophobic residues (Figure 
1.12e, f), which has been hypothesised to be involved in sequestering unfolded 
substrates to prevent their misfolding and aggregation
105; 106
.  Indeed, this has now been 
shown to be correct by both NMR spectroscopy and MD simulation data
92; 102; 104
.  In 
spite of low sequence identity, structural comparisons have been made between Skp and 
prefoldin, a cytosolic chaperone from Methanobacterium thermoautotrophicum, which 
protects partially folded proteins from aggregation and passes its clients to other 
chaperones to promote folding
105; 106
.  Additionally, a putative LPS-binding site was 
identified on the outer edge of the Skp α-helices, similar to an LPS-binding motif found 
on the OMP FhuA
106
.  This finding has led to the suggestion that Skp may act as a stress 
chaperone, acting to rescue OMPs which fall off the SurA chaperone pathway
107
. 
The ability of Skp to prevent aggregation of soluble proteins has also been tested 
against lysozyme
106
 and single chain antibodies
108
, revealing that Skp is able to 
chaperone soluble clients as well as OMPs.  This may point to Skp as a dual-function 
chaperone in the periplasm, which interacts with all unfolded proteins following their 
translocation via the Sec machinery into the periplasm.  In contrast with SurA, no 
common binding motif has been identified for the interaction of Skp with its 
substrates
76
.  Both electrostatic and hydrophobic interactions have been implicated as 
being important in binding
101; 104; 108
, with OMP interactions being shown to rely heavily 
on electrostatic interactions
104
, and soluble client interactions suggested to be driven 
more by hydrophobic interactions
108
. 
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Figure 1.12 Crystallographic structure and surface properties of Skp from E. coli.  Ribbon diagram representing the (a) side and (b) bottom views of 
the Skp trimer with the subunits A, B and C coloured in green, magenta and blue, respectively.  Surface representations of the Skp trimer from the 
(c) side and (d) bottom with electrostatic potential mapped in red (negative) and blue (positive).  Surface representations of the Skp trimer from the 
(e) side and (f) bottom with hydrophobic residues mapped in green.  This figure has been adapted from Walton and Sousa (2004)
106
. 
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1.5.2.3 Other Periplasmic Folding Factors 
While SurA and Skp remain the most studied of the periplasmic folding factors, many 
others have been identified and shown to have varying effects on OMP biogenesis.  
Two disulphide bond isomerases, DsbA and DsbC, have been shown to function 
alongside the IM proteins DsbB and DsbD, respectively
109
.  DsbA and DsbB are 
thought to catalyse initial disulphide bond formation, while DsbC and DsbD act as a 
proof-reading mechanism to rearrange any disulphide bonds which have been paired 
incorrectly
109
.  Disulphide bonds are a rare structural feature in OMPs, particularly in 
the transmembrane domains, leading to the conclusion that DsbA and DsbC most likely 
have little involvement in OMP assembly
76
. 
The PPIase activity of SurA has been shown to be non-essential in vivo, as deletion of 
both domains did not affect OMP biogenesis
87
.  One explanation for this is the presence 
of other PPIase proteins in the periplasm which can interact with OMPs.  Three other 
PPIase enzymes  are currently known: PpiA, PpiD and FkpA
65
.  While PpiA has been 
shown to have the highest activity of these proteins in vitro, its deletion did not have 
any detectable effect on the assembly of OMPs in vivo and, as yet, no evidence has 
directly linked PpiA to OMP biogenesis
65; 76
.  In contrast, deletion of the inner 
membrane-anchored PpiD was reported to cause a reduction in the levels of OmpC, 
OmpF, OmpA and LamB in the OM of the mutant cells and a double ppiD surA mutant 
was reported to be lethal, implicating the involvement of PPiD in OMP folding
65; 76
.  
Later studies did not replicate these findings, however, and the role of PpiD, if any, in 
OMP assembly remains to be elucidated
65
. 
FkpA, like SurA, is an example of a dual PPIase-chaperone folding factor and fkpA null 
mutants have been shown to be viable, but to display increased OM permeability and an 
up-regulation of periplasmic proteases
67
.  Structural studies revealed that FkpA has an 
N-terminal chaperone domain, through which dimerisation occurs forming a v-shaped 
cleft, and a C-terminal PPIase domain (Figure 1.13)
110
.  It has been hypothesised that 
substrate binding occurs in this cleft
110
, however, no data are currently available to 
support this hypothesis.  Until recently, chaperone activity of FkpA had been reported 
only for soluble proteins and the involvement of FkpA in OMP biogenesis was not well 
supported
65; 110
.  Creation of a skp fkpA double mutant by Schwalm and co-workers 
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showed that assembly of LptD is compromised in this strain and has provided the first 
conclusive evidence that FkpA does indeed chaperone OMPs in the periplasm
100
.  
 
 
Figure 1.13 Crystallographic structure of FkpA from E. coli.  Ribbon diagram of the 
FkpA dimer showing the N-terminal chaperone domains (red and orange) through 
which dimerisation occurs and the C-terminal PPIase domains (blue and light blue).  
This figure was created using PDB file 1Q6H
110
 in UCSF Chimera molecular 
visualisation application
44
. 
 
Another example of a dual-function chaperone in the periplasm is the protease-
chaperone DegP which, alongside DegS, belongs to the HtrA family of proteases
76
.  
Temperature changes were initially thought to cause the switch between the two 
activities of DegP, with the chaperone activity being dominant at 28 °C and the protease 
activity becoming dominant at 42 °C
76
.  Structure-function analysis of DegP concluded 
that the resting state of DegP is a hexamer, in which the interactions between subunits 
block the protease sites and the central cavity is large enough to accommodate unfolded 
substrates
111
.  Similarly to DegS, DegP recognises the C-terminal residues of misfolded 
OMPs via its PDZ domains and this was thought to cause structural reorganisation to 
larger proteolytically active oligomers comprised of 12 or 24 DegP monomers
83; 112; 113
.  
Cyro-electron microscopy of DegP in the presence of OmpC revealed a tetrahedral 
arrangement of DegP trimers with the inner cavity filled by a cylindrical area of electron 
density into which the structure of folded OmpC could be modelled (Figure 1.14)
112
.  
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This led to the conclusion that the fate of DegP-bound substrates lies in their ability to 
adopt their native structure within the cavity, as only unfolded substrates can be 
degraded
112
.  Recent data using cage-deficient mutants of DegP, which can only 
associate into trimers, revealed that these mutants are able to bind and degrade 
substrates without the need to form higher order oligomers formation, suggesting that 
cage formation in response to substrate binding may be linked solely to the chaperone 
function of DegP
114
. 
 
 
Figure 1.14 Cryo-electron microscopy structure of dodecameric DegP encapsulating 
OmpC.  A central section of the electron microscopy map of DegP is depicted showing 
three DegP trimers in maroon, orange and gold.  Adjacent PDZ domains interacting 
between neighbouring trimers are shown in cyan and magenta.  Three protease sites are 
shown in green, red and blue and are magnified on the right.  A folded OmpC monomer 
(blue) has been modelled into the electron density in the central cavity.  This figure has 
been adapted from Krojer et al (2008)
112
.  
 
The most recently discovered periplasmic chaperone, Spy, was identified by its induced 
over-expression in bacterial strains expressing unstable periplasmic proteins
115
.  In vitro 
characterisation of Spy revealed it to be an effective chaperone, suppressing aggregation 
and protecting substrates including the IM protein DsbB from inactivation by tannins
115
.  
Spy has a novel α-helical cradle structure, which is unlike that of any known 
chaperone
115
.  It is not currently known if Spy is involved in OMP biogenesis, but the 
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discovery of a previously unknown chaperone only two years ago suggests that there is 
much still to be learned about the complex chaperone network in the E. coli periplasm.  
Additionally, studies on the periplasmic chaperones of Neisseria meningitides (N. 
meningitides) show than SurA deletion causes no detectable OMP assembly defects, 
while deletion of Skp caused lower levels of some porins, but did not affect all 
OMPs
116
.  Complementation of the skp null mutant was not possible using E. coli Skp, 
suggesting that periplasmic chaperones may act in a species-specific manner and that 
generic principles of periplasmic chaperoning may be challenging to understand
116
. 
 
1.5.3 INSERTION INTO THE OUTER MEMBRANE 
Following chaperone-assisted transport across the periplasm, unfolded OMPs must 
insert and fold into the OM, a process which is assisted by the BAM complex in E. 
coli
117
.  The BAM complex (Figure 1.15) is comprised of the OM protein BamA 
(previously YaeT) and four accessory lipoproteins, BamB (YfgL), BamC (NlpB), 
BamD (YfiO) and BamE (SmpA)
107; 117
.  BamA is an essential protein, the depletion of 
which causes an accumulation of aggregated OMPs in the periplasm, leading to cell 
death
118
.  BamA belongs to the conserved Omp85 super-family and was first identified 
in N. meningitides
119
.  Homologues are found also in mitochondria (Sam50) and 
chloroplasts (Toc75)
120
.  All of the homologues identified thus far have a C-terminal 
transmembrane β-barrel domain and a water-soluble N-terminal region117.  Before its 
recent elucidation, the β-barrel domain of BamA was hypothesised to be structurally 
similar to that of FhaC, a secretory protein in Bordetella pertussis
117
.  FhaC forms a 
16-stranded β-barrel with a conserved loop which can fold over the pore to close it121.  
The conserved VRGY sequence at the tip of the loop has been shown to be functionally 
important in FhaC and current evidence suggests that this loop is also functionally 
important in BamA
117; 122; 123.  While the BamA β-barrel is also 16-stranded, the root 
mean squared deviation (RMSD) of the BamA and FhaC β-barrels is greater than 10 Å 
due to the differences in shear number and β-barrel architecture122. 
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Figure 1.15 Structure of the BAM complex.  (a) Schematic of the BAM complex with 
BAM proteins labelled A–E and POTRA domains labelled P1–5 taken from McMorran 
et al (2013)
124
 (b) Crystal structure of N. gonorrhoeae BamA (4K3B 
122
). The β-barrel 
domain is shown in orange. POTRA domains are labelled as in (a) and are shown in 
pink, blue, green, purple and yellow. (c) Crystal structure of E. coli BamB (3P1L 
125
). 
The blades of the β-propeller structure are coloured individually and labelled 1–8. (d) 
Crystal structure of the N-terminal domain of E. coli BamC bound to BamD (2YHC 
126
). BamC is shown in blue and the five TPR motifs of BamD coloured in light blue, 
yellow, green, pink and orange. (e) Lowest energy structure of E. coli BamE solved by 
NMR spectroscopy (2KXX 
127
). Secondary structural elements of BamE are coloured.  
All images were generated from the PDB files from the accession numbers given in 
brackets using UCSF Chimera molecular visualisation application 
44
.  
 
The soluble region of BamA is made up of a varying number of polypeptide transport-
associated (POTRA) domains.  Bacterial BamA homologues tend to have five POTRA 
domains, however, in chloroplasts Toc75 has three POTRA domains and in 
mitochondria Sam50 has only one POTRA domain
117
.  Crystallisation of the four 
N-terminal POTRA domains (POTRAs 1–4) of E. coli revealed that in spite of low 
sequence identity between domains, the overall fold, a 3-stranded β-sheet with 2 
α-helices, is conserved120.  Previous binding studies of BamA revealed a direct 
interaction with unfolded OMPs and peptides mimicking the conserved aromatic-rich 
C-terminal sequence of OMPs
128, while evidence of β-augmentation between POTRA 
domains of neighbouring proteins in the crystal structure suggested a possible 
mechanism for substrate binding
120
.  Deletion of individual POTRA domains from 
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BamA demonstrated that one of the functions of this soluble region is to scaffold the 
lipoproteins which make up the BAM complex alongside BamA
120
.  Interestingly, while 
POTRAs 3–5 are essential for cell viability in E. coli, only POTRA 5 is essential in N. 
meningitides
117
, suggesting differences in the roles of these conserved domains between 
bacterial species. 
Of the four accessory lipoproteins in the BAM complex, only BamD has been shown to 
be essential for cell viability in E. coli, implying an important role in OMP 
biogenesis
117
.  The crystal structure of BamD showed it to be a predominantly α-helical 
protein with five tetratricopeptide repeat (TPR) motifs, which shares structural 
similarity to other proteins which recognise C-terminal targeting sequences
129
.  BamD 
interacts with the BamA POTRA 5 domain
117
 and recent co-crystallisation with the non-
essential lipoprotein BamC revealed that a binding pocket in the N-terminal region of 
BamD is the site of interaction of these two lipoproteins
126
.  A truncated variant of 
BamD was used to demonstrate binding of this lipoprotein to synthetic peptides based 
on the OMP C-terminal targeting sequence, and this interaction occurred at the same 
binding pocket as the interaction with BamC
117; 126
.  Together, these data have led to the 
hypothesis that BamC may act as a regulator of BamD substrate binding
117
.  It was 
recently discovered, however, that regions of the BamC structure are surface exposed in 
intact E. coli cells, an incredibly unusual feature of an E. coli lipoprotein, and the 
functional implications of this observation, as yet, are unclear
130
. 
The most recently discovered of the accessory lipoproteins of the BAM complex is 
BamE.  This lipoprotein associates with the BAM complex via interaction with BamD 
and has been shown to cause only minor OMP assembly defects when depleted
117; 131
.  
NMR spectroscopy revealed that BamE binds preferentially to PG lipids
131
, which have 
been shown to enhance the insertion of OMPs into liposomes in vitro
117
.  These data 
suggest that the role of BamE may be to promote OMP insertion into the OM.  While 
BamC and BamE are associated with BamA via the interaction of BamD with the 
soluble POTRA domains, BamB is associated directly with BamA via POTRAs 2–5117; 
120
.  Although not essential for cell viability, deletion of BamB results in reduced OMP 
assembly and a phenotype similar to SurA depletion mutants
132
.  The crystal structure of 
BamB revealed it to an 8-bladed β-propeller with conserved residues on one face 
corresponding to the BamA interaction site
125; 133; 134; 135
.  Crystal contacts are observed 
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on the outermost β-strands of each blade, suggesting possible substrate interaction 
sites
133
.  In BamB deletion mutants, the OMPs most affected were those with larger 
β-barrels and, thus, it has been suggested that BamB has a role in substrate delivery to 
BamA, perhaps by increasing the substrate binding capacity of the BAM complex
117
.  
Indeed, BamB and BamD have been recently shown to bind to unfolded OmpA and 
BamA in the absence of other BAM components
136
.  Both BamB and BamD accelerated 
BamA assembly into liposomes, however, OmpA folding was not similarly assisted by 
either lipoprotein, suggesting that one role of the BAM lipoproteins is to facilitate 
assembly of BamA
136
. 
Recently, a groundbreaking study was undertaken in which the BAM complex was 
over-expressed and purified as two sub-complexes, then reconstituted in vitro
137
.  The 
complex was found to have a 1:1:1:1 ratio of BamA:B:C:D, but the stoichiometry of 
BamE present could not be determined due to its small size
137
.  The activity of the BAM 
complex was monitored using the folding of the OM β-barrel peptidase enzyme, OmpT 
(Figure 1.3c), whose activity, and hence folding, can be monitored using a fluorogenic 
peptide
138
.  OmpT was denatured in urea and then incubated with SurA before being 
added to a solution of liposomes containing the reconstituted BAM complex, LPS and 
the fluorogenic peptide
137
.  Although OmpT could fold into liposomes in the absence of 
the BAM complex, the rate of assembly was increased in its presence.  Moreover, 
solutions of liposomes containing Bam subcomplexes, BamAB or BamACDE, also 
showed reduced OmpT activity.  The lower rates of OmpT folding seen in experiments 
using BAM subcomplexes, or in the absence of SurA, is consistent with observations of 
reduced viability of bacterial strains which lack either bamB or surA, while cells lacking 
both genes show severely reduced OMP assembly.  These results have led to the 
conclusion that BamB and SurA have similar, but not redundant, roles in vivo
117; 137
. 
Based on all of the data currently available, the leading hypothesis suggests that newly 
translocated OMPs are chaperoned across the periplasm by SurA and delivered to the 
BAM complex (Figure 1.16)
107
.  OMPs which are diverted from this pathway for any 
reason are picked up by the parallel Skp/DegP pathway where they may be degraded or 
refolded
107
.  The mechanism of action of the BAM complex in OMP folding and 
membrane insertion is currently unknown, but several models have been proposed
117
.  
Possible models suggest that substrates are first translocated across the OM before 
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folding into the OM from outside the cell; that the BamA β-barrel acts as a scaffold for 
substrate β-sheet formation following insertion from the periplasmic side of the 
membrane; or that BamA forms multimers which create a pore in the OM into which 
the substrate can insert
117
.  The elucidation of the BamA crystal structure, however, 
shows a large cavity in the β-barrel that is closed on the extracellular side and within 
which a substrate could be accommodated
122
.  Additionally, MD simulation data point 
to the possible existence of a lateral gate in the BamA β-barrel, allowing substrates to 
move from the barrel interior into the membrane
122
.  While the emergence of recent 
structural data has fuelled much progress in the study of OMP biogenesis, the exact 
roles of each of the BAM complex components and their combined mechanism of 
action remain to be elucidated. 
 
Figure 1.16 Schematic of the current model of biogenesis and chaperoning of OMPs in 
E. coli.  OMPs are synthesised on the ribosome before post-translational translocation 
across the IM by the SecYEG translocon.  Unfolded OMPs are then chaperoned across 
the periplasm to the β-barrel assembly (BAM) complex, which aids folding and 
insertion into the OM.  BAM complex proteins are labelled A-E, and the periplasmic 
polypeptide transport-associated (POTRA) domains of BamA are labelled P1-5. 
Horizontal black lines indicate the approximate position of the inner and outer 
membranes.  Taken from McMorran et al (2013)
124
. 
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1.6 FOLDING STUDIES ON OUTER MEMBRANE PROTEINS IN VITRO 
The study of OMP folding in vitro has been pioneered by work on the ion channel 
OmpA (Figure 1.3b) from E. coli, with initial experiments conducted by Schweizer et al 
as early as 1978
139
 demonstrating that OmpA can fold in the presence of LPS and Triton 
X-100 detergent using a combination of sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) and protease digestion.  This study was aided by the 
observation that OMP samples prepared for SDS-PAGE without boiling (cold SDS-
PAGE) migrate such that the folded and unfolded species have different apparent 
molecular weights as a consequence of the high stability of these proteins to 
denaturation with SDS when correctly folded
140; 141
.  It was not until over a decade later 
that Surrey and Jähnig reported folding of OmpA into lipid bilayers
142
, opening the door 
to studies of membrane protein folding that had lagged significantly behind studies of 
soluble protein folding.  OmpA, solubilised in 8 M urea, was shown by these authors to 
insert spontaneously into diC14:0PC small unilamellar vesicles (SUVs) upon rapid urea 
dilution
142
.  Detailed kinetic studies were carried out subsequently by Surrey and 
Jähnig, as well as Kleinschmidt and Tamm, on the refolding of urea unfolded OmpA 
into liposomes using cold SDS-PAGE, far-ultra-violet (UV) circular dichroism (CD) 
and tryptophan fluorescence emission
143; 144
.  Three kinetically distinct phases, as well 
as a rapid phase which manifested through a fluorescence increase upon initiation of the 
folding reaction, were observed
143; 144
.  A scheme for the refolding pathway was 
proposed, beginning with collapse of the protein in the aqueous solution, followed by 
adsorption to the lipid membrane and folding to the native state via a speculative 
partially inserted intermediate (Figure 1.17)
143; 144
.  The observed rates were concluded 
to be slower than would be likely in vivo, even at high temperatures, so the role of 
periplasmic chaperones in folding was implied
144
. 
Development of a method of time-resolved distance determination by fluorescence 
quenching, in which single tryptophan mutants were refolded into bilayers composed of 
brominated lipids, allowed a more detailed analysis of the folding mechanism of 
OmpA
145
.  The results showed that the eight β-strands which make up the OmpA 
β-barrel insert into the membrane at the same time and so the previously suggested 
kinetic scheme was further developed to describe the intermediates as progressively 
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penetrating deeper into the membrane as the β-structure forms and packs together145.  
This provided the first evidence of the concerted nature of OMP folding and membrane 
insertion
145; 146
.   
 
 
Figure 1.17 Proposed mechanism of OmpA folding and insertion into lipid bilayers in 
vitro.  U is the unfolded state, Iw the collapsed state in water, A represents off-pathway 
aggregates, IM1 is a membrane-bound state, IM2 is a partially folded and inserted state, 
and N is the native state.  Black triangles indicate hydrophobic regions.  The timescale 
on which each step in the pathway occurs is indicated.  Taken from Kleinschmidt and 
Tamm (1996)
144
.  
 
Analysis of the effect of membrane thickness on the kinetics of OmpA insertion and 
folding revealed that folding is slowed in large unilamellar vesicles (LUVs) in which 
the length of the lipid hydrocarbon chains is increased from ten to fourteen carbon 
atoms, at which point spontaneous insertion is no longer observed
147
.   When SUVs of 
the same lipids were used, however, insertion was possible into thicker membranes due 
to the higher curvature of the vesicle
147
.  This observation was supported by a study of 
amphipathic helix insertion into single liposomes of different diameters by Hatzakis et 
al, which suggested that high curvature would introduce packing defects that could aid 
insertion
148
.  Kleinschmidt and Tamm suggested that since SUVs are more curved than 
biological membranes, OMPs would only insert into thinner membranes in vivo and this 
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could be a possible mechanism by which OMPs are prevented from inserting into the 
thick bacterial IM following translocation into the periplasm
147
.  The same study also 
investigated the kinetics of secondary structure formation (using far-UV CD 
spectroscopy) and tertiary structure formation (using tryptophan fluorescence), 
revealing second order rate constants that were indistinguishable
147
.  The simultaneous 
formation of secondary and tertiary structure was proposed to be necessary to form a 
hydrophobic surface capable of inserting into the bilayer
147
. 
More recently, measurement of the stability of OmpA has been achieved in several 
membrane mimetic environments
149; 150; 151
.  Finding experimental conditions under 
which membrane protein folding is completely reversible and reaches equilibrium on an 
appropriate timescale is challenging and continues to impede studies on membrane 
protein stability
152
.  Folding of OmpA into SUVs composed of 92.5 % C16:0C18:1PC and 
7.5 % C16:0C18:1PG was reported to be reversible and analysis of the folding reaction by 
both tryptophan fluorescence emission and cold SDS-PAGE revealed good agreement 
between the two techniques, implying a two-state folding mechanism
149
.  Introduction 
of guest lipids into this reversible system allowed the effects of bilayer thickness and 
the extent of lipid acyl chain saturation on OmpA stability to be measured, revealing 
that forces within the bilayer, such as curvature stress, affect thermodynamic stability
149
.  
Kinetic analysis of OmpA refolding into LUVs of varying diameter confirmed the role 
of curvature elastic stress in modulating folding rate, suggesting that irreversibility of 
folding of OmpA in LUVs may be a kinetic trapping effect
153
.   
The established conditions under which OmpA folds reversibility in 92.5 % 
C16:0C18:1PC and 7.5 % C16:0C18:1PG SUVs were utilised to conduct double mutant cycle 
analyses
154; 155
.  The first application of this method was used to probe the interactions 
of residues in the suggested pore region of OmpA, revealing that salt bridge formation 
and rearrangement provide stabilising interactions, but also allow opening and closing 
of the OmpA pore
154
.  Furthermore, replacement of the Glu52-Arg138 salt bridge with a 
disulphide bond not only blocked the pore but also caused growth defects in cells 
subjected to osmotic shock, suggesting that these interactions are functionally relevant 
in vivo
154
.  A second application of this technique was used to probe how the 
interactions between aromatic residues in the intrafacial region of the β-barrel contribute 
to stability
155.  In both α-helical and β-sheet membrane proteins, aromatic residues are 
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enriched in the intrafacial region forming “aromatic girdles”156.  This has been 
hypothesised to be stabilising, based on the partitioning energies of small model 
peptides into a model bilayer from aqueous solution
157
.  Indeed, double mutant cycle 
analysis of OmpA provided the first evidence that in a fully assembled OMP clustering 
of aromatic residues provides a driving force for folding
155
. 
Analysis of OmpA folding in octyl maltoside (Figure 1.18a) micelles showed that, 
although OmpA folding remained irreversible when urea was used as a denaturant, 
reversibility could be obtained using guanidine hydrochloride (GuHCl) as an alternative 
denaturant
150
.  A full kinetic characterisation was undertaken and revealed that OmpA 
folds via a three-state folding mechanism in octyl maltoside, and the calculated 
thermodynamic stability was much higher than that measured in SUVs 
(ΔG°octylmaltoside ≈ -65.2 kJ/mol, compared with ΔG°PC:PG-SUVs ≈ -14.2 kJ/mol), however, 
no explanation has been put forward for this seemingly counterintuitive result
149; 150
.  
This result was confirmed in a subsequent study of OmpA folding into detergent 
micelles of N-lauryl-N,N-dimethylammonium-N-oxide (LDAO, Figure 1.18b), 
revealing that the thermodynamic stability of OmpA in LDAO micelles is comparable 
to that in octyl maltoside micelles (ΔG°LDAO ≈ -60 kJ/mol) and that high kinetic stability 
is a barrier to reversibility studies
151
.  The thermodynamic stability of OmpA in the 
Apol A8-35 (Figure 1.18c) was also measured and found to be much lower than that in 
detergent (ΔG°A8-35 ≈ -8 kJ/mol), and the time taken to reach equilibrium was reduced to 
25 days, compared with 52 days in LDAO
151
.  Due to the low stability of liposomes in 
aqueous solution, incubation on these timescales to achieve equilibrium is not 
possible
158
. These studies clearly demonstrate the utility of alternative bilayer mimics to 
study membrane protein stability and function. 
 
 56 
 
 
Figure 1.18 Structure of selected amphipatic molecules.  Detergents (a) octylmaltoside 
and (b) LDAO, and (c) amphipol A8-35.  Typically, x = 29–34 %, y = 25–28 %, and 
z = 39–44 %.  
 
OmpA has also been used as the model folding system in the first in vitro study of the 
effect of a periplasmic chaperone on OMP folding into bilayers.  Skp (see Section 
1.5.2.2) was shown to solubilise unfolded OmpA in low urea concentrations (≈ 0.4 M) 
and to accelerate OmpA folding into negatively charged SUVs composed of 50 % 
diC18:1PC, 30 % diC18:1PE, and 20 % diC18:1PG, but inhibit folding into zwitterionic 
diC18:1PC  SUVs over a 4 h time-course
159
.  Additionally, pre-binding of the Skp:OmpA 
complex to LPS prior to addition to lipid was shown to promote folding into either lipid 
composition and LPS was suggested to have a role in OMP assembly
159
.  This 
investigation was furthered recently by the inclusion of BamA in the OmpA refolding 
assay.  Full-length BamA incorporated into liposomes increased the folding rate 
constant of OmpA into diC12:0PC LUVs in a manner that was found to be dependent on 
the periplasmic POTRA domains
160
.  While the transmembrane domain of BamA alone 
gave a small, two-fold increase in the folding rate, this was comparable to the rate 
increase seen when FomA, an OMP not implicated in OMP assembly, was incorporated 
into the liposomes.  This suggests that the rate increase observed with the BamA 
β-barrel alone is due to non-specific perturbations of the local lipid environment by the 
incorporated OMP
160
.  This study also showed that incorporation of 20 % diC12:0PE into 
the diC12:0PC LUVs has an inhibitory effect on OmpA folding which was overcome by 
the incorporation of BamA into the liposomes, suggesting how OMPs may overcome 
this inhibition in vivo as the OM is composed of approximately 80 % PE lipids
160
.  
Finally, the effect of BamA on the Skp-mediated folded of OmpA was investigated, 
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revealing that in the presence of BamA the previously observed retardation of OmpA 
folding into zwitterionic bilayers in the presence of Skp is ablated, possibly through the 
interaction of negatively charged patches on the surface of the POTRA domains with 
positively charged Skp
160; 161
.  The available data on OmpA folding has provided 
valuable insights into the forces that govern the folding of OMPs.  Lack of such 
extensive data on other OMPs, however, makes general conclusions hard to draw.   
A recent study by Burgess et al adopted a screening approach using cold SDS-PAGE 
analysis to determine the folding yield of nine different OMPs (OmpX, OmpW, OmpA, 
PagP, OmpT, OmpLa, FadL, Omp85 (BamA) and OmpF) under different conditions
162
.  
The effects of pH, temperature, vesicle size and lipid composition were investigated, 
revealing that, in general, folding yield was increased by using higher pH, lipids with 
shorter acyl chains and smaller vesicle diameter.  A single condition to maximise the 
folding yield of all nine OMPs could not be identified, however
162
.  In previous studies, 
higher temperatures were reported to increase the folding yield of both OmpA
144
 and 
FomA
163
, however, increasing the reaction temperature had varying effects on the 
folded yield of the nine different OMPs
162
.   For example, higher temperatures 
decreased the folding efficiency of OmpX, increased the folding efficiency of PagP, and 
had little effect on the folding efficiency of OmpW
162
.  This variation was proposed to 
arise from the different aggregation propensities of these OMPs at higher 
temperatures
162
.  Sedimentation velocity analytical ultra-centrifugation was employed to 
determine the aggregation propensities of the nine OMPs in the urea-unfolded state 
revealing varied results which did not correlate well with folding efficiency
164
.  Some 
trends were observed, however, showing that the presence of salt and lower pH increase 
self-association, while the presence of ≥ 4 M urea kept all the OMPs in a monomeric 
state
164
.  A thorough screen was then conducted to establish conditions for the reversible 
folding of OmpLa, which was attained using 100 mM citrate, pH 3.8 in diC12:0PC LUVs 
at 37 °C
165
.  These conditions also allowed reversible folding of PagP and OmpW, but 
not the other OMPs studied.  Other studies providing useful information on the folding 
of OMPs into liposomes in vitro have not been discussed in detail here, however, a 
summary is provided in Table 1.1. 
  
 
5
8
  
Protein Notes Techniques Used Selected References 
OmpA Folding studies of OmpA are described in detail in Section 1.6 See Section 1.6 
Kleinschmidt 
(2006)146 
PagP 
Folding studies of a C-terminally his-tagged construct of PagP (HT PagP) 
are described in detail in Section 1.8.2 
See Section 1.8.2 
Bishop et al (2000)166 
Ahn et al (2004)49 
Huysmans et al 
(2010)167 
hVDAC 
Human voltage-dependent anion-selective channel (hVDAC) can be folded 
to the native state in LUVs composed of lipids of varying acyl chain length 
(diC10:0PC to diC18:1PC).  Folding yield was estimated to be 94 % in 
diC12:0PC LUVs.  Secondary structure content of VDAC in diC12:0PC LUVs 
was not affected by changing pH from 7.0 to 3.0. 
SDS-PAGE, far-UV CD, 
Trp fluorescence, sucrose 
density gradient 
centrifugation and 
proteolysis 
Shanmugavadivu et al 
(2007)168 
FomA 
FomA can be folded to the native state in both diC10:0PC and diC18:1PC 
(LUVs and SUVs).  Kinetic analysis of folding into diC10:0PC and diC18:1PC 
SUVs suggested that FomA folds via parallel pathways into both lipids.  The 
folding halftime is dependent on acyl chain length and reaction temperature. 
SDS-PAGE, Trp 
fluorescence, far-UV CD 
Pocanschi et al 
(2006)163 
OmpG 
The porin OmpG reconstituted in native E. coli lipids is gated by 
conformational changes in extracellular loops in a pH-dependent manner 
(closed at pH 5.0). Unfolding under force reveals each β-hairpin unfolds 
individually. Refolding from this mechanically unfolded state also proceeds 
by sequential folding of individual β-hairpins. 
Atomic force 
miscroscopy (AFM) 
Sapra et al (2009)169 
Damaghi et al 
(2010)170 
Mari et al (2010)171 
Damaghi et al 
(2011)172 
OmpF 
Refolding of urea-solubilised OmpF into diC14:0PC SUVs occurred at only 
15 % yield.  Refolding kinetics were biphasic but much slower than OmpA.   
SDS-PAGE, Trp 
fluorescence, far-UV CD 
Surrey et al (1996)173 
Table 1.1 Summary of in vitro folding studies of OMPs into lipid bilayers. 
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1.7 FOLDING STUDIES ON PROTEIN FAMILIES: USING A COMMON TOPOLOGY TO 
FIND GENERIC PRINCIPLES 
The OMP folding screens undertaken by the Fleming group
162; 164; 165; 174
 are the first 
examples of comparative folding studies on a family of membrane proteins, however, 
the study of homologous proteins has been widely utilised in the field of protein folding.  
This approach has yielded valuable insights into the role of protein topology, amino 
acid sequence and secondary structure propensity on folding mechanism
175
.  Following 
the detailed characterisation of the folding mechanism of the engrailed homeodomain 
(En-HD), four other members of the homeodomain-like super-family, c-Myb, hRAP1, 
Pit1 and hTRF1 were studied
13; 176
.  This revealed that the mechanism varied from a 
pure “framework” mechanism (En-HD, Figure 1.19a) to a pure nucleation-condensation 
type mechanism (hTRF1), with the other proteins studied exhibiting mixed folding 
mechanisms
13; 176
.  A similar scenario was seen in the peripheral subunit-binding 
domain superfamily and, as with the homeodomain-like superfamily proteins, the 
observed folding mechanism is determined by the inherent stability of individual 
secondary structural elements
175; 177
. 
Like the homeodomain-like proteins, spectrin domains also have an α-helical bundle 
topology and display varied folding mechanisms
177
.  The spectrin domains R15, R16 
and R17 (Figure 1.19b) have approximately 30 % sequence identity and similar 
thermodynamic stabilities, however, R15 folds around a thousand times faster than R16 
and R17
21
.  This observation could not be explained by simulation data or by 
characterising the transition state for folding, as all three domains showed transition 
states with similar structure and stability
175
.  Instead, this difference was caused by 
increased folding landscape ruggedness, or internal friction, in the R16 and R17 
domains
21
.  By grafting the core of the R15 domain into R16 and R17, which was 
possible due to the nearly identical structure of these proteins, the internal friction of the 
latter domains was reduced and folding rate increased dramatically
21
. 
Differences in the kinetic profiles of related proteins do not always indicate a different 
folding pathway.  For example, the bacterial immunity protein Im9 folds through a 
simple two-state pathway while its homologue, Im7 (Figure 1.19c), shows three-state 
folding via a populated intermediate
178; 179
.  In spite of this difference, the 
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characterisation of the rate-limiting transition states of both proteins revealed that the 
transition states are remarkably similar overall
179
.  Both transition states are compact 
and have three of the native helices formed.  In the case of the Im7, however, the 
transition state was more conformationally restricted
179
.  The hypothesis that the two 
proteins fold via the same pathway was confirmed by using protein engineering on Im9 
to mimic the non-native interactions which stabilise the Im7 folding intermediate
180
.  
This resulted in a shift to a three-state folding mechanism of Im9, as the engineered 
stabilising interactions lowered the energy of the intermediate species on the folding 
pathway sufficiently for it to become significantly populated.  Furthermore, the three-
state folding variant of Im9 folded approximately twenty times faster than wild-type 
Im9, indicating that intermediate formation can increase folding rate even if non-native 
contacts are made
180
. 
Proteins with an all-β, immunoglobulin-like (Ig-like) fold have a characteristic “Greek-
key” topology, with varying numbers and arrangements of β-strands, but there is low 
sequence identity between families
175
.  Characterisation of the transition states of 
members of the fibronectin type III (fnIII) family revealed a highly conserved “obligate 
nucleus” between four hydrophobic residues from neighbouring β-strands177.  
Formation of this nucleus is required to initiate correct folding of the complex folded 
topology of these proteins, and only one Ig-like domain, CAfn2, was identified which 
lacked this domain
177
.  Analysis of the transition state of this protein revealed that the 
nucleus was in fact still present, but had “slipped” down to an adjacent set of 
hydrophobic residues
181
.  The evolutionarily unrelated Ig-like domain titin I27 (Figure 
1.19b) was also found to have an obligate nucleus of structurally similar residues to 
those in the fnIII domains; however, I27 was also found to have an alternative folding 
pathway through a second obligate nucleus revealing the malleability of the folding 
pathways in Ig-like proteins
182
. 
Overall, the “fold approach” to studying protein folding mechanisms has been a useful 
tool for the understanding of the folding of soluble proteins.  By selecting common 
topologies and evaluating the similarities and differences in the folding kinetics and 
structural mechanisms, many valuable insights have been gained
175; 177
.  The application 
of this approach to the folding of membrane proteins will be critical in understanding 
the underlying principles in this challenging field. 
  
61 
 
 
 
Figure 1.19 Structures of selected members of protein families which have been the 
subject of comparative folding studies.  (a) Engrailed homeodomain (En-HD, 2JWT
183
) 
coloured violet (N-terminus) to red (C-terminus); (b) domains R15 (red), R16 (yellow) 
and R17 (blue) of α-spectrin (1U4Q184); (c) Im7 with helix I coloured red, helix II 
coloured yellow, helix III coloured green and helix IV coloured blue (1AYI
185
) and 
(d) titin I27 (1TIT
186
) coloured violet (N-terminus) to red (C-terminus).  All images 
were generated from the Protein Data Bank
43
 files from the accession numbers given in 
brackets using UCSF Chimera molecular visualisation application
44
.  
 
1.8 APPLICATION OF PROTEIN FOLDING METHODS TO THE STUDY OF MEMBRANE 
PROTEIN FOLDING 
In recent years, many techniques have been developed to study the folding of water-
soluble proteins yielding a near-atomistic view of the folding landscapes of these 
proteins
17
.  In contrast, the experimental toolbox for the study of membrane protein 
folding thus far has been more limited, with fewer techniques successfully employed, 
often due to the interference of the membrane mimetic with spectroscopic signatures 
and the small differences in spectroscopic signals between the folded and unfolded 
states
187
.  Much of the information available on membrane protein folding is the result 
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of simple techniques such as cold SDS-PAGE, tryptophan fluorescence emission and 
far-UV CD on a limited subset of proteins, as indicated by the studies summarised in 
Section 1.6 and Table 1.1.  In spite of the challenges faced, new methodologies are 
continually being developed to aid the study of membrane protein folding. 
The use of NMR spectroscopy to study residual structure in the unfolded ensemble of 
water-soluble proteins has revealed significant deviations from a random coil structure, 
for example in hen egg-white lysozyme
188
 and in Im7 both under denaturing
189
 and 
non-denaturing conditions
16
.  It has been suggested that this residual structure is 
important in initiating folding by facilitating collapse of the polypeptide chain, and 
regions of residual structure in the natively unfolded variant of Im7 have been shown to 
correspond to the helices in the folded state
16
.  This approach has been applied to the 
urea-denatured state of OmpX, revealing that the protein is globally unfolded but has 
two regions of non-random structure: one hydrophobic cluster and one helical region
190
.  
Analysis of peptides corresponding to these regions showed independent binding of the 
clusters to detergent micelles suggesting a role of residual structure in the initiation of 
folding and membrane-insertion
191
.  The application of NMR spectroscopy to folded 
membrane proteins is complicated by the need to find a suitable membrane mimetic 
environment.  Detergent micelles are widely used; however, problems with long term 
stability and maintaining proteins in a functional state are commonly encountered
192
.  
As a result, development of alternative non-micellar systems to stabilise the folded state 
of membrane proteins has become an active research area
192; 193; 194
.   
Protein engineering methods have been the most successful in probing the folding 
mechanisms of membrane proteins, having been used on the IM proteins bR
195; 196
 (see 
Section 1.8.1) and DsbB
197
 as well as the OMP, PagP
167
 (see Section 1.8.2).  Φ-value 
analysis is a powerful protein engineering technique, which can be used to map the 
formation of contacts in the transition states and intermediates formed during protein 
folding (Figure 1.20)
198; 199; 200
.  Specific side chain interactions are deleted via strategic 
mutations, and the effect of these on the kinetic and thermodynamic parameters of the 
variant protein is measured and compared with wild-type
200
.  The mutation causes a 
change in the free energy of activation (kinetic) and the equilibrium (thermodynamic) 
free energy of the folding reaction.  The ratio of these changes is the Φ-value, which is 
usually between 0 and 1, and gives a measure of the change of stability of the transition 
state (or intermediate), compared with the change in stability of the native state
200
.  Both 
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stabilities are measured relative to the denatured state, whose energy is assumed to be 
unaffected by the mutation
200.  Φ-values close to zero indicate that the transition state is 
unfolded in the region of the amino acid substitution, while higher Φ-values indicate 
that the region is folded in the transition state
198; 199
.  Partial Φ-values are also observed 
and can be interpreted in several ways, for example, that native contacts have partially 
formed in the transition state or that multiple folding routes exist
200
.  Φ-values can 
provide a wealth of information on the structure of the transition state and hence the 
folding mechanism of the protein
200
.  Furthermore, the use of experimental Φ-values as 
constraints in protein folding simulations allows atomistic models of these ensembles to 
be created
201
.  The main stumbling block for the application of this analysis is the need 
to find experimental conditions that promote reversible folding for the protein of 
interest, which has proved difficult for many membrane proteins
48; 150; 165
.  Another 
potential pitfall of this technique is the relevance of measuring the equilibrium between 
folded and membrane inserted protein with unfolded protein in aqueous solution since it 
is not known if this equilibrium is likely to exist in vivo.  It should be noted, however, 
that water-soluble proteins which do not unfold during their lifetime in the cell do exist 
and have been studied by kinetic and thermodynamic methods
202; 203; 204
. 
A promising approach for the study of transiently populated folding intermediates 
involves the use of a laser pulse to generate hydroxyl radicals (HO•) from a dilute 
solution of hydrogen peroxide (0.04 %)
205.  Exposure to HO• causes labelling of solvent 
accessible side chains at reaction rates close to the diffusion limit
205
.  Laser pulses can 
be reduced to a duration of approximately 1 μs, allowing characterisation of rapid 
conformational changes
205.  Following HO• labelling, tryptic digestion and subsequent 
mass spectrometry analysis provides information on the protein conformation at the 
time the laser pulse was initiated
205
.  This approach has been used successfully to study 
the dynamics of apo-myoglobin revealing structural flexibility of helix F
206
 and the 
conformation of the intermediate in acid-induced myoglobin unfolding revealing a 
molten globule state
207
. It has also been used to study the temperature induced folding 
of barstar, which indentified a cluster of residues involved in folding nucleation by their 
decreasing oxidation levels in the initial stages of folding
208
.  This technique has also 
been used to probe the conformation of bR
209; 210
 as described in Section 1.8.1. 
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Figure 1.20 Schematic of the principles of Φ-value analysis.  (a) A mutation (shown as 
a red dot) is made in a region of the protein which is native-like in the transition state 
(‡) leading to equal destabilisation of ‡ and the native state (N) resulting in a Φ-value of 
1 or (b) a mutation is made in a region of the protein which is unfolded in ‡, leading to 
destabilisation of N only and a Φ-value of 0.  It is assumed that the mutation does not 
affect the energy of the unfolded ensemble (U).  Abbreviations:       
  refers to the 
difference in the free energy change of folding upon mutation,       
  refers to the 
difference in the free energy change between U and ‡ upon mutation,       
 
 refers to 
the difference in the free energy change between N and ‡ upon mutation and ku is the 
unfolding rate constant.  This image was adapted with permission from Dr Gerard H. M. 
Huysmans (Institut Pasteur).  
 
Another recently developed technique to probe protein folding is pulse proteolysis, 
which exploits the increased susceptibility of unfolded proteins to proteolytic digestion 
compared with that of folded proteins
211
.  This method uses SDS-PAGE to quantify the 
digestion, circumventing the need to have large differences in spectroscopic signals 
between the native and unfolded states
211
.  Additionally, small quantities of protein are 
required and the analysis can be carried out on crude protein samples compared with the 
large quantities of pure protein required for biophysical analysis
211
.  This method was 
first tested on RNase H and the resulting free energy of unfolding was comparable to 
that calculated using far-UV CD as a folding probe
211
.  Additionally, pulse proteolysis 
can be used to probe ligand binding.  The stability of maltose binding protein was 
calculated in the presence and absence of maltose, and the change in free energy of 
unfolding used to calculate the binding free energy and dissociation constant of the 
complex.  This yielded values in excellent agreement with those calculated by 
  
65 
 
fluorescence titration methods
211
.  Recently, pulse proteolysis has been used to probe 
the stability of bR
212
 as described in Section 1.8.1. 
 
1.8.1 BACTERIORHODOPSIN 
bR is a seven-helical bundle protein, which functions as a proton pump in the purple 
membrane of Halobacterium salinarium (Figure 1.2b)
213
.  Oesterhelt and Stoeckenius 
successfully isolated bR in 1971, identifying the retinal co-factor
214
 and went on to 
show that retinal binding is reversible
215
.  In the early 1980s, Khorana and co-workers 
showed for the first time that bR denatured using SDS could be refolded to the native 
state in vitro, the first time this had been achieved with a membrane protein
216; 217
.  The 
ability of soluble proteins to refold from a denatured state was demonstrated twenty 
years previously by Anfinsen’s experiments on RNase A4, illustrating how knowledge 
of membrane protein folding lags behind that of soluble proteins.  Work by Popot and 
colleagues found that chymotrypsin-cleaved bR formed two fragments – one composed 
of helices A and B and the other of helices C–G, and these could be reconstituted into 
separate liposomes
218
.  Following liposome fusion, the two fragments re-associated, 
bound to retinal and regenerated the cleaved bR structure.
218
  This work led to the 
proposal that folding of bR follows a two step model where the helices form and then 
associate
29
.  This model assumes that each helix can form stable secondary structure in 
isolation.  The study of the stability of isolated bR helices in phospholipid vesicles, 
however, has shown that not all of the helices are independently stable, suggesting that 
simultaneous formation of secondary and tertiary contacts is required for the protein to 
fold
29; 219
. 
Kinetic analysis of SDS-denatured bR (bacterioopsin, bO) revealed that although bO 
retains approximated 42 % helical structure in the denatured state, its refolding kinetics 
are multiphasic
220
.  Refolding in the absence of retinal occurs via three exponential 
phases to yield a non-native apo-protein containing helical content equivalent to seven 
α-helices220.  When retinal is added, a further two exponential phases are seen which are 
attributable to the non-covalent then covalent binding of this co-factor
221
.  Formation of 
the helices to yield the apo-protein is found to be the rate-limiting step, and this process 
can be slowed by increasing the proportion of diC14:0PC in the mixed micelles into 
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which folding takes place to increase their rigidity, or by increasing the pH
222
.  This 
effect was also observed also in lipid bilayers as increasing the amount of PE lipids 
present in PC vesicles slowed bR folding and this was proposed to be due to the 
increased lateral pressure in the chain region of the membrane either slowing insertion 
or slowing rearrangement of the inserted helices
223
. 
A complete thermodynamic and kinetic analysis was undertaken in mixed micelles of 
3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) and diC14:0PC 
for denaturation from the folded state of bR to a partially unfolded retinal-bound state 
using SDS
224
.  The natural logarithm of the folding and unfolding rate constants in 
different concentrations of SDS were found to give a chevron plot with linear folding 
and unfolding branches over the limited range of SDS concentrations used in the 
experiment.  The results are consistent with the two-state assumption (Figure 1.21)
224
.  
It should be noted, however, that a long extrapolation is required to obtain the folding 
and unfolding rate constants in the absence of SDS
224
.  In spite of the experimental 
limitations, this study showed a reversible unfolding transition of bR, with an associated 
large free energy change of approximately 83 kJ/mol
224
.   
Using the reversible folding conditions found in this study, a Φ-value analysis of bR 
was carried out by conducting an alanine scan on helix B
195
 and helix G
196
 (Figure 
1.22).  In helix B, most of the calculated Φ-values were close to one, indicating that this 
region of protein is highly structured in the transition state, with many native contacts 
having formed
195
.  Two residues with lower Φ-values were observed, Y43 and T46, 
where helix B packs on to other helices in the native state
195.  The fractional Φ-values 
observed in these positions suggest partial formation of tertiary structure at these 
residues in the transition state as the helices begin to pack together
195
.  In contrast, the 
Φ-values in helix G were mostly close to 0 indicating that this helix is mostly 
unstructured in the transition state and suggests folding is polarised with the N-terminal 
helices folding first
196.  Double mutant cycle analysis revealed that the low Φ-value at 
T46 is due to a missing hydrogen bond with neighbouring helix C and missing 
hydrogen bonds were also found between helices F and G, most likely due to the lack of 
structure in this region
196
.  While this study paved the way for further application of this 
technique to integral membrane proteins, the results concentrate mostly on two 
neighbouring helices and do not give a full picture of the transition state for folding of 
bR. 
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Figure 1.21 The linear chevron plot obtained for the folding and unfolding of 
bacteriorhodopsin.  The natural logarithm of the observed folding (open squares) and 
unfolding (open circles) rate constants (ln kobs) is plotted against the mole fraction of 
SDS (χSDS) and fitted to a two-state equation.  Non linear refolding from bO390 (inset, 
filled squares) is observed.  This figure is taken from Curnow et al, 2007
224
. 
  
The four helix bundle DsbB has also been subjected recently to a Φ-value analysis in 
mixed n-dodecyl-β-D-maltopyranoside (DDM)/SDS micelles based on kinetic 
measurements
197; 225
.  Kinetics were thought to represent a three-state process with a 
reaction intermediate, and assume the reaction reaches equilibrium in the timescale 
used
225
.  Twelve mutations were made throughout the structure of DsbB and used to 
investigate the structure of the rate-limiting transition state, which leads to the formation 
of the folding intermediate
197.  The Φ-values obtained, in general, are close to 0 
indicating a lack of structure in this transition state, however, three higher Φ-values 
clustered on one end of the helices suggest polarisation in the transition state similar to 
that seen for bR
197; 226
. 
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Figure 1.22 Schematic of the transition state structure of bacteriorhodopsin from 
Φ-value analysis.  Alanine scanning revealed that in the transition state (top left) helix B 
is mostly helical as in the native state (top right) while helix G is mostly unstructured.  
Helix B inserts into the membrane earlier than helix G in vivo (bottom).  Regions with 
Φ-values close to 1 are shown in red, regions with Φ-values close to 0 are shown in blue 
and undetermined Φ-values are grey. Helices B and G are shown outlined in bold. The 
cytoplasmic side is at the top and extracellular side at the bottom of the diagram.  This 
figure was taken from Booth (2012)
226
.  
 
The technique of pulse proteolysis (described in Section 1.8) has also been used to study 
the folding of bR
212
.  The results were compared with those obtained when using the 
absorbance at 560 nm (A560), which reports on the retinal co-factor, as a probe.  These 
studies demonstrated good agreement between the two techniques
212
.  Refolding using 
pulse proteolysis revealed a large hysteresis suggesting that bR does not refold on this 
timescale as had been previously suggested by Curnow and Booth
224; 227
.  In fact, the 
refolding rate constant was approximately forty-fold lower than that reported at the 
same mole fraction of SDS, a discrepancy arising from experimental differences.  In the 
pulse proteolysis method the mole fraction of diC14:0PC/CHAPS was kept constant as 
SDS was varied, however, in the Booth method the mole fraction of diC14:0PC/CHAPS 
was allowed to vary as SDS varied
224; 227
.  Even at very high concentrations of 
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diC14:0PC/CHAPS, the pulse proteolysis method resulted in much lower folding and 
unfolding rate constants and suggested that the previous analysis may have been 
performed without reaching a true conformational equilibrium
224; 227
. 
Studies of folding, whether followed using Φ-values and traditional spectroscopic 
techniques or using newer techniques such as pulse proteolysis, provide an indirect view 
of the transition state for folding.  Direct methods to probe transiently populated species 
have been used to study bR with some success.  Hydrogen-deuterium exchange in 
conjunction with double mutant cycle analysis was used to probe the effect of mutations 
which disrupt hydrogen-bonding in bR, revealing that stabilisation from hydrogen-
bonding is weak and up to 4 % of the possible hydrogen bonds in the core of the 
membrane-spanning region are unsatisfied
228
.   
One major drawback with hydrogen-deuterium exchange is the back-exchange of 
protons following the quenching step
229
, which can be circumvented using covalent 
labelling techniques.  Many covalent labels react too slowly to be effective in the study 
of transiently populated species
205
, however, the use of hydroxyl radicals as described in 
Section 1.8 allows the study of these species.  Interestingly, when bR in native purple 
membrane was studied using oxidative labelling, methionine residues were selectively 
labelled in contrast with the labelling behaviour of soluble proteins which was shown to 
be much less specific
209
.  Three solvent-exposed methionine residues were extensively 
labelled, while the remaining six methionine residues showed much lower levels of 
oxidation consistent with the native structure of bR
209
.  This analysis was then repeated 
under denaturing conditions using SDS, low pH or heat
210
.  Under acidic conditions, the 
labelling pattern was unchanged from native bR, consistent with crystallography data
210
.  
SDS and heat denaturation produced similar results showing almost complete 
deprotection of helix A and partial deprotection of helix D
210
.  Following hydrolysis of 
the chromophore in the SDS-denatured state, refolding of bO was initiated and the 
extent of labelling of this refolded conformation examined
210
.  In refolded bO helix A is 
protected from oxidation as in refolded bR, however, in helix D some labelling is 
observed in bO suggesting a role of chromophore binding in the stabilisation of this 
helix
210
.  While this technique has not yet been widely applied to membrane proteins, 
the work on bR demonstrates the potential of this method to probe structural changes 
within membrane proteins. 
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1.8.2 PAGP 
1.8.2.1 Structure and Catalytic Activity 
PagP is a palmitoyl transferase enzyme, which transfers a palmitate chain from a 
phospholipid to hexa-acylated lipid A (Figure 1.23) and helps to reinforce the structure 
of the OM
230
.  Additionally, modification of lipid A has been shown to help pathogenic 
bacteria evade recognition by the host immune system and attenuate the inflammatory 
response to endotoxin
230
.  PagP is an OMP from E. coli that forms an 8-stranded 
β-barrel with a 19-residue amphipathic α-helix at its N-terminus (Figure 1.3a)49; 231; 232.  
The structure of PagP was originally solved by NMR spectroscopy in 
dodecylphosphocholine/n-octyl-β-D-glucoside detergent micelles showing a well-defined 
β-barrel with structural flexibility of the extracellular loops, particularly L1231.  The 
position of the N-terminal α-helix could not be defined in this structure231.  The 
subsequent crystallisation of PagP in LDAO micelles determined that the α-helix lies 
along the interface of the membrane with the aqueous environment and is packed 
against the β-barrel49.  In both structures, the β-barrel is tilted by approximately 25° to 
the membrane normal
49; 231
, a membrane position stabilised by the interactions of the 
aromatic girdles with the membrane intrafacial region (Figure 1.24a)
233
. 
In PagP homologues, the residues histidine-33, aspartate-76 and serine-77 are 
absolutely conserved and have been shown to be important for catalytic activity
231
.  
These residues are found at the extracellular face of the PagP β-barrel (Figure 1.24b) 
where they are positioned to interact with the polar head-groups of LPS molecules in 
the outer leaflet of the OM
231
.  In both the NMR and crystal structures this region is not 
well resolved due to high conformational flexibility
49; 231
, however, upon lowering the 
temperature in the NMR spectroscopy experiments a second conformer of PagP was 
observed in which this region becomes more structurally defined
234
.  It was postulated 
that switching between these two states may be a feature of the catalytic cycle of PagP 
in vivo
234
. 
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Figure 1.23 Transfer of a palmitate chain to lipid A by the acyltransferase enzyme, 
PagP.  A palmitate chain is transferred from the sn-1 position of a phospholipid 
(phosphoethanolamine (PtdEtn) in the above depiction) to Re endotoxin, the simplest 
form of LPS in E. coli.  The transferred chain is shown in red.  This figure was taken 
from Bishop (2005)
230
.  
 
The interior of the PagP β-barrel is unusual in that the upper half of the barrel is lined 
with hydrophobic residues and water molecules are completely excluded while the 
lower half is lined with polar side chains in a more typical manner
49
.  In both crystal 
structures reported to date, the hydrophobic pocket of the β-barrel is occupied by a 
single detergent molecule with the polar head-group facing the extracellular 
environment and the acyl tail nestled in the barrel (Figure 1.24b)
49; 232
.  The hypothesis 
that this hydrophobic pocket represented the palmitate transfer site was confirmed by 
the use of LDAO to inhibit the catalytic activity of PagP
49
.  In contrast, the inclusion of 
bulky detergents did not affect PagP catalytic activity, presumably as they cannot fit 
into the binding pocket
49
.  Mutation of glycine-88, which forms the floor of the cavity, 
to the larger residues cysteine or methionine changed the specificity of PagP to 
preferentially transfer shorter chain lipids
49
.  Using the G88C mutant of PagP, a method 
was developed to alkylate this residue in a site specific manner so the substrate 
specificity of PagP could be altered
235
.  Using this technique to introduce different 
carbon chain lengths on cysteine-88, it was possible to create PagP variants which were 
highly specific for C12, C11 and C10 acyl chains, revealing that the substrate 
recognition mechanism of PagP is using a “hydrocarbon ruler”236. 
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Figure 1.24 Ribbon diagrams of PagP highlighting structural features.  (a) Ribbon 
diagram highlighting the position of tryptophan residues (blue) in PagP and (b) ribbon 
diagram highlighting the position of the bound LDAO molecule (green space fill) in the 
centre of the barrel with the conserved residues histidine-33 (purple), aspartate-76 
(orange) and serine-77 (red).  Side chains are shown using stick representation.  The 
approximate position of the OM is shown by black bold lines.  Images were generated 
from the Protein Data Bank
43
 file 1THQ
49
 using UCSF Chimera molecular visualisation 
application
44
.  
 
Structural analysis of PagP revealed conserved proline residues between strands F and 
G and also between strands A and B (Figure 1.25), which serve to disrupt hydrogen-
bonding between these strands
49
.  It was hypothesised that disruption of the hydrogen-
bonding in the upper half of the PagP β-barrel could serve as a possible mechanism by 
which the substrate phospholipid could enter the active site
49
.  MD simulations based on 
the more recent SDS crystal structure of PagP revealed that phospholipid access to the 
active site is most likely through the crenel between the F/G strands
232
.  Mutation of the 
proline residues, which disrupt hydrogen-bonding between the F/G strands, to cysteine 
residues and their subsequent cross-linking was able to prevent the palmitoyl transferase 
reaction, indicating that this is indeed the site of substrate entry
237
. 
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Figure 1.25 Ribbon diagrams of PagP showing conserved proline residues.  Conserved 
proline residues (P28, P50, P127 and P144) are shown in red, while tryptophan-17 is 
shown in blue.  The β-strands are labelled A–H beginning at the N-terminus.  Side 
chains are shown using stick representation.  Images were generated from the Protein 
Data Bank
43
 file 1THQ
49
 using UCSF Chimera molecular visualisation application
44
.  
 
1.8.2.2 Folding Mechanism In Vitro 
PagP was found to be able to refold into both detergent micelles and liposomes in vitro, 
however, unlike OmpA, a high concentration of urea (7 M) was required to solubilise 
the protein and prevent aggregation prior to insertion
145; 238
.  Far-UV CD spectroscopy 
was used to follow the formation of β-sheet structure at 218 nm as well as the formation 
of tertiary structure via a Cotton effect between tyrosine-26 and tryptophan-66 at 
232 nm (Figure 1.26)
235
.  This showed that secondary and tertiary structure form 
concomitantly, as had already been shown for OmpA
147
.  Mutants of PagP were then 
created to investigate the function and role in folding of the α-helix, since the possession 
of a periplasmic α-helix is an unusual feature of an OMP238.  While deletion of the helix 
did not prevent the refolding of the protein, analysis of the thermal stability of the 
PagPΔ(1-19) mutant and other mutants in which key interactions between the helix and 
β-barrel were deleted was carried out238.  This study revealed that the helix greatly 
increases the stability of the folded protein in liposomes but this effect was not so 
pronounced in detergent, which illustrates the importance of the lipid bilayer to the 
stability of the native protein
238
.   One mutant, in which the conserved residue 
tryptophan-17 (Figure 1.25) was replaced with alanine, unfolded fifty times more 
rapidly that the wild-type
238.  Moreover, in the PagPΔ1-19 construct, mutation of 
arginine-59 to tryptophan restored wild-type kinetics and stability in liposomes, 
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demonstrating the importance of the aromatic “girdle” which has been observed in 
OMPs and was speculated to help anchor these proteins into the membrane
45; 238; 239
. 
By systematically varying the protein concentration and studying folding under a range 
of lipid-to-protein ratios (LPRs), conditions were established under which the PagP 
unfolding transition is completely reversible in diC12:0PC LUVs
167
.  Equilibrium and 
kinetic analysis of PagP revealed that the protein folds via a two-state mechanism over 
the range of urea concentrations studied (7.8–10 M) (Figure 1.27), however, refolding 
kinetics at urea concentrations below 7.8 M showed two exponential phases
167
.  
Irrespective of the final urea concentration, the exponential phase was always preceded 
by a burst-phase in the dead-time (≈30 s) of the experiment167.  A Φ-value analysis was 
undertaken on 19 mutants of PagP (Figure 1.28).  The PagP variants all showed two-
state folding at the urea concentrations used, and suggested a polarised transition state 
since mutations in the N-terminal half of the protein increased the unfolding rate 
constants more than mutations in the C-terminal half of the protein
167
.  Residues with 
the highest Φ-values were observed in the C-terminal half of the protein, with lower 
Φ-values in the N-terminal half (Figure 1.28a)167.  This suggests that the C-terminal 
residues insert into the membrane first and begin to fold, while the N-terminal region is 
still largely unstructured in the transition state (Figure 1.28b).  Two negative Φ-values 
were observed, providing evidence for stabilisation of the transition state by non-native 
interactions
167
.  This mechanism of tilted insertion is consistent with the mechanism of 
concerted folding and insertion suggested for OmpA
145
. 
  
75 
 
 
Figure 1.26 The Cotton effect observed in the far-UV CD spectrum of PagP.  Far-UV 
CD spectra (left) of PagP folded in cyclofos-7 micelles (solid line) and diC12:0PC LUVs 
(dashed line).  The spectrum of PagP unfolded in 8 M urea is also shown (dotted line).  
The Cotton effect is seen as a band of positive ellipticity at 232 nm and arises from 
interaction of tyrosine-26 and tryptophan-66.  The ribbon diagram (right) of PagP shows 
tyrosine-26 (red) and tryptophan-66 (blue) using stick representation.  The ribbon 
diagram was generated from the Protein Data Bank
43
 file 1THQ
49
 using UCSF Chimera 
molecular visualisation application
44
.  The far-UV CD spectra are reproduced from 
Huysmans et al (2007)
238
.  
 
 
Figure 1.27 Reversible two-state unfolding of PagP.  (a) Equilibrium folding (solid 
squares) and unfolding (open squares) of PagP.  Solid and dotted black lines represent 
fits in the folding and unfolding direction, respectively.  (b) Urea dependence of the 
folding (filled symbols) and unfolding (open symbols) rate constants of PagP.  In both 
graphs, solid lines indicate appropriate fits to the data.  All experiments contained 0.4 μM 
PagP in 100 nm diC12:0PC LUVs at an LPR of 3200:1 and were performed in 50 mM 
sodium phosphate buffer pH 8 at 25 °C.  Adapted from Huysmans (2008)
239
 and 
Huysmans et al (2010)
167
.  
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Figure 1.28 Φ-value analysis of PagP.  ΦF-values determined from kinetic analysis of PagP 
variants are (a) mapped onto a ribbon diagram (left) and a topology model (right) of the 
native structure. (b) The proposed mechanism for PagP folding into membranes.  Folding is 
initiated from an unfolded membrane associated state (I) and proceeds via  a tilted insertion 
mechanism through a highly polarised transition state (II), before assembly of the 
N-terminal α-helix yields native PagP (III). ΦF > 0.5 are shown in blue, 0.3 ≤ ΦF ≥ 0.5 are in 
purple, ΦF < 0.3 are in red and ΦF < 0 in orange. This figure is taken from Huysmans et al 
(2010)167.  
 
Further kinetic analysis of PagP folding into 100 nm diC12:0PC LUVs revealed that 
lowering the LPR to 800:1 or lowering the PagP concentration to 0.1 μM resulted in a 
burst phase followed by an exponential phase that was no longer well described by a 
single exponential function, but a second slower exponential phase was required to fit 
the data satisfactorily
240
.  Interrupted refolding experiments, where folding is allowed to 
proceed for varying times before the initiation of unfolding, were carried out revealing 
that the rate of formation of the native state was best described by two rate constants 
indicative of parallel folding pathways
240
.  Introduction of up to 40 % diC12:0PS at an 
LPR of 3200:1 and PagP concentration of 4 μM (i.e. under conditions where the 
exponential folding phase is well described by a single exponential function) showed 
that diC12:0PS does not alter the folding pathway of PagP
240
.  By contrast, introduction 
of as little as 5 % diC12:0PE under the same conditions caused a shift to an exponential 
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phase best described by a double exponential function, suggesting that this lipid can 
shift the preferred folding pathway of PagP
240
.  The small size of the PE head-group in 
comparison to PC or PS head-groups (Figure 1.4) results in increased lateral pressure 
within the bilayer upon inclusion of PE lipids, slowing insertion of PagP
240
.  While 
inclusion of diC12:0PS did not alter the folding pathway of PagP, electrostatic effects due 
to the presence of this negatively charged lipid lead to smaller folding rate constants in 
the presence of this lipid
240
.  Overall, the lipid properties were shown to be important in 
modulating the folding of PagP between two parallel pathways.  Since the unfolding 
kinetics of PagP were well described by single exponential functions under all 
conditions tested, there was insufficient evidence for an alternative native-like state of 
PagP
240
.  Rather, the slower pathway is most likely due to a second population of 
folding-competent PagP in solution ready to adsorb on to the lipid surface upon 
exposure of free membrane surface (Figure 1.29)
240
. 
 
 
Figure 1.29 Schematic representation of the parallel folding pathways of PagP.  
(1) Folding is initiated by rapid adsorption on to the membrane surface.  (a) The 
amplitude of this process is increased by high lipid-to-protein ratio (LPR) and the 
presence of diC12:0PC and diC12:0PS lipids, leading to a (2) predominantly fast folding 
route.  (b) The amplitude of the lipid adsorption phase is reduced by low LPR or the 
presence of diC12:0PE lipid, leading to folding by a (3) predominantly slow route.  
Inclusion of diC12:0PS does not change the preferred folding route, but does affect the 
rate of membrane insertion.  The thickness of the arrows indicates the relative amplitude 
of the folding phases.  This figure was taken from Huysmans et al (2012)
240
. 
  
78 
 
1.9 AIMS OF THIS THESIS 
The overall aim of this study is to build on the previous work in the laboratory towards 
understand the folding mechanism of β-barrel OMPs.  This problem was approached in 
two ways: firstly, the development of a new model folding system for OMP study with 
the aim of using structurally related proteins to look for generic folding rules and 
secondly, to continue the investigation into PagP folding by investigating the effects of 
periplasmic chaperones on the folding pathway. 
To establish a new model system for OMP folding the OM proteases, OmpT and OmpP, 
of E. coli were chosen.  Although structurally related to established OMP folding 
models, OmpA (see Section 1.6) and PagP (see Section 1.8.2), a Basic Local Alignment 
Search Tool (BLAST) alignment shows there is only ≈20 % sequence similarilty 
between OmpA and OmpT and no sequence similarity between OmpT and PagP
241
.  
The crystal structure of OmpT has been solved
51
, allowing the obtained results to be 
structurally characterised and the previous establishment of an enzyme activity assay for 
OmpT allows the presence of the native state to be unequivocally detected
138; 242; 243
.  
While OmpP has not been crystallised, its high sequence similarity (87 %) to OmpT
244
 
allows a homology model to be created and thus structural rationalisation of results is 
possible.  Additionally, the substrate specificity of OmpP is known
245
 allowing activity 
assays to be carried out to detect the native state.  The work described in Chapter 3 
describes experiments that were used to clone OmpT and OmpP from E. coli DNA and 
establish protocols for the over-expression, purification and refolding of these proteins.  
The effect of acyl chain length and saturation on stability is investigated, revealing the 
ability of these proteins to assume the native state in spite of hydrophobic mis-match 
with the bilayer.   
A recurring problem in OMP folding studies is the establishment of conditions under 
which completely reversible folding can be achieved
150; 165
.  The work described in 
Chapter 4 shows that under many conditions, the unfolding and refolding denaturation 
curves of OmpT display hysteresis.  By kinetic examination of known reversible and 
irreversible folding conditions of OmpT, C-terminally His-tagged PagP
167; 238; 240
 and 
the untagged PagP construct reported by Burgess et al
162
 a possible mechanism is 
revealed by which this phenomenon could arise. 
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Finally, the work described in Chapter 5 focuses on the effect of periplasmic chaperones 
on OMP folding.  Burgess et al
162
 previously reported an untagged PagP construct 
which remains soluble and folding-competent in as little as 1 M urea, in stark contrast 
with the need to use urea concentrations as high as 7 M to study the folding pathway of 
his-tagged PagP
167; 238; 240
.  Building on previous work in the laboratory to establish 
purification and folding protocols of this untagged construct
246
, a kinetic refolding assay 
of untagged PagP was developed and used to study the effects of the E. coli periplasmic 
chaperones Skp and SurA.  This work lays the foundation for future studies with the 
aim of fully elucidating the mechanisms by which OMPs are chaperoned across the 
aqueous periplasm to the OM in vivo.  The results of the work and findings of the thesis 
are summarised in Chapter 6 and placed in context of the field.  Future avenues of 
research are pointed out that address key questions in this exciting and rapidly 
developing field. 
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2 MATERIALS AND METHODS 
2.1 MATERIALS AND REAGENTS 
2.1.1 GENERAL CHEMICALS 
Greater than 15 MΩ resistance water (dH2O) (Purite) was used in all protocols.  
Isopropyl β-D-1-thiogalactopyranoside (IPTG), agarose, bacto-agar, lysogeny broth 
(LB) granulated medium, carbenicillin disodium salt, Tris 
(hydroxymethyl)-aminomethane (Tris) and GuHCl were purchased from Melford 
Laboratories, UK.  Granulated super optimal broth (SOB) was purchased from Merck, 
UK.  Ultrapure urea was purchased from MP Biomedicals, UK.  
Ethylenediaminetetraacetic acid (EDTA), glycerol, sodium chloride (NaCl), sodium 
dodecyl sulphate (SDS), acetic acid, glucose and ethanol were purchased from Fisher 
Scientific, UK.  30 % (w/v) acrylamide: 0.8 % (w/v) bis-acrylamide was purchased from 
Severn Biotech Ltd, UK.  Triton X-100 protein grade detergent was purchased from 
Calbiochem, UK.  The fluorogenic peptide, ortho-aminobenzoic acid (Abz)-Ala-Arg-
Arg-Ala-Tyr(NO2)-NH2 was purchased from Cambridge peptides, UK.  Kanamycin 
monosulphate was purchased from ForMedium, UK.  Polymyxin B sulphate was 
purchased from VWR International, UK.  All lipids were purchased from Avanti Polar 
Lipids, Alabama, USA; except lipopolysaccharide (LPS, from E. coli strain 0111:B4) 
which was purchased from Sigma, UK.  All other chemicals were purchased from 
Sigma-Aldrich, UK and were of analytical grade. 
 
2.1.2 MOLECULAR BIOLOGY MATERIALS 
Oligonucleotide primers were purchased from Eurofins MWG Operon, UK.  Vent 
polymerase, Taq polymerase, NdeI, BamHI and Quick Ligase enzymes, as well as 
bovine serum albumin (BSA) were purchased from New England Biolabs, USA.  The 
pGEM-T Easy Vector System, 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside 
(X-Gal), deoxyribonucleotide triphosphates (dNTPs), 6 × Blue/Orange Loading Dye 
and DNA markers for electrophoresis were purchased from Promega, UK.  The 
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QIAprep Spin Miniprep Kit and QIAquick Gel Extraction kit were purchased from 
QIAGEN, UK.  E. coli strains XL1-Blue (competent and supercompetent) and BL21 
(DE3) competent were purchased from Stratagene, UK. 
Plasmid pET11a (Novagen) containing the gene encoding the mature form of PagP
162
 
was kindly provided by Dr. Karen Fleming (T.C. Jenkins Department of Biophysics, 
Johns Hopkins University, USA).  
Plasmid pETCrcAHΔS, which contains the gene encoding PagP with a C-terminal 
hexa-histidine tag in a plasmid derived from pET21a
+
 
166
, was a generous gift from Prof. 
Russell Bishop (Department of Biochemistry and Biomedical Sciences, McMaster 
University, Canada). 
Plasmid pET21b (Novagen) containing the gene encoding Skp was kindly provided by 
Dr. James Bardwell (Department of Biophysics, University of Michigan, USA). 
Plasmid pSK257 containing the gene encoding the mature form of SurA with an 
N-terminal hexa-histidine tag
137
, and a thrombin cleavage site to facilitate its removal 
following purification, was a kind gift from Prof. Daniel Kahne (Department of 
Biological Chemistry & Molecular Pharmacology, Harvard University, USA). 
 
2.1.3 PROTEIN CHEMISTRY MATERIALS 
SnakeSkin dialysis tubing (3,500 Da molecular weight cut off (MWCO)) was purchased 
from Thermo Scientific, UK.  The HiLoad 26/60 Superdex75 column, nickel Sepharose 
resin, HiTrap Q column and HiTrap SP column were purchased from GE Healthcare, 
UK.  All buffers used during protein purification were filtered and degassed before use 
either by vacuum filtration through 0.22 μm filters purchased from Millipore, UK, or for 
small volumes by filtration through 0.2 μm or 0.45 μm Minisart syringe filters 
purchased from Sartorius, UK.  Vivaspin 20 concentrators (MWCO 5 kDa or 10 kDa) 
were purchased from Sartorius, UK.  
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2.2 MOLECULAR BIOLOGY METHODS 
2.2.1 BACTERIAL STRAINS 
E. coli XL1-Blue (recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F’ proAB 
lacl
q
ZΔM15 Tn10 (Tetr)])247 
E. coli BL21(DE3) (F
– 
dcm ompT hsdS
B
 (rB
–
, mB
–
) gal λ(DE3))248 
 
2.2.2 GROWTH MEDIA 
Super optimal broth with catabolite repression (SOC) medium was used to culture XL1-
blue supercompetent cells following transformation, and was made by addition of 25 g 
SOB granulated medium (Merck, UK) to 1 litre of deionised water.  The medium was 
sterilised using an autoclave (121 °C, 15 psi, 20 min).  Before use, filter-sterilised 
glucose and magnesium sulphate were added to the cooled medium to a final 
concentration of 20 mM. 
In all other experiments, bacteria were cultured in lysogeny broth (LB)
249
, which was 
prepared by addition of 25 g of granulated LB (Melford laboratories, UK) to 1 litre of 
deionised water.  The medium was sterilised using an autoclave (121 °C, 15 psi, 
20 min).  Antibiotics were filter-sterilised and added to the cooled medium as detailed 
in Table 2.1. 
 
Antibiotic Dissolve in 
Stock Conc
n
 
(mg ml
-1
) 
Final Conc
n
 
(μg ml-1) 
Tetracycline EtOH 1 10 
Carbenicillin dH2O 100 100 
Kanamycin dH2O 20 50 
Table 2.1 Summary of antibiotics used in molecular biology methods.  Each antibiotic 
was dissolved in an appropriate solvent at the concentration (conc
n
) listed and sterilised 
before use.  
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LB-agar plates were made by the addition of 15 g bacto-agar (Melford laboratories, UK) 
per litre of LB medium prior to autoclaving.  Where blue/white colour screening plates 
were required, X-Gal (80 μg ml-1) and filter-sterilised IPTG (0.5 mM) were added to the 
cooling agar.  
 
2.2.3 AGAROSE GEL ELECTROPHORESIS 
Agarose gel electrophoresis was carried out in Tris-acetate-EDTA (TAE) buffer, which 
was prepared as a 50 × stock as follows: 
 Tris       121 g 
 Acetic Acid (glacial)     28.55 ml 
EDTA (0.5 M)     50 ml 
The solution was adjusted to pH 8.0 and made up to 500 ml using deionised water.  
Gels were made by dissolving 1.3 % (w/v) agarose in hot 1 × TAE buffer, and adding 
ethidium bromide (0.5 µg ml
-1
) to the cooling solution.  The gel was then poured into a 
12 × 15 cm gel tray with a comb and allowed to set before use.  DNA samples were 
mixed 5:1 with 6 × Loading Buffer (Promega, UK) before loading.  5 µl of 1 kbp and 
100 bp DNA ladders (Promega, UK) mixed with 1 µl 6 × Loading Buffer were also 
loaded to aid size determination.  Samples were resolved at a constant voltage of 90 V 
in 1 × TAE buffer.   
After electrophoresis, gels were visualised using a transilluminator emitting ultra violet 
(UV) light and photographed using a Syngene InGenius gel documentation system 
(Syngene, UK). 
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2.2.4 TRANSFORMATION OF E. COLI  
Plasmid DNA (50–200 ng) was added to 100 μl of competent cells.  After incubation on 
ice for 30 min, the mixture was heat shocked at 42 °C for 45 seconds and returned to ice 
for 2 min.  400 μl of sterile medium (SOC for supercompetent XL1-blue cells, LB for 
all other cell strains) was added and the transformation mixture incubated at 37 °C, 
200 rpm for 60 min.  Cells were then plated in 50 μl and 200 μl aliquots onto LB-agar 
containing the appropriate antibiotic and incubated overnight at 37 °C. 
 
2.2.5 PREPARATION OF PLASMIDS 
A 5 ml overnight culture of XL1-blue cells (Stratagene, UK) containing the desired 
plasmid was grown under antibiotic selection.  After the cells were pelleted, plasmid 
DNA was extracted using the QIAprep Spin Mini-Prep Kit (QIAGEN, UK) according 
to the manufacturer’s instructions.  The concentration of plasmid DNA was determined 
by measuring the absorbance of the sample at 260 nm (A260) in a cuvette with a 1 cm 
path length.  An A260 of 1 was assumed to be equivalent to 50 ng µl
-1 
dsDNA. 
 
2.2.6 POLYMERASE CHAIN REACTION (PCR) 
The genes coding for the OMPs, OmpT and OmpP, were amplified from the 
chromosomal DNA of XL1-blue cells (Stratagene, UK).  A 5 ml culture of XL1-blue 
cells was grown in LB medium containing 10 µg ml
-1
 tetracycline (see Section 2.2.2) 
until an OD600 of 0.25 was reached.  A 20 µl aliquot was removed and diluted to 1 ml in 
sterile dH2O.  This sample was boiled for 5 min before incubation on ice for 5 min to 
create a cell lysate that could be used as the DNA template.  Primers were designed to 
amplify the desired gene, and add an N-terminal hexa-histidine and Tobacco Etch Virus 
protease (TEVp) cut site (Table 2.2).  Polymerase chain reactions (PCR) were set up to 
amplify the desired gene.  A typical reaction contained the following components:  
Cell lysate      25 µl 
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Primers      100 pmol 
dNTPs       250 μM 
MgSO4      2, 4 or 6 mM 
DMSO       1 µl 
Vent DNA polymerase (2000 U ml
-1
)  1 U 
Vent DNA polymerase buffer    1 × 
Nuclease-free deionised water   to 100 µl 
 
 
Primer Sequence (5’ to 3’) 
OmpT forward 
GCTACATATGCATCATCACCATCACCACGAAAATCTG 
TACTTCCAGGGTTCTACCGAGACTTTATCGTTTA 
OmpT reverse GGCGGATCCTTAAAATGTGTACTTAAGACCAG 
OmpP forward 
GCTACATATGCATCATCACCATCACCACGAAAAT 
CTGTACTTCCAGGGTTCTGATTTCTTCGGCCCGGA 
OmpP reverse GGCGGATCCTTAAAACGTGTACTTCAGACCG 
Table 2.2 Oligonucleotide primers used to amplify the OmpT and OmpP genes from 
the chromosomal DNA of XL1-blue cells.  The restriction enzyme recognition sites are 
highlighted in red (NdeI) and blue (BamHI).  Forward primers include a DNA sequence 
encoding a hexa-histidine tag and a TEVp site (ENLYFQG).  
 
In all experiments, an appropriate negative control sample lacking a DNA template was 
included.  Amplification was then carried out according to the temperature cycle 
outlined in Table 2.3. 
The PCR products were purified by agarose gel electrophoresis (see Section 2.2.3) then 
extracted using the QIAquick Gel Extraction Kit (QIAGEN, UK) according to the 
manufacturer’s instructions. 
PCR using plasmid DNA as a template was carried out according to the same method, 
however, cell lysate was replaced by 100 ng of the appropriate plasmid and the volume 
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of water in the reaction was adjusted accordingly.  This method was used to amplify the 
genes encoding OmpT and OmpP from existing plasmids to remove the His-tag and the 
TEVp cleavage site.  The primer sequences used are given in Table 2.4. 
 
Step Temp (°C) Time (s) 
Initial denaturation 95 300 
Denaturation 95 30 
Annealing 53 30 
Elongation 72 90 
Repeat denaturation, annealing and elongation (× 29) 
Final elongation 72 300 
Table 2.3 Temperature cycle for a typical PCR reaction. 
 
Primer Sequence (5’ to 3’) 
OmpT forward GGAGACACATATACATATGTCTACCGAGACTTTATCGTTTA 
OmpT reverse GGAGACACATATACATATGTCTGATTTCTTCGGCCCGGA 
pET11a_rev TCCTTTCGGGCTTTGTTAGC 
Table 2.4 Oligonucleotide primers used to amplify the OmpT and OmpP genes from 
plasmid DNA.  These primers remove the N-terminal his-tag and TEVp cleavage site 
leaving just the sequence encoding the mature protein.  The restriction enzyme 
recognition sites are highlighted in red (NdeI).   
  
2.2.7 BLUNT ENDED LIGATION INTO A SHUTTLE VECTOR 
To ensure efficient restriction endonuclease digestion, purified PCR products were 
ligated directly into the pGEM-T Easy Vector (Promega, UK).  PCR products were first 
A-tailed by incubating the following components at 70 °C for 25 min: 
 Taq DNA polymerase     5 U 
 Taq DNA polymerase buffer    1 × 
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 dATP       200 μM 
 Purified PCR fragment    to 10 μl 
Taq DNA polymerase was used for this reaction as it lacks 3’ to 5’ exonuclease activity. 
The tailed PCR product was then ligated into the pGEM-T Easy Vector.  Typically, 
ligation reactions were incubated overnight at 4 °C and contained the following 
components: 
10 × rapid Ligation buffer for T4 DNA Ligase 1 μl 
pGEM-T Easy Vector     50 ng 
T4 DNA Ligase (3 U µl
-1
)    3 U 
A-tailed PCR product     to 10 µl 
A control reaction containing deionised water instead of PCR product was included. 
Ligation products were transformed into XL1-blue supercompetent cells (Stratagene, 
UK) and then plated onto colour screening plates containing 100 µg ml
-1
 carbenicillin 
(see Sections 2.2.2 and 2.2.4).  Single white colonies were picked from the plate and 
grown overnight (37 C, 200 rpm) in 5 ml LB medium containing 100 µg ml-1 
carbenicillin.  Plasmid DNA was purified and the concentration determined as described 
in Section 2.2.5. 
 
2.2.8 DIGESTION OF PLASMID DNA 
Restriction digestion reactions were carried out using enzymes and buffers from New 
England Biolabs, USA (NEB) and typically contained the following components: 
Plasmid DNA or purified PCR product  1 μg 
10 × NEB buffer 3     3 μl    
BSA       100 μg ml-1 
NdeI (20 U μl-1)     20 U  
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BamHI (20 U μl-1)     20 U  
Nuclease-free deionised water   to 30 μl 
All reactions were accompanied by the appropriate single enzyme and enzyme-free 
control samples.  Reactions were incubated at 37 °C for 30 min, following by enzyme 
inactivation at 65 °C for 20 min. 
Digested DNA was purified by agarose gel electrophoresis (see Section 2.2.3) and then 
extracted using the QIAquick Gel Extraction Kit (QIAGEN, UK) according to the 
manufacturer’s instructions. 
 
2.2.9 LIGATION OF DIGESTED DNA 
Ligation reactions were carried out using the NEB Quick Ligation kit according to the 
following scheme: 
Digested pET11a vector    100 ng 
2 × Quick Ligation Buffer    10 μl 
Quick T4 DNA Ligase (2000 U μl-1)   2000 U 
Digested insert     to 20 μl 
Appropriate control reactions containing nuclease-free deionised water instead of a 
digested insert were carried out.  The pET11a vector was not dephosphorylated before 
ligation.  Reactions were incubated at 25 °C for 15 min before chilling on ice prior to 
transformation into XL1-blue supercompetent cells (see Section 2.2.4).  Plasmid DNA 
was purified according to the method in Section 2.2.5. 
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2.2.10 DNA SEQUENCING 
DNA sequencing was carried out by Beckman Coulter Genomics, UK.  Sequencing of 
genes inserted into pET vectors was carried out using the T7 promoter and T7 
terminator primers.  The T7 promoter primer alone was used for sequencing of 
pGEM-T Easy vectors. 
 
2.2.11 SUMMARY OF CREATED PLASMIDS 
The plasmids created for use in this thesis are described in Table 2.5, and were made 
using the techniques described in the rest of Section 2.2. 
 
Name 
Vector 
backbone 
Insert 
PCR Template 
used 
pLMM01 pET11a 
Mature OmpT with N-terminal His-
tag and TEVp site 
XL1-blue 
chromosomal DNA 
pLMM02 pET11a 
Mature OmpP with N-terminal His-
tag and TEVp site 
XL1-blue 
chromosomal DNA 
pLMM03 pET11a Mature OmpT Plasmid pLMM01 
pLMM04 pET11a Mature OmpP Plasmid pLMM02 
Table 2.5 Plasmids created for use in this thesis 
 
2.3 PROTEIN METHODS 
2.3.1 SODIUM DODECYL SULPHATE POLYACRYLAMIDE GEL ELECTROPHORESIS (SDS-PAGE) 
Tris-tricine buffered SDS-PAGE gels (Table 2.6) were used to monitor over-expression, 
purification and refolding of recombinant OMPs.   
Protein samples were diluted two-fold in 2 × SDS loading buffer (50 mM Tris-HCl 
pH 6.8, 2 % (w/v) SDS, 0.1 % (w/v) bromophenol blue, 10 % (w/v) glycerol) and boiled 
  
90 
 
(5 min) prior to loading. Mark12™ Unstained Protein Standards (Invitrogen, UK) or 
Precision Plus Protein™ Dual Xtra Standards (Bio-Rad, UK) were loaded into one lane 
to aid size determination and identification of protein bands.  Gels were 
electrophoreised with the inner reservoir of the gel tank buffered with cathode buffer 
(100 mM Tris, 100 mM tricine, 0.1 % (w/v)  SDS, pH 8.25) and the outer reservoir 
buffered with anode buffer (200 mM Tris-HCl, pH 8.9).  A constant current of 30 mA 
was applied until the samples entered the resolving gel, and then the current was 
adjusted to 65 mA until the dye front reached the bottom of the gel.  Gels were stained 
using Instant Blue stain (Expedeon, UK) and photographed using a Syngene InGenius 
gel documentation system (Syngene, UK). 
 
Solution Component 
Volume Added to 
Resolving Gel (ml) 
Volume Added to 
Stacking Gel (ml) 
30 % (w/v) acrylamide : 0.8 % (w/v) 
bis-acrylamide 
7.50 0.83 
3 M Tris-HCl, 0.3 % (w/v) SDS, pH 
8.45 
5.00 1.55 
dH2O 0.44 3.72 
Glycerol 2.00 - 
10 % (w/v) ammonium persulphate 0.05 0.10 
Tetramethylethylenediamine (TEMED) 0.01 0.01 
Table 2.6 Components of a Tris-tricine buffered SDS-PAGE gel.  The volumes stated 
allow casting of two mini-gels (8 cm × 10 cm) using a 1.5 mm spacer.  
 
2.3.2 TRICHLOROACETIC ACID (TCA) PRECIPITATION 
Trichloroacetic acid (TCA) precipitation was used to remove GuHCl from protein 
samples to facilitate analysis by SDS-PAGE.  An equal volume of 12.5 % TCA was 
added to the sample, which was then incubated on ice for 20 min.  The precipitated 
protein was collected by centrifugation in a microfuge (13000 rpm, 10 min, 4 °C) and 
the supernatant was discarded.  The pellet was washed with 1 ml ice cold EtOH and 
collected by centrifugation as before.  The supernatant was again discarded and any 
residual solvent was removed from the protein pellet by drying in a heat block at 95 °C.  
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The dried pellet was resuspended in SDS-PAGE loading buffer (see Section 2.3.1 for 
recipe) and boiled for 5 minutes before loading onto a gel. 
 
2.3.3 WESTERN BLOTTING 
Following SDS-PAGE, proteins were transferred onto polyvinylidene fluoride (PVDF) 
transfer membrane (GE Healthcare, UK) at 12 V for 1 h using a Trans-blot semi-dry 
electrophoretic transfer cell (Bio-Rad, UK) in transfer buffer (15 mM Tris-HCl, 
150 mM glycine, 0.02 % (w/v) SDS, 20 % (v/v) methanol).  The membrane was blocked 
with 2 % (w/v) skimmed milk powder (Marvel) in phosphate buffered saline (PBS: 
137 mM NaCl, 2.7 mM potassium chloride, 10 mM dibasic sodium phosphate, 2 mM 
monobasic potassium phosphate, pH 7.4) containing 0.2 % (v/v) Tween-20 for 1 h at 
room temperature with shaking.  The membrane was incubated with 0.2 μg ml-1 mouse 
anti-histidine tag monoclonal antibody (AbD Serotec, UK) with 2 % skimmed milk 
powder in PBS containing 0.2 % (v/v) Tween-20 for 1 h at room temperature with 
shaking.  The membrane was then washed with 5 ml 2 % skimmed milk powder in PBS 
containing 0.2 % (v/v) Tween-20 three times before incubation with 0.2 μg ml-1 
horseradish peroxidise-conjugated rat anti-mouse IgM monoclonal antibody (BD 
Pharmingen, UK) in 2 % skimmed milk powder in PBS containing 0.2 % (v/v) 
Tween-20 for 1 h at room temperature with shaking.  The membrane was washed three 
times with 5 ml 2 % skimmed milk powder in PBS containing 0.2 % (v/v) Tween-20.  
Antibody binding was visualised using SuperSignal West Pico Chemiluminescent 
Substrate (Thermo Scientific) and Amersham Hyperfilm ECL (GE Healthcare) and 
developed. 
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2.4 PROTEIN EXPRESSION AND PURIFICATION 
2.4.1 OVER-EXPRESSION OF OUTER MEMBRANE PROTEINS 
All of the OMPs used in this thesis were over-expressed using the following method 
(Burgess et al
162
).  BL21 (DE3) cells were transformed with the relevant plasmid (see 
Table 2.7) as described in Section 2.2.4.  A single colony from a fresh transformation 
was used to inoculate 5 ml LB medium containing 100 μg ml-1 carbenicillin and 
incubated overnight at 37 °C with shaking at 200 rpm.  The overnight culture was used 
to inoculate 0.5 L LB containing 100 μg ml-1 carbenicillin.  This culture was incubated 
at 37 °C, 200 rpm until an approximate OD600 of 0.6 was reached, when protein 
expression was induced by addition of filter-sterilised IPTG to a final concentration of 
1 mM.  Cells were harvested by centrifugation (10000 g, 15 min, 4 °C) 4 h after 
induction. 
 
Plasmid Name Insert Vector Backbone 
pETCrcAHΔS166 His-tagged PagP pET21a+ 
pET11a-PagP162 Untagged PagP pET11a 
pLMM01 His-tagged OmpT pET11a 
pLMM02 His-tagged OmpP pET11a 
pLMM03 Untagged OmpT pET11a 
pLMM04 Untagged OmpP pET11a 
Table 2.7  Plasmids used in the over-expression of OMPs in BL21 (DE3) cells. 
 
2.4.2 ISOLATION OF OUTER MEMBRANE PROTEIN INCLUSION BODIES 
Cell pellets were resuspended in 50 mM Tris-HCl, 5 mM EDTA, 1 mM 
phenylmethanesulfonylfluoride (PMSF), pH 8.0 and lysed by sonication (6 × 1 min, 
using a W-225R sonicator (Ultrasonics, Inc)). The insoluble fraction was pelleted by 
centrifugation (25000 g, 30 minutes, 4 ºC). The pellet from a 500 ml culture was 
resuspended in 20 ml 50 mM Tris-HCl, pH 8.0 containing 2 % (v/v) Triton X-100 and 
stirred at room temperature for 1 hour to dissolve the membranes.  The inclusion bodies 
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were then pelleted by centrifugation as before and resuspended in 50 mM Tris-HCl, 
pH 8.0. The resuspended pellet was left stirring for 1 hour at room temperature to 
ensure removal of residual detergent. The wash step in 50 mM Tris-HCl, pH 8.0 was 
repeated twice, pelleting the inclusion bodies by centrifugation after each resuspension.  
 
2.4.3 PURIFICATION OF HIS-TAGGED CONSTRUCTS OF OMPT AND OMPP 
Inclusion bodies of HT OmpT and HT OmpP were solubilised in 10 ml of 6 M GuHCl, 
50 mM sodium phosphate, 250 mM NaCl, pH 8.0 at room temperature until fully 
dissolved and the resulting solution spun down to remove aggregates (20 min, 25000 g, 
4 C).  Nickel Sepharose resin (GE Healthcare, UK) was pre-equilibrated with 6 M 
GuHCl, 50 mM sodium phosphate, 250 mM NaCl, pH 8.0 at room temperature, mixed 
with the dissolved inclusion bodies and incubated at room temperature for 2 h.  The 
resin was pelleted gently (500 g, 1 min) and washed with 25 ml 6 M GuHCl, 50 mM 
sodium phosphate, 250 mM NaCl, 5 mM imidazole, pH 8.0 for 1 h at room temperature.  
The resin was then packed into an empty PD-10 column (Bio-Rad, USA) and the His-
tagged protein eluted using 10 ml 6 M GuHCl, 50 mM sodium phosphate, 250 mM 
NaCl, 250 mM imidazole, pH 8.0.  Purified HT OmpT/P was precipitated by dialysis 
(using a membrane with an MWCO of 3.5 kDa, Medicell International Ltd, UK) against 
deionised water (1 h, room temperature).  Precipitated protein was pelleted (20 min, 
25000 g, 4 C) and then dissolved in 6 M GuHCl, 25 mM Tris-HCl for storage in 200 µl 
aliquots at a protein concentration of approximately 500 µM, at -80 C. 
 
2.4.4 PURIFICATION OF HIS-TAGGED PAGP 
Inclusion bodies of His-tagged PagP (HT PagP) were solubilised in 10 ml of 6 M 
GuHCl, 10 mM Tris-HCl, 250 mM NaCl, pH 8.0 at room temperature and the resulting 
solution spun down to remove aggregates (25000 g, 20 min, 4 C).  Nickel Sepharose 
resin (GE Healthcare, UK) were pre-equilibrated with 6 M GuHCl, 10 mM Tris-HCl, 
250 mM NaCl, 5 mM imidazole, pH 8.0 at room temperature, mixed with the dissolved 
inclusion bodies and incubated at room temperature for 2 h.  The nickel Sepharose resin 
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was pelleted gently (500 g, 1 min) and washed with 25 ml 6 M GuHCl, 10 mM 
Tris-HCl, 250 mM NaCl, 20 mM imidazole, pH 8.0 for 1 h at room temperature.  The 
nickel Sepharose resin was then packed into an empty PD-10 column (Bio-Rad, USA) 
and the HT PagP eluted using 10 ml 6 M GuHCl, 10 mM Tris-HCl, 250 mM NaCl, 
250 mM imidazole, pH 8.0.  Purified HT PagP was precipitated by dialysis using a 
membrane with an MWCO of 3.5 kDa against deionised water (1 h, room temperature).  
Precipitated protein was pelleted (25000 g, 20 min, 4 C) and then dissolved in 6 M 
GuHCl, 25 mM Tris-HCl for storage in 50 µl aliquots at a protein concentration of 
approximately 500 µM, at -80 C. 
 
2.4.5 PURIFICATION OF UNTAGGED OUTER MEMBRANE PROTEINS 
Inclusion bodies from a 0.5 L culture were solubilised in 10 ml 6 M GuHCl, 25 mM 
Tris-HCl, pH 8.0. Solubilised inclusion bodies were then centrifuged (20000 g, 20 min, 
4 ºC).  After filtration through a 0.2 μM syringe filter, the OMP solution was further 
purified by gel filtration using a Superdex 75 HiLoad 26/60 column (GE Healthcare) on 
the ÄKTA Prime chromatography system.  The column was washed with two column 
volumes of dH2O and equilibrated by washing with two column volumes of 6 M 
GuHCl, 25 mM Tris-HCl, pH 8.0.  For each gel filtration run, 5 ml of solubilised 
protein was loaded into a 5 ml loop at a concentration of up to 10 mg ml
-1
 and eluted 
using the program detailed in Table 2.8.  Following gel filtration, OMP containing 
fractions were concentrated to approximately 500 μM using Vivaspin 20 concentrators 
(MWCO 10 kDa).  Purity was assessed by SDS PAGE (see Section 2.3.1) following 
TCA precipitation (see Section 2.3.2).  OMPs were stored in 50 μl aliquots at -80 °C. 
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Breakpoint (ml) 
Flow rate 
(ml min
-1
) 
Fraction size 
(ml) 
Injection 
Valve Position 
Auto zero 
0 2 0 Load No 
10 2 0 Inject Yes 
20 2 0 Load No 
90 2 3 Load No 
320 2 0 Load No 
Table 2.8 ÄKTA programme parameters for purification of untagged OMPs.  Gel 
filtration was carried out using a Superdex 75 HiLoad 26/60 column in 6 M GuHCl, 25 
mM Tris-HCl (pH 8.0).  
 
2.4.6 EXPRESSION AND PURIFICATION OF SURA 
Plasmid pSK257 containing the mature form of SurA with an N-terminal His-tag was 
kindly provided by Daniel Kahne (Harvard University)
137; 250
 . Over expression and 
purification of SurA followed the method of Hagan et al
137
.  The plasmid pET28b was 
transformed into BL21 (DE3) cells (Stratagene, UK) as described in Section 2.2.4.  A 
single colony from a fresh transformation was used to inoculate 125 ml LB medium 
containing 50 μg ml-1 kanamycin and incubated overnight at 37 °C with shaking at 
200 rpm.  The overnight culture was used to inoculate LB, containing 50 μg ml-1 
kanamycin, at a ratio of 1:100.  This culture was incubated at 37 °C, 200 rpm until an 
approximate OD600 of 1.0 was reached.  The temperature was reduced to 16 °C and 
protein expression was induced by addition of filter-sterilised IPTG solution to a final 
concentration of 0.1 mM.  Following overnight expression at 16 °C, 200 rpm, cells were 
harvested using a Heraeus Contifuge at 15000 rpm (Rotor 8575). 
The cell pellet was resuspended in 150 ml 20 mM Tris-HCl, 5 mM imidazole, pH 8.0.  
Protease inhibitors were excluded as they reduce the efficiency of the CleanCleave kit 
in subsequent steps.  Cells were lysed using a cell disruptor (Constant Cell Disruption 
Systems) and the insoluble fraction removed by centrifugation (25000 g, 4 °C, 1 h).  
Nickel Sepharose (25 ml, GE Healthcare) packed into a XK 26 casing (GE Healthcare) 
was equilibrated on the ÄKTA Prime chromatography system with 20 mM Tris-HCl, 
5 mM imidazole, pH 8.0 and the cell lysate loaded following filtration through a 0.2 μm 
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syringe filter.  The column was washed with 20 mM Tris-HCl, 10 mM imidazole, 
pH 8.0 and bound proteins eluted using 20 mM Tris-HCl, 500 mM imidazole, pH 8.0 in 
25 % steps according to the program in Table 2.9.   
The N-terminal His-tag was removed using a CleanCleave kit (Sigma), following the 
manufacturer’s recommended protocol and any residual His-tagged SurA removed 
using a second nickel Sepharose pull down. The cleaved SurA was concentrated to 
~150 µM using Vivaspin 20 concentrators (MWCO 5 kDa) and then diluted five-fold 
with Tris buffered saline (TBS: 50 mM Tris-HCl, 150 mM sodum chloride, pH 7.4) to 
remove residual imidazole, before concentrating again to ~150 µM. Purity was assessed 
by SDS-PAGE (see Section 2.3.1). 
 
Volume 
(ml) 
Flow Rate  
(ml min
-1
) 
Line 
Valve  
Position 
Percentage 
B (%) 
Fraction 
Volume (ml) 
Auto 
zero 
Event 
Mark 
0 10 A1 Load 0 0 No No 
100 5 A2 Load 0 0 Yes Yes 
340 10 A1 Load 0 0 No Yes 
590 10 A1 Load 0 0 No No 
590.1 10 A1 Load 25 5 No Yes 
690 10 A1 Load 25 5 No No 
690.1 10 A1 Load 50 5 No Yes 
790 10 A1 Load 50 5 No No 
790.1 10 A1 Load 75 5 No Yes 
890 10 A1 Load 75 5 No No 
890.1 10 A1 Load 100 5 No Yes 
990 10 A1 Load 100 5 No No 
Table 2.9  ÄKTA programme parameters for purification of His-tagged SurA.  
Volumes may be adjusted according to the volume of cleared lysate.  Nickel Sepharose 
resin packed into XK 26 column was used for this protocol, along with the following 
buffers: Line A1 = 10 mM imidazole, 20 mM Tris-HCl, pH 8.0; Line A2 = cleared cell 
lysate; Line B = 500 mM imidazole, 20 mM Tris-HCl, pH 8.0.  
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2.4.7 EXPRESSION AND PURIFICATION OF SKP 
Plasmid pET21b containing the Skp clone was kindly provided by James Bardwell 
(University of Michigan). BL21 (DE3) cells (Stratagene) were transformed with 
pET21b containing the Skp gene as described in Section 2.2.4.  A single colony was 
used to inoculate 125 ml LB containing 100 μg ml-1 carbenicillin and incubated 
overnight at 37 °C with shaking at 200 rpm. The overnight culture was used to inoculate 
LB, containing 100 μg ml-1 carbenicillin, at a ratio of 1:100 and incubated at 27 °C, with 
shaking. Protein expression was induced by addition of sterile IPTG to give a final 
concentration of 25 µM once an OD600 of approximately 0.6 was reached.  The cells 
were then grown overnight at 27 °C before harvesting using a Heraeus Contifuge at 
15000 rpm (Rotor 8575). 
The cell pellet was gently resuspended in 50 mM Tris-HCl, 5 mM EDTA, 50 mM NaCl, 
pH 7.5 at 4 °C using approximately 20 ml buffer per litre of cell culture. Following 
addition of 1 mg ml
-1
 polymyxin B sulphate, the resuspended cells were incubated at 
4 °C for 1 h.  The spheroplasts were sedimented by centrifugation (12000 g, 20 min 
4 °C) and the resulting periplasmic extract was dialysed against 20 mM Tris-HCl, 
pH 8.0, 100 mM NaCl (Buffer A) overnight at 4 °C.  
The periplasmic extract was filtered using 0.2 μm syringe filters and loaded onto a 
HiTrap Q (5 ml) column equilibrated in Buffer A and then washed with 3 column 
volumes of Buffer A. Around 80 ml of periplasmic extract was loaded per run and the 
column washed with 5 column volumes 20 mM Tris-HCl, pH 8.0, 750 mM NaCl 
(Buffer B) between runs.  The flow through from this column, excluding the wash steps 
in Buffer B, was collected then loaded onto a HiTrap SP (5 ml) column in 100 ml 
aliquots, washed with 5 column volumes of Buffer A and Skp eluted with a gradient 
running from 0–100 % Buffer B over 15 column volumes. Purified Skp was dialysed 
against 20 mM Tris-HCl, pH 8.0 to remove NaCl and concentrated to ~150 µM using 
Vivaspin 20 concentrators (MWCO 5 kDa). Purity was assessed by SDS-PAGE (see 
Section 2.3.1). 
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2.4.8 DETERMINATION OF PROTEIN CONCENTRATION 
Protein concentration of purified protein samples was determined by measuring the 
absorbance of the sample at 280 nm (A280) in a cuvette with a 1 cm path length.  The 
theoretical molar extinction coefficient of each protein was estimated using the ExPASy 
ProtParam tool
251
 and then used to calculate protein concentration according to the 
Beer-Lambert law.  The molar extinction coefficients used to calculate concentrations of 
proteins in this thesis are provided in Table 2.10. 
 
Protein ε280 (M
-1
 cm
-1
) 
HT OmpT 79760 
HT OmpP 83770 
OmpT 78270 
OmpP 82280 
HT PagP 82390 
PagP 82390 
SurA 29450 
Skp 1490 
Table 2.10 Theoretical molar extinction coefficients of proteins used in this thesis.  The 
theoretical molar extinction coefficient of each protein was estimated using the ExPASy 
ProtParam tool
251
. 
 
2.5 OUTER MEMBRANE PROTEIN FOLDING ASSAYS 
2.5.1 PREPARATION OF LIPOSOMES 
Appropriate mixtures of lipids were weighed into glass tubes and dissolved in 9:1 
chloroform:methanol (v/v).  The solvent was evaporated under a gentle stream of N2 to 
create a thin lipid film, which was further dried in vacuo (> 2.5 h).  The lipid film was 
resuspended in an appropriate buffer to give a lipid concentration of 40 mM and 
allowed to stand at room temperature for 30 minutes.  Unilamellar vesicles were created 
by extruding the lipid suspension through polycarbonate membranes (Nuclepore, 
Whatman, UK) of either 0.1 μm or 0.05 μm pore size to create LUVs and SUVs, 
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respectively, using a mini extruder (Avanti, Alabama, USA).  The lipids used are 
summarised in Table 2.11. 
 
Name Abbreviation Supplier 
1,2-dilauroyl-sn-glycero-3-phosphocholine diC12:0PC Avanti 
1,2-dimyristoyl-sn-glycero-3-phosphocholine diC14:0PC Avanti 
1,2-dipalmitoleoyl-sn-glycero-3-phosphocholine diC16:1PC Avanti 
1,2-dilauroyl-sn-glycero-3-phospho-(1'-rac-glycerol) diC12:0PG Avanti 
1,2-dioleoyl-sn-glycero-3-phospho-L-serine-N-(5-
dimethylamino-1-naphthalenesulfonyl) 
diC18:1PS-
dansyl 
Avanti 
Lipopolysaccharide from E. coli strain 0111:B4 LPS Sigma 
Table 2.11 Summary of lipids used in this thesis.  
 
2.5.2 SDS-PAGE REFOLDING ASSAY 
The chosen OMP (~500 µM) in 6 M GuHCl was diluted to a final concentration of 
4.8 µM in the presence of liposomes at an LPR of 3200:1 and varying concentrations of 
urea.  The liposome stock was prepared as described in Section 2.5.1.  Samples were 
typically allowed to refold for 16 h at either 25 °C or 37 °C before the addition of 2 × 
SDS-PAGE loading buffer (see Section 2.3.1) to quench the reaction.  The samples 
were then loaded on to an SDS-PAGE gel without boiling to resolve the folded and 
unfolded populations.  Boiled samples were included in the gel to allow identification of 
the unfolded band.  The folded population was estimated by comparing the relative 
intensities of the folded and unfolded bands by densitometry using GeneTools software 
(Syngene, UK) and a Syngene InGenius gel documentation system (Syngene, UK).  
The following buffers were used to give the desired pH: 
 50 mM citrate, pH 3.8 
 50 mM sodium phosphate, pH 7.0 or pH 8.0 
 50 mM glycine, pH 9.0 or pH 9.5 
 50 mM sodium borate, pH 10.0 
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2.5.3 TRYPTOPHAN FLUORESCENCE EMISSION SPECTRA 
Spectra were acquired using a Photon Technology International fluorimieter (Ford, 
West Sussex, UK).  Samples typically contained 0.4 μM OMP at an LPR of 3200:1 in 
50 mM buffer at the appropriate pH (see Section 2.5.2 for buffers used) and were 
incubated overnight at either 25 °C or 37 °C before measurement.  Spectra were 
recorded using an excitation wavelength of 280 nm, and recording emission from 
300 nm to 400 nm with excitation and emission slit widths set at 3 nm.  A step size of 
1 nm and resolution time of 1 s were used.  Corresponding blank spectra were 
subtracted for each sample. 
 
2.5.4 FAR-UV CIRCULAR DICHROISM 
Far-UV CD spectra were acquired on a Chirascan plus circular dichroism spectrometer 
(Applied PhotoPhysics) with a bandwidth of 1 nm, scan speed of 20 nm min
-1
, step size 
of 1 nm and a pathlength of either 0.1 mm or 1 mm.  The average of eight scans was 
taken to enhance signal to noise.  Samples typically contained 10 μM OMP in either 
50 mM sodium phosphate buffer, pH 8.0 or 50 mM glycine buffer, pH 9.5.  An LPR of 
800:1 was used to reduce light scattering.  Samples were refolded for 16 h before 
measurement.  Corresponding blank spectra were subtracted for each sample. 
 
2.5.5 OMPT AND OMPP ENZYME ACTIVITY ASSAYS 
5 μM OmpT or OmpP was refolded (16 h, 25 °C) into liposomes (prepared as described 
in Section 2.5.1) at an LPR of 3200:1 in 50 mM sodium phosphate, 5 mM EDTA, 
0.8 mg ml
-1
 LPS, pH 7.0 containing 3 M urea (OmpT) or 5 M urea (OmpP).  The folded 
OMP was diluted into a 50 μM solution of the internally quenched fluorogenic peptide 
Abz-Ala-Arg-Arg-Ala-Tyr(NO2)-NH2 to a final OMP concentration of 40–400 nM.  
The fluorescence change of the Abz group was monitored over time using a Photon 
Technology International fluorimeter (Ford, West Sussex, UK) using an excitation 
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wavelength of 325 nm and an emission wavelength of 430 nm.  Both excitation and 
emission slit widths were fixed at 3 nm.  Samples of 50 μM Abz-Ala-Arg-Arg-Ala-
Tyr(NO2)-NH2 in the presence of unfolded OMP or folded OMP in the absence of LPS 
were measured as controls.  The fluorescence of 50 μM Abz-Ala-Arg-Arg-Ala-
Tyr(NO2)-NH2 was subtracted from each trace. 
Initial enzyme activity was calculated as shown in Equation 2.1 using only the initial, 
linear part of the fluorescence trace. 
     
  
  
   
 
[   ]
 Equation 2.1 
 
where v0 is the initial activity of the enzyme in nmol μM
-1
 min
-1 
(nmol of substrate 
processed per μM enzyme per minute), 
  
  
 is the change in relative fluorescence intensity 
with respect to time (where the relative intensity is the intensity at time t divided by the 
maximum intensity at the endpoint of the reaction), S is the total amount of substrate in 
nmol, [OMP] is the concentration of enzyme in μM. 
The initial activity of the enzyme was calculated over a range of concentrations then 
averaged, and the standard error of the mean (SEM, Equation 2.2) determined. 
     
 
√ 
 Equation 2.2 
 
where σ is the standard deviation (calculated using Equation 2.3) of the rates and N is 
the number of liposome batch replicates.  
   
√
   (    ̅)
 
 
 Equation 2.3 
 
where xi is the initial activity of the enzyme at each enzyme concentration,  ̅ is the mean 
initial activity of the enzyme and N is the number of replicates. 
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2.5.6 EQUILIBRIUM DENATURATION ASSAYS 
To measure equilibrium curves in the unfolding direction, the chosen OMP (~500 µM) 
in 6 M GuHCl was diluted to 1.2 μM in an appropriate concentration of urea containing 
liposomes (prepared as described in Section 2.5.1) at an LPR of 3200:1 and refolded 
overnight at 25 °C.  This stock was then diluted to give samples containing 0.4 μM 
OMP (LPR 3200:1) with final urea concentrations in the range 3–10 M urea, as 
appropriate, and incubated for a minimum of 8 h at 25 °C before measuring.  To 
measure equilibrium curves in the refolding direction, the chosen OMP (~500 µM) in 
6 M GuHCl was diluted to 3.6 μM in an appropriate concentration of urea at an LPR of 
3200:1 and refolded overnight at 25 °C.  This stock was then diluted to 1.2 μM OMP in 
10 M urea at an LPR of 3200:1 and unfolded for a minimum of 8 h at 25 °C.  Samples 
were then prepared from the unfolded stock which contained 0.4 μM OMP (LPR 
3200:1) with final urea concentrations in the range 3–10 M urea and incubated 
overnight at 25 °C before measuring. 
The fluorescence emission spectrum of each sample was then measured as described in 
Section 2.5.3.  Corresponding blank spectra were subtracted from each spectrum and the 
average wavelength (< λ >) of each resulting spectrum was calculated according to 
Equation 2.4: 
 
      
        
     
 Equation 2.4 
 
where λi is the wavelength and Ii is the fluorescence intensity at that wavelength.   
< λ > was calculated over the range i = 320–370 nm in order to abolish the variation in 
absolute intensity which arises from pipetting liposomes
167.  < λ > does not vary linearly 
with the fraction of folded protein present in the solution
252
, however, it can be 
normalised using the ratio of the quantum yields of the folded and unfolded 
conformations over the same range of wavelengths used to calculate < λ > as shown in 
Equation 2.5
149; 252
: 
 
     
      
( )
      
( )
 Equation 2.5 
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where       ( ) is the sum of the intensities of the folded state spectrum over the range 
of wavelengths used to calculate < λ >,       ( ) is the sum of the intensities of the 
unfolded state spectrum over the range of wavelengths used to calculate < λ > and QR is 
the quantum ratio correction. 
Where the OMP equilibrium curves in the folding and unfolding directions could be 
overlaid, indicating folding reversibility, the equilibrium stability and denaturant 
dependence of the OMP were calculated by fitting to Equation 2.6, which defines a two-
state transition including a correction for quantum yield, using Igor Pro (Wavemetrics). 
 
       
 
  
[( [ ]   )    ((     
        [ ])   )]  ( [ ]    )
  
 
  
[   ((     
        [ ])   )]
 Equation 2.6 
 
where Sobs is the observed signal, a and c are the signals of the native and denatured states, 
respectively, in the absence of denaturant, b and d are the denaturant dependence of the 
signal of the native and denatured states, respectively, [D] is the denaturant concentration, 
     
     is the free energy of unfolding in the absence of denaturant,     is the m-value 
(which reflects the denaturant dependence of      
   ) and QR is the quantum yield ratio as 
defined in Equation 2.5. 
Where curves were not reversible, the apparent denaturation midpoint ([D]50% app) was 
estimated by fitting the unfolding transition to Equation 2.6 and using the obtained 
apparent values of           
    and         according to Equation 2.7. 
          
              [ ]        Equation 2.7 
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2.5.7 KINETIC UNFOLDING ASSAYS 
Changes in Trp fluorescence emission measured at 335 nm upon excitation at 280 nm 
were used to monitor OMP unfolding using a Photon Technology International 
Fluorimeter (Ford, West Sussex, UK) equipped with a thermally controlled four-cell 
changer. The temperature was maintained using a circulating water bath. 
The chosen OMP (~500 µM) in 6 M GuHCl was diluted to 4 µM in buffer containing 
liposomes (prepared as described in Section 2.5.1) at an LPR of 3200:1 and urea (3 M 
for OmpT, 7 M for PagP and HT PagP) and allowed to refold overnight.  Unfolding was 
initiated by rapid dilution into buffer containing high concentrations of urea (9–10 M).  
Samples were mixed manually and contained a final concentration of 0.4 µM OMP, 
1.28 mM liposomes (LPR 3200:1) and either 9 M urea (OmpT) or 10 M urea (PagP and 
HT PagP).  Kinetic transients were followed for up to 2 h and the kinetic traces were 
fitted to a single exponential function (Equation 2.8). 
             Equation 2.8 
 
where A is the signal change upon unfolding, k is the unfolding rate constant and c is the 
fluorescence end point. 
If a single exponential function did not satisfactorily fit the data as determined by the 
residuals of the fit, a double exponential equation was instead used (Equation 2.9). 
   (    
    )  (    
    )     Equation 2.9 
 
where A is the signal change upon unfolding, k is the unfolding rate constant and c is the 
fluorescence end point. 
  
105 
 
2.5.8 KINETIC UNFOLDING ASSAYS USING DANSYL-LABELLED LIPID 
The chosen OMP (~500 µM) in 6 M GuHCl was diluted to 4 µM in buffer containing 
liposomes doped with 1 % diC18:1PS-dansyl (prepared as described in Section 2.5.1) at 
an LPR of 3200:1 and 7 M urea and allowed to refold overnight.  Unfolding was 
initiated by rapid dilution into buffer containing 10 M urea.  Samples were mixed 
manually and contained a final concentration of 0.4 µM OMP, 1.28 mM liposomes 
(LPR 3200:1) and 10 M urea. 
OMP unfolding was monitored using a Photon Technology International Fluorimeter 
(Ford, West Sussex, UK) equipped with a thermally controlled four-cell changer.  
Samples were excited at 280 nm and emission was measured between 300–550 nm at 
regular intervals for up to 2 h.  Trp emission (300–400 nm) was used to follow OMP 
unfolding and the < λ > calculated as described in Equation 2.4.  Dansyl emission by 
FRET from nearby Trp residues was measured between 450–550 nm and used as a 
measure of the relative distance between the OMP and the liposome surface. 
The approximate area under the dansyl emission curve at each time point was estimated 
by calculating the sum of the fluorescence intensities between 450–550 nm.  The area 
was then normalised according to Equation 2.10 to give a measure of the proportion of 
FRET occurring relative to that of folded OMP in dansyl-doped liposomes. 
 
                  
              
           
 Equation 2.10 
 
where Asample is the area under the curve of the sample, Ablank is the area under the curve 
of the dansyl-doped liposomes in the absence of OMP and Amax is the area under the 
curve of the OMP folded in dansyl-doped liposomes. 
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2.6 FOLDING ASSAYS IN THE PRESENCE OF PERIPLASMIC CHAPERONES 
2.6.1 KINETIC REFOLDING ASSAYS 
Changes in Trp fluorescence emission measured at 335 nm upon excitation at 280 nm 
were used to monitor PagP folding using a Photon Technology International fluorimeter 
(Ford, West Sussex, UK) equipped with a thermally controlled four-cell changer. The 
temperature was maintained at 37 °C using a circulating water bath. A stock of 100 µM 
PagP unfolded in 10 M urea was rapidly diluted into buffer containing liposomes 
(prepared as described in Section 2.5.1) and urea to initiate folding. Samples were 
mixed manually and contained a final concentration of 0.4 µM PagP, 1.28 mM 
liposomes (LPR 3200:1) and varying concentrations of urea. Kinetic transients were 
followed for up to 2 h. For the kinetic experiments in the presence of periplasmic 
folding factors or lysozyme, PagP was first incubated in the presence of an excess of 
chaperone or lysozyme (three-fold molar excess of SurA or lysozyme; or a two-fold 
molar excess of Skp trimers) for 5 min at room temperature in 50 mM glycine buffer, 
pH 9.5, 0.24 M urea before being diluted six-fold into 50 mM glycine buffer, pH 9.5 
containing liposomes and varying concentrations of urea (2–4 M). Samples contained a 
final concentration of 0.4 µM PagP, 1.28 mM liposomes (LPR 3200:1).  Control 
experiments were carried out to ensure that this protocol did not alter the observed rate 
of PagP folding in the absence of Skp or SurA.   
For each sample four or more replicate traces were fitted using the global fit package in 
Igor Pro 6.0 (Wavemetrics) sharing the rate constants.  Kinetic traces were fitted to a 
single exponential function (Equation 2.8), using a negative value for the amplitude (A) 
to reflect the increase in fluorescence signal upon folding.  Each experiment was 
measured using three different batches of liposomes, and the rate constant obtained 
from the global fits for each batch averaged.  The standard error of the mean was then 
calculated (Equation 2.2). 
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2.6.2 SDS-PAGE ANALYSIS OF FOLDING YIELD 
An unfolded PagP stock was diluted to a concentration of 4 μM in the presence of 
liposomes (prepared as described in Section 2.5.1) at an LPR of 3200:1 and an excess of 
chaperone or lysozyme (three-fold molar excess of SurA or lysozyme; or a two-fold 
molar excess of Skp trimers), in 50 mM glycine buffer, pH 9.5 containing the specified 
concentration of urea. Typically samples were allowed to refold for 16 h at 37 °C before 
folding was quenched by the addition of 2 × SDS-PAGE loading buffer (see Section 
2.3.1). The samples were then loaded onto a Tris-tricine SDS-PAGE gel without boiling 
and electrophoreised (see Section 2.3.1) 
 
2.6.3 ANALYTICAL GEL FILTRATION 
To analyse the interaction between PagP and SurA, a stock solution of PagP unfolded in 
50 mM glycine, pH 9.5 containing 10 M urea was diluted to 10 μM in 50 mM glycine, 
pH 9.5 in 0.24 M urea and allowed to incubate at room temperature for 5 min in the 
presence of 60 μM SurA. To analyse the interaction between lysozyme and PagP, 2 μM 
PagP was added to 6 μM lysozyme in 50 mM glycine, pH 9.5 containing 0.24 M urea 
and incubated for 5 min at room temperature.  In all experiments, 200 μL of the sample 
was then injected onto a Superdex 75 10/300 GL column (GE Healthcare, UK) 
equilibrated in 50 mM glycine, pH 9.5 and controlled by an ÄKTA prime purification 
system. The protein was eluted at a flow rate of 0.5 ml min
-1
 and 0.5 ml fractions were 
collected for analysis by SDS-PAGE (see Section 2.3.1).  Under these conditions, 
lysozyme interacted with the Superdex resin hence the requirement to use very low 
protein concentrations, which prevented the analysis of the eluted fractions by SDS-
PAGE.  Appropriate PagP only, SurA only, and lysozyme only samples were also 
analysed.  
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2.6.4 ANS BINDING 
Fluorescence emission spectra of 8-anilinonaphthalene-1-sulfonic acid (ANS) were 
acquired using a Photon Technology International fluorimieter (Ford, West Sussex, UK) 
in the presence or absence of PagP.  100 μM PagP in 50 mM glycine buffer, pH 9.5 was 
diluted to a final concentration of 1 μM PagP in buffer containing 250 μM ANS, 0.24 M 
urea, 50 mM glycine, pH 9.5 and allowed to incubate for 5 min at 25 °C before 
measurement.  The spectrum of 1 μM PagP in buffer containing 250 μM ANS, 10 M 
urea, 50 mM glycine, pH 9.5 was also measured as a non-binding control, along with 
the spectra of 250 μM ANS in both buffer conditions in the absence of PagP. 
Spectra were acquired by excitation of ANS at 389 nm and measurement of the 
emission between 400 nm and 600 nm with 1 nm resolution and 1 s integration time.  
The excitation and emission slit widths were set at 4 nm.  Three spectra were recorded 
for each sample and averaged. 
 
2.6.5 CHAPERONE BINDING TO NICKEL-SEPHAROSE-IMMOBILISED HT PAGP 
10 μM HT PagP was bound to nickel Sepharose resin (GE Healthcare) equilibrated in 
6 M GuHCl, 250 mM NaCl, 10 mM Tris, pH 8.0 containing 5 mM imidiazole for 2 h at 
4 °C.  The resin was then washed with deionised water followed by equilibration in 
50 mM glycine, pH 9.5.  10 μM lysozyme, SurA or Skp was then added and allowed to 
bind for 1 h in 50 mM glycine buffer, pH 9.5 containing 5 mM imidazole.  The resin 
was then washed with 20 mM imidazole in 50 mM glycine, pH 9.5.  Elution of bound 
protein was carried out at room temperature using 50 mM glycine, pH 9.5 containing 
5 M urea and 500 mM imidazole.  The final eluent and the unbound fractions were 
analysed by SDS-PAGE (see Section 2.3.1). 
  
109 
 
2.6.6 SKP HOLDASE ASSAY 
HT PagP (21.6 µM) was incubated in 50 mM glycine, pH 9.5, 1 M urea in the presence 
of a two-fold molar excess of Skp trimers or a six-fold molar excess of hen egg white 
lysozyme.  After 5 min, the samples were diluted six-fold into diC12:0PC liposomes 
(prepared as described in Section 2.5.1) at an LPR of 3200:1 and allowed to equilibrate 
overnight at 37 °C.  The supernatant of each sample after centrifugation in a microfuge 
(13000 rpm, 30 min) was analysed by SDS-PAGE (see Section 2.3.1), with and without 
boiling, and by Western blotting (see Section 2.3.3).  As a control, each protein was 
incubated in 1 M urea then mixed with liposomes individually.  In order to estimate the 
amount of HT PagP rescued from aggregation by Skp, 3.6 μM HT PagP solubilised in 
50 mM glycine, pH 9.5 containing 10 M urea was included on the gels as a loading 
control (data not shown).  Densitometry was carried out using GeneTools image 
analysis software (Syngene) to estimate the intensity of the relevant bands and the 
fraction rescued calculated by dividing the intensity of the test band by the intensity of 
the loading control. 
 
2.6.7 EQUILIBRIUM DENATURATION OF PERIPLASMIC CHAPERONES 
SurA was dissolved in 50 mM glycine buffer, pH 9.5 and diluted into separate aliquots 
of 50 mM glycine buffer containing different concentrations of urea (0–8 M in 0.2 M 
increments).  The final concentration of protein was 2.5 μM.  The aliquots were 
equilibrated overnight (16 h) at 37 °C before measurement.  The fluorescence emission 
intensity was measured at 335 nm (following excitation at 280 nm), due to the large 
intensity difference between the folded and unfolded states at this wavelength, for 60 s 
and the average signal calculated. 
Equilibrium denaturation of Skp was also carried out in 50 mM glycine, pH 9.5 and 
followed a similar protocol, however, the final concentration of Skp in each aliquot was 
increased to 15 μM.  Following overnight equilibration at 37 °C, the far-UV CD signal 
at 222 nm of each sample was recorded for 60 s and averaged.  Far-UV CD was used as 
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Skp contains no Trp residues and thus cannot easily be studied using tryptophan 
fluorescence emission. 
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3 OMPT AND OMPP: ESTABLISHING A NEW MODEL FOLDING SYSTEM  
3.1 INTRODUCTION 
The first detailed investigation on the folding mechanism of an OMP was that on 
OmpA, an ion channel from E. coli. These studies revealed that folding and membrane 
insertion occurs as a concerted process that is highly dependent on bilayer properties 
(see Section 1.6)
144; 145; 147; 153; 161
.  Only one other OMP, a C-terminally his-tagged 
construct of the E. coli acyltransferease PagP, has been the subject of a detailed folding 
analysis (described in Section 1.8.2)
167; 238; 240
.  The work of Huysmans et al
167; 238; 240
 
revealed that folding of HT PagP is also highly influenced by membrane properties
240
 
and proceeds via a tilted insertion mechanism, with concerted folding and membrane 
insertion
167
.  From these data it can be concluded that folding and membrane insertion 
of bacterial OMPs is likely to be a concerted process, however, the polarised transition 
state for HT PagP folding
167
 could arise from the presence of an N-terminal α-helix 
(Figure 1.3a)
49; 231; 232
 in the structure of this protein which is not conserved in the OMP 
family (Figure 1.3).  The N-terminal α-helix has been shown to increase the stability of 
folded PagP as its deletion causes an increased rate of PagP unfolding
238
, suggesting 
that this structural feature does indeed influence the folding pathway.  While similarities 
and differences in the folding mechanisms of OmpA and HT PagP are apparent, it is 
clear that detailed folding information on a larger subset of OMPs will be required to 
fully understand the underlying principles of OMP folding. 
The use of the “fold approach”, that is, the study of structurally related proteins in order 
to find generic folding principles, has been long established in the field of soluble 
protein folding (see Section 1.7)
175; 177
.  Recently, the work of the Fleming group has 
begun to apply this approach to OMP folding by conducting folding screens of nine 
different OMPs in order to find the optimal folding conditions for maximum folding 
efficiency
162; 164; 174
.  These studies have so far been unable to achieve the level of 
mechanistic detail reported for OmpA
144; 145; 147; 153; 161
 or HT PagP
167; 238; 240
, resulting in 
limited opportunities to compare and contrast OMP folding pathways.  In order to 
expand current knowledge in this area, the OM proteases, OmpT and OmpP, were 
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selected as the subject of preliminary folding studies to assess their suitability as OMP 
folding models. 
 
3.1.1 THE OUTER MEMBRANE PROTEASES OMPT AND OMPP 
The OM proteases, OmpT and OmpP, of E. coli have been linked to bacterial 
pathogenicity, due to their ability to cleave antimicrobial peptides such as colicins 
secreted by competing bacteria and proteamines secreted by mammalian urinary tract 
epithelial cells
253; 254
.  The crystal structure of OmpT (Figure 1.3c) revealed it to be a 
10-stranded, antiparallel β-barrel with long loops protruding from the extracellular face 
of the OM, which form the active site
51
.  Determination of the inhibitor profile of OmpT 
led to its classification as a serine protease
255
 and mutagenesis studies were later 
undertaken using a fluorogenic peptide to monitor peptidase activity to test this 
classification with the results suggesting that histidine-212 and serine-99 are active site 
residues
242
.  Unlike a conventional serine protease, however, the mutation of the serine 
did not completely abolish enzymatic activity
242
.  Analysis of the crystal structure 
showed that serine-99 is approximately 9 Å away from histidine-212, suggesting that 
this serine residue was unlikely to be directly involved in the catalytic mechanism 
(Figure 3.1)
51
.   
Further mutagenesis work was undertaken to elucidate the OmpT catalytic 
mechanism
256
.  The very negative environment of the active site was suggested to 
promote the specific cleavage between basic residues, with aspartate-210 and histidine-
212 making up a novel catalytic dyad
51; 256
.  Activation of a water molecule by histidine-
212 creates the nucleophile for the reaction, with aspartate-210 acting to stabilise the 
build up of positive charge on histidine-212 during catalysis
51; 256
.  Serine-99 was 
proposed to orient the substrate in the active site, explaining why mutation of this 
residue causes lowered peptidase activity
256
.  These results were supported by 
microsecond-long MD simulations of OmpT, which suggested that mutation of serine-
99 caused the loss of a hydrogen bond with the substrate, leading to its dissociation 
from the enzyme
257
.  Mutation of either aspartate-83 or aspartate-85 to alanine also 
abolished the protease activity of OmpT, suggesting these residues play an important 
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role in the catalytic mechanism, perhaps by coordinating the water molecule and 
activating it as a nucleophile
256
. 
 
 
Figure 3.1 The active site residues of OmpT.  Ribbon diagram showing the location of 
the active site residues aspartate-210 and histidine-212 in yellow and aspartate-83 and 
aspartate-85, which coordinate the water nucleophile, in red (left).  The enlargement 
shows the same residues viewed from above (right).  Side chains of active site residues 
are shown using stick representation.  The position of serine-99 is also shown in red; 
however crystallisation was carried out on the S99A variant of the protein.  Amino acids 
are labelled using the standard three-letter codes.  This image was generated from 
Protein Data Bank (PDB)
43
 file (1I78
51
) using UCSF Chimera molecular visualization 
application
44
.   
 
OmpT refolding in vitro (monitored by cold SDS-PAGE assays) was first reported into 
micelles of N-dodecyl-N,N-dimethyl-1-ammonio-3-propanesulphonate
138
.  Acquisition 
of far-UV CD spectra of OmpT in these detergent micelles confirmed the high β-sheet 
content of the sample, suggesting that it is indeed folded in this environment.  Despite 
successful refolding, the enzyme was found to be inactive until LPS was added 
indicating that although this molecule is not required for folding of OmpT, it is required 
for its activity
138
.  Further investigation revealed that other membrane lipids are unable 
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to activate the enzyme
258
.  It was proposed that this is a safety mechanism to prevent 
activation of OmpT during trafficking to the OM and that LPS may allosterically 
activate the enzyme via a subtle conformational change in the active site since the far-
UV CD spectrum of the LPS-OmpT complex was not significantly different from the 
spectrum of OmpT alone
258
. 
More recently, cold SDS-PAGE has been used to monitor the folding of OmpT into 
lipid vesicles alongside eight other OMPs
162
.  The results suggest that OmpT folding 
yield is highest in liposomes composed of PC lipids with shorter acyl chains at high pH 
but PE and PG are tolerated as guest lipids
162
.  In liposomes composed of lipids with 
longer acyl chains, folding yield of OmpT was improved by decreasing vesicle diameter 
and hence increasing membrane curvature
162
.  The rate of OmpT folding and insertion 
into SUVs of native E. coli lipids was shown to be unaffected by the presence of the 
molecular crowding agent Ficoll 70, but with a reduced overall folding efficiency
259
.  
Analysis of analytical ultracentrifugation data allowed the aggregation propensity of 
unfolded OMPs to be assessed and revealed that OmpT is particularly aggregation 
prone below 3 M urea or in the presence of salt but that higher pH (8–10) can reduce the 
extent of aggregation
164
. 
In contrast with OmpT, little is known about OmpP; a crystal structure has not been 
obtained and refolding in vitro has not been reported.  The substrate specificity of 
OmpP, however, has been studied and is very similar to OmpT
243; 245
.  Both proteins 
cleave peptides between basic residues with arginine being preferred in the P1 and P1’ 
positions, but OmpP showed a greater ability to accept lysine in either position
243; 245
.  
The similar but non-identical substrate specificities of OmpT and OmpP, and their co-
expression in vivo, suggests that these proteins work together to provide protection 
against a range of antimicrobial peptides
51; 245; 254
.  Disregarding the N-terminal signal 
sequences, OmpT shares 87 % sequence similarity (and 71 % sequence identity) with 
OmpP
244; 245
 allowing a homology model of OmpP to be created from the crystal 
structure of OmpT (Figure 3.2).  While the residues responsible for the catalytic 
mechanism are conserved, the active site cleft of OmpP contains approximately half of 
the non-conserved residues and these differences could explain how the differences in 
substrate specificity of the two proteins arise
243; 245
. 
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Figure 3.2  Homology model of OmpP showing non-conserved residues.  Ribbon 
diagram showing the location of the active site residues aspartate-207 and histidine-209 
in yellow and aspartate-80, aspartate-82 and serine-96, which are also involved in 
catalysis, in red (left).  Residues which are not conserved in OmpT are shown in blue.  
Extra aromatic residues in the periplasmic aromatic girdle which are not found in OmpT 
(tryptophan-60, phenylalanine-117 and phenylalanine-191) are indicated by black 
arrows.  The enlargement shows the same residues viewed from above (right).  Side 
chains of coloured residues are shown using stick representation.  This model was 
created from the Protein Data Bank (PDB)
43
 file (1I78
51
) of the OmpT crystal structure 
using MODELLER
260
 with help from Theodoros Karamanos (University of Leeds) and 
the image was generated using UCSF Chimera molecular visualization application
44
.   
 
The previous work on OmpT demonstrates the viability of this protein as a subject for in 
vitro folding studies as it can be over-expressed and purified in E. coli, and refolded in 
the absence of chaperones
138; 162; 259
.  The protease activity of OmpT has also been 
shown to be a useful reporter of correct folding of this protein in vitro
137
.  The parallel 
study of the homologous protein, OmpP, aims to identify the similarities and differences 
between the folding of OMPs which are similar in structure and sequence.  Both OmpT 
and OmpP were cloned from E. coli DNA, and protocols were established for the over-
expression and purification of both His-tagged and untagged constructs.  Folding 
screens were then carried out on the untagged construct of both proteins into diC12:0PC, 
diC14:0PC and diC16:1PC liposomes (Figure 3.3), revealing that these OMPs are able to 
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fold with high efficiency to the native state in a range of lipid conditions.  Under all 
conditions tested, OmpT is seen to require lower urea concentrations than OmpP to 
reduce aggregation and promote folding.  Additionally, once inserted, OmpP requires 
lower concentrations of denaturant to induce unfolding.  Given that many of the non-
conserved residues in OmpP are localised in the active site, these results suggest that the 
reduced stability of OmpP and increased aggregation propensity result from the need to 
sacrifice stability and folding efficiency in order to optimise function. 
 
 
Figure 3.3 Structures of PC lipids used in this chapter.  (a) 1,2-dilauroyl-sn-glycero-3-
phosphocholine (diC12:0PC); (b) 1,2-dimyristoyl-sn-glycero-3-phosphocholine 
(diC14:0PC); and (c) 1,2-dipalmitoleoyl-sn-glycero-3-phosphocholine (diC16:1PC). 
  
Following the development of folding and functional assays to study OmpT and OmpP 
insertion into liposomes, these experiments were adapted in collaboration with Aneika 
C. Leney (University of Leeds) to fold OmpT into the Apol, A8-35.  OmpT folded with 
almost 100 % efficiency to its native state and study of the protein by electrospray 
ionisation-mass spectrometry (ESI-MS) was successful.   
The work described in Section 3.2.6 has been published in: Leney, A. C., McMorran, L. 
M., Radford, S. E. & Ashcroft, A. E. (2012). Amphipathic polymers enable the study of 
functional membrane proteins in the gas phase. Anal. Chem. 84, 9841-9847. © 2012 
American Chemical Society. 
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3.2 RESULTS 
3.2.1 CLONING, OVER-EXPRESSION AND PURIFICATION OF HIS-TAGGED CONSTRUCTS 
3.2.1.1 Gene Cloning 
The genes encoding the OmpT and OmpP proteins were amplified from E. coli strain 
XL1-blue (Stratagene, UK)
247
 as described in Section 2.2.  Primers were designed to 
allow amplification of the DNA encoding the mature protein sequences, that is, the 
proteins without the N-terminal signal sequences that result in targeting to the OM.  
Removal of the signal sequence results in cytoplasmic protein expression as insoluble 
inclusion bodies
162
.  Primers included an NdeI restriction site 5’ to the gene as this 
introduces an ATG start codon to the sequence and a BamHI restriction site 3’ to the 
gene.  Digestion of the amplified genes with these enzymes creates overhangs that are 
complementary to those within a pET11a plasmid digested with the same enzymes, 
allowing the ligation of the genes into the desired vector.  Additionally, a sequence 
encoding a hexa-histidine tag (His-tag) was included on the N-terminal primers between 
the NdeI restriction site and the sequence coding for the mature proteins to facilitate 
purification.  In order to remove the His-tag following protein purification, a 
recognition site for Tobacco Etch Virus protease (TEVp) was encoded between the gene 
sequence and the His-tag on each N-terminal primer.  The sequences of the primers 
used are provided in Table 2.2 and a schematic of the designed primers is shown in 
Figure 3.4.  The full DNA and protein sequences for His-tagged OmpT (HT OmpT) and 
His-tagged OmpP (HT OmpP) are provided in the Appendix. 
Bacterial chromosomal DNA was extracted from E. coli XL1-blue cells by diluting a 
liquid culture of the bacteria with deionised water and boiling to lyse the cells.  This 
solution was then used directly as a DNA template in a series of polymerase chain 
reactions (PCR) containing different concentrations of Mg
2+
 to find the optimum 
amplification conditions as described in Section 2.2.6.  Amplification of the HT OmpT 
and HT OmpP genes from the bacterial DNA was successful (Figure 3.5) and following 
gel electrophoresis the desired bands were excised from the gel and purified by gel 
extraction (see Section 2.2.6).  The amplified genes were “A-tailed” by incubation with 
dATP and Taq polymerase before ligation into a shuttle vector, pGEM-T Easy vector 
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(Promega, UK), which is supplied as a linearised plasmid with a single T overhang at 
the 5’ end of each DNA strand (Section 2.2.7).  The ligation products were transformed 
into E. coli XL1-blue cells and colonies containing putative inserts identified using 
blue/white colour screening (Section 2.2.7).  Following ligation of both the genes, the 
transformation plates contained around 200 colonies, of which half were white.  Six 
white colonies were selected from each plate and grown in a 5 ml overnight liquid 
culture before the plasmid DNA was extracted and then digested using the restriction 
enzymes BamHI and NdeI as described in Section 2.2.8.  Plasmids that were found to 
contain an insert of the expected size (939 bp and 924 bp for HT OmpT and HT OmpP, 
respectively) were sent for DNA sequencing.  Once the correct sequence had been 
confirmed, inserts were purified by restriction digestion followed by agarose gel 
electrophoresis and gel extraction. 
Ligation into the pET11a vector, which had been digested with the same restriction 
enzymes as the HT OmpT and HT OmpP genes, was carried out as described in Section 
2.2.9.  These reactions led to successful transformation of E. coli XL1-blue cells, with 
around 150 colonies on each transformation plate.   Six colonies were picked and grown 
as liquid cultures from which plasmid DNA was purified. Samples of DNA from each 
culture were digested using the restriction enzymes BamHI and NdeI to confirm the 
presence of inserted genes (Figure 3.6).  Plasmids which contained digested inserts of 
the correct size (939 bp and 924 bp for HT OmpT and HT OmpP, respectively) were 
sent for DNA sequencing and confirmed to contain the correct sequences for HT OmpT 
(plasmid pLMM01) and HT OmpP (plasmid pLMM02) (see Appendix). 
 
 
Figure 3.4 Schematic of primers designed to create HT OmpT and HT OmpP 
constructs.  The location of the NdeI restriction site is shown in red, the sequence 
coding for a Tobacco Etch Virus protease (TEVp) cut site shown in yellow, the 
sequence coding for the hexa-histidine tag (His-tag) shown in green and the BamHI 
restriction site shown in blue.   
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Figure 3.5 Agraose gel electrophoresis following PCR to amplify genes encoding HT 
OmpT and HT OmpP from E. coli chromosomal DNA.  PCR was carried out to amplify 
the genes encoding (a) OmpT and (b) OmpP from the DNA of XL1-blue E. coli cells.  
Lanes show replicate samples and are labelled according to the final concentration of 
Mg
2+
 in each sample.  Control reactions contained all components except the DNA 
template.  The number of base pairs (bp) corresponding to bands in the DNA marker are 
indicated.  DNA fragments of correct expected size are labelled with red arrows.  Note 
that the amplified OmpT is expected to contain 952 bp and the amplified OmpP is 
expected to contain 937 bp.  
 
 
Figure 3.6 Analytical restriction digests following ligation of the genes encoding HT 
OmpT and HT OmpP into the pET11a plasmid vector.  Sample lanes contain the 
products of digestion reactions of DNA taken from different single colonies transformed 
with (a) HT OmpT gene and (b) HT OmpP gene ligation mixtures.  DNA fragments of 
correct expected size are labelled with red arrows.  Single enzyme digestion reactions 
and enzyme-free reactions of pET11a are included.  The number of base pairs (bp) 
corresponding to bands in the DNA marker are indicated.   
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3.2.1.2 Over-Expression  
The plasmid vectors containing the genes for HT OmpT (pLMM01) or HT OmpP 
(pLMM02) were transformed into E. coli strain BL21 (DE3)
248
 (Stratagene, UK) and 
grown on agar under antibiotic selection.  Single colonies were used to inoculate 5 ml 
overnight cultures, which in turn were used to inoculate 100 ml lysogeny broth (LB) 
cultures at a ratio of 1:100.  Protein production was induced by addition of isopropyl-β-
D-thiogalactoside (IPTG) to a final concentration of 1 mM upon the culture reaching an 
OD600 of 0.6 (see Section 2.4.1).  After induction of protein expression, 1 ml samples 
were removed from the cultures every two hours to monitor protein over-expression.  
To ensure comparative loadings at each of the time points, the OD600 of each sample 
was measured, the cells harvested by centrifugation and then resuspended in 100 µl 
SDS-loading buffer for each OD600 unit.  Bands corresponding to proteins of the 
expected molecular masses (35.3 kDa and 34.9 kDa for HT OmpT and HT OmpP, 
respectively) were observed in the cell lysate of whole cell boils by SDS-PAGE (Figure 
3.7).  Protein expression reached a maximum four hours after induction, indicating that 
this is a sufficient amount of time for protein production to occur before the cells are 
harvested. 
 
 
Figure 3.7 Small-scale expression trials of HT OmpT and HT OmpP.  100 ml E. coli 
BL21 (DE3) cultures were transformed with (a) pLMM01 encoding HT OmpT and (b) 
pLMM02 encoding HT OmpP and grown at 37 °C with shaking.  Protein expression 
was induced at an OD600 of 0.6 with 1 mM IPTG.  Samples are labelled according to the 
time after induction at which they were removed.  The size in kiloDaltons (kDa) of the 
protein markers is indicated.  
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Given the high levels of over-expression observed for both HT OmpT and HT OmpP in 
small scale expression trials, the use of large volumes of bacterial culture were deemed 
unnecessary for the production of these proteins.  Instead, a single 1000 ml culture or 
two 500 ml cultures of BL21 (DE3) cells transformed with pLMM01 and pLMM02 
were grown.  Expression was induced with 1 mM IPTG at an OD600 of 0.6 and cell 
growth continued for a further four hours (37 
o
C, 200 rpm).  Cells were harvested by 
centrifugation and the cell pellets weighed (Table 3.1).  The higher yield of bacterial 
cells from the two 500 ml cultures grown in two-litre conical flasks compared with one 
1000 ml culture grown in a two-litre conical flask suggests that growing the bacteria in 
smaller volumes relative to the total volume of the conical flask will increase the final 
protein yield.  This procedure was adopted for all further experiments. 
 
Culture volume 
(ml) 
Mass of HT OmpT 
cell pellet (g) 
Mass of HT OmpP 
cell pellet (g) 
1 × 1000 2.76 2.74 
2 × 500 3.46 3.57 
Table 3.1  Cell pellet yields for BL21 (DE3) cultures transformed with either plasmid 
pLMM01 (encoding HT OmpT) or pLMM02 (encoding HT OmpP).  All cultures were 
grown in conical flasks with a capacity of two litres.  
 
3.2.1.3 Purification 
To enable purification of HT OmpT and HT OmpP, two 500 ml cultures of BL21 (DE3) 
cells transformed with the appropriate plasmid were grown as described above (Section 
3.2.1.2). The cells were then harvested by centrifugation before lysis by sonication 
(Section 2.4.2). Lysed cells were treated with a 2 % (v/v) solution of Triton X-100 
(Calbiochem, Germany) to solubilise the membranes.  The insoluble fraction was then 
collected by centrifugation and washed with 25 mM Tris-HCl, pH 8.0 to remove any 
residual detergent (Section 2.4.2).  Many of the impurities present are removed with the 
soluble fraction and only a small amount of the desired protein is lost (Figure 3.8). 
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The isolated inclusion bodies were next solubilised and HT OmpT and HT OmpP 
purified further by nickel affinity chromatography (see Section 2.4.3).  Briefly, the 
inclusion body was solubilised in 6 M GuHCl, 50 mM sodium phosphate, 250 mM 
NaCl, pH 8.0 and bound to 4 ml of nickel Sepharose resin (GE Healthcare, UK).  The 
resin was washed with buffer containing 5 mM imidazole, before elution in buffer 
containing 250 mM imidazole.  The protein was then dialysed against dH2O and the 
precipitate redissolved in 6 M GuHCl, 25 mM Tris-HCl, pH 8.0 and stored in 200 µl 
aliquots at -80 °C.  Protein greater than 95 % in purity was obtained for both HT OmpT 
and HT OmpP with yields of approximately 80 mg pure protein per litre of culture 
(Figure 3.9).  
 
Figure 3.8  SDS-PAGE gels showing the protein content of the discarded soluble 
fractions during inclusion body isolation.  During isolation of (a) HT OmpT and (b) HT 
OmpP inclusion bodies, small amounts of the desired protein are lost.  Lanes are 
labelled as follows: lane 1 contains the soluble fraction of the whole cell lysate, lanes 2 
and 3 contain the supernatant from subsequent detergent treatments after the insoluble 
fraction was collected by centrifugation and lanes 4–6 contain the supernatant from 
subsequent buffer washes after the insoluble fraction was collected by centrifugation.  
The size in kiloDaltons (kDa) of the protein markers is indicated. 
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Figure 3.9 Purification of HT OmpT and HT OmpP using nickel affinity 
chromatography.  SDS-PAGE gels showing (I) impure solubilised inclusion bodies, 
(B) buffer containing unbound protein after addition to nickel Sepharose resin, 
(W) wash buffer containing 5 mM imidazole and (E) eluted protein after addition of 
250 mM imidazole of both (a) HT OmpT and (b) HT OmpP.  Purification of both 
proteins was carried out in 50 mM sodium phosphate, 6 M GuHCl, 250 mM NaCl, 
pH 8.0.  The size in kiloDaltons (kDa) of the protein markers is indicated.  
 
3.2.1.4 Tobacco Etch Virus Protease (TEVp) Cleavage 
Following purification of HT OmpT and HT OmpP, removal of the His-tag was 
attempted using TEVp (kindly provided by Alessandro Sicorello, University of Leeds).  
His-tagged OMPs in 50 mM sodium phosphate, pH 8.0 containing 10 M urea were 
diluted into low urea (final concentration of 2, 3 or 4 M) or added to 12 mM Tween-20 
in the presence of 1 M urea.  TEVp was added at an OMP:TEVp ratio of 1:5 and 
incubated for 3 h at either 25 °C or 30 °C.  In all experiments, the OMP concentration 
was 5 μM.  Following analysis of the reactions by SDS-PAGE, it was shown that for 
HT OmpT a small amount of cleaved product was observable in 2 M urea or in Tween-
20 and 1 M urea, while for HT OmpP only 2 M urea gave any observable cleaved 
product (Figure 3.10).  This may be due to unfolding of TEVp in the presence of urea or 
Tween-20. Alternatively, inaccessibility of the TEVp cut site due to collapse of the 
OMPs in the presence of low urea or burial of the cut site within the Tween-20 micelle.  
Since no condition tested gave a high yield of cleaved product, it was instead decided to 
use a purification strategy based on untagged constructs in order to improve the final 
yield of protein obtained. 
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Figure 3.10 Cleaving the His-tag from OmpT and OmpP using Tobacco Etch Virus 
protease (TEVp).  (a) HT OmpT and (b) HT OmpP were diluted to 2, 3 or 4 M urea, or 
1 M urea in the presence of 12 mM Tween-20 (indicated at 2M, 3M, 4M and Tween, 
respectively) and incubated for 3 h in the presence of a 1:5 excess of TEVp.  Reactions 
were carried out at either 25 °C or 30 °C.  Black arrows indicate the bands 
corresponding to uncleaved OmpT/P and TEVp, while the red arrow indicates the band 
corresponding to cleaved OmpT/P.  All reactions were carried out on 5 μM protein in 
50 mM sodium phosphate, pH 8.0.  The size in kiloDaltons (kDa) of the protein markers 
is indicated.  TEVp was kindly supplied by Alessandro Sicorello, University of Leeds.  
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3.2.2 CLONING, OVER-EXPRESSION AND PURIFICATION OF UNTAGGED CONSTRUCTS 
3.2.2.1 Cloning 
To create constructs for the over-expression of untagged variants of OmpT and OmpP, 
primers were designed to amplify the genes encoding the mature sequences of the 
proteins using the plasmids pLMM01 and pLMM02 as templates.  Forward primers 
were designed to include an NdeI restriction site 5’ to the gene as this introduces an 
ATG start codon to the sequence.  The reverse primer was designed to adhere to the 
pET11a plasmid 3’ to the end of the gene encoding the desired protein, no restriction 
site was included in this primer, as the original pLMM01 and pLMM02 plasmids 
include a BamHI restriction site 3’ to the gene.  The sequences of the primers used are 
provided in Table 2.4 and a schematic of the designed primers is shown in Figure 3.11.  
The full gene and protein sequences for untagged variants of OmpT and OmpP are 
provided in the Appendix. 
 
 
Figure 3.11 Schematic of the cloning strategy used to create untagged OmpT and 
OmpP constructs.  The location of NdeI restriction sites are shown in red, the sequence 
coding for a Tobacco Etch Virus protease (TEVp) cut site shown in yellow, the 
sequence coding for the hexa-histidine tag (His-tag) shown in green and the BamHI cut 
site shown in blue.  The designed primers are shown as black lines at the approximate 
locations where they bind to the plasmid template.  
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Amplification of the genes encoding OmpT and OmpP was successful using a series of 
PCR reactions containing different concentrations of Mg
2+
 to find the optimum 
amplification conditions (Figure 3.12) as described in Section 2.2.6.  Following gel 
electrophoresis the desired bands were excised from the gel and purified by gel 
extraction (see Section 2.2.6).  The expected sizes of the fragments were 937 bp for 
OmpT and 922 bp for OmpP.   
 
 
Figure 3.12 Agarose gel electrophoresis following PCR to amplify genes encoding 
OmpT and OmpP.  PCR was carried out to amplify the genes encoding (a) OmpT and 
(b) OmpP using plasmid templates.  Lanes show replicate samples and are labelled 
according to the final concentration of Mg
2+
 in each sample.  Control reactions 
contained all components except the DNA template.  The number of base pairs (bp) 
corresponding to bands in the DNA marker are indicated.  DNA fragments of correct 
expected size are labelled with red arrows.  Note that the amplified OmpT fragment is 
expected to contain 937 bp and the amplified OmpP fragment is expected to contain 922 
bp.  
 
The cloning strategy employed resulted in amplified fragments with a minimum of 12 
bp on either side of the restriction enzyme binding sites, so the use of a shuttle vector 
was deemed unnecessary.  Following restriction digestion reactions with NdeI and 
BamHI enzymes as described in Section 2.2.8, inserts were ligated directly into pET11a 
digested with NdeI and BamHI as described in Section 2.2.9.  These reactions led to 
successful transformation of E. coli XL1-blue cells, with around 50 colonies on each 
transformation plate.   Six colonies were picked and grown as liquid cultures from 
which plasmid DNA was purified. Samples of DNA from each culture were digested 
using the restriction enzymes BamHI and NdeI to confirm the presence of inserted 
sequences (Figure 3.13).  Plasmids which contained digested inserts of the correct size 
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(900 bp and 885 bp for OmpT and OmpP, respectively) were sent for DNA sequencing 
and confirmed to contain the correct sequences for OmpT (plasmid pLMM03) and 
OmpP (plasmid pLMM04) (see Appendix). 
 
 
Figure 3.13 Analytical restriction digests following ligation of the genes encoding 
OmpT and OmpP into the pET11a plasmid vector.  Sample lanes contain the products 
of digestion reactions of DNA taken from different single colonies transformed with 
ligation mixtures containing (a) the gene encoding OmpT and (b) the gene encoding 
OmpP.  DNA fragments of correct expected size are labelled with red arrows.  Single 
enzyme digestion reactions and enzyme-free reactions of pET11a are included.  The 
number of base pairs (bp) corresponding to bands in the DNA marker are indicated.   
 
3.2.2.2 Over-Expression  
The plasmid vectors containing the genes encoding OmpT (pLMM03) or OmpP 
(pLMM04) were transformed into E. coli strain BL21 (DE3) (Stratagene, UK) and 
grown on agar under antibiotic selection.  Single colonies were used to inoculate 5 ml 
overnight cultures, which in turn were used to inoculate 100 ml LB cultures at a ratio of 
1:100.  Protein production was induced by addition of IPTG to a final concentration of 1 
mM upon the culture reaching an OD600 of 0.6 (see Section 2.4.1).  Protein over-
expression was monitored as described for the His-tagged proteins in Section 3.2.1.2.  
Bands corresponding to proteins of the expected molecular masses (33.6 kDa and 33.2 
kDa for OmpT and OmpP, respectively) were observed in the cell lysate of whole cell 
boils by SDS-PAGE (Figure 3.14).  Protein expression reached a maximum four hours 
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after induction, indicating that this is a sufficient amount of time for protein production 
to occur before the cells are harvested. 
 
 
Figure 3.14 Small-scale expression trials of OmpT and OmpP.  100 ml E. coli BL21 
(DE3) cultures were transformed with plasmids (a) pLMM03 encoding OmpT and (b) 
pLMM04 encoding OmpP and grown at 37 °C with shaking.  Protein expression was 
induced at an OD600 of 0.6 with 1 mM IPTG.  Samples are labelled according to the 
time after induction at which they were removed.  The size in kiloDaltons (kDa) of the 
protein markers is indicated.  
 
High levels of over-expression were observed for both OmpT and OmpP and so the 
protocol used for all subsequent large scale expression experiments was identical to that 
used for the His-tagged constructs (see Section 3.2.1.2).  Briefly, two 500 ml cultures of 
BL21 (DE3) cells transformed with the desired plasmid were grown in LB medium in 
two-litre conical flasks.  Protein expression was induced with 1 mM IPTG when the 
cultures reached an OD600 of 0.6 and expression was allowed to continue for a further 4 
h (37 
o
C, 200 rpm) before cells were harvested by centrifugation. 
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3.2.2.3 Purification 
To enable purification of OmpT and OmpP, two 500 ml cultures of BL21 (DE3) cells 
transformed with the appropriate plasmid were grown as described above (Section 
3.2.2.2).  The cells were then harvested by centrifugation before lysis by sonication and 
isolation of inclusion bodies was carried out as previously described (Section 2.4.2).  
The isolated inclusion bodies were next solubilised in 6M GuHCl, 25mM Tris, pH 8.0 
and OmpT and OmpP purified further by size exclusion chromatography (see Section 
2.4.5) using a Superdex 75 HiLoad 26/60 column (GE Healthcare).  OmpT or OmpP 
containing fractions were pooled and concentrated to approximately 500 μM and stored 
in aliquots at -80 
o
C.  Protein greater than 90 % in purity was obtained for both OmpT 
and OmpP with yields of approximately 65 mg pure protein per litre of culture (Figure 
3.15). 
 
 
Figure 3.15 Purification of OmpT and OmpP.  (a) Typical OmpT elution profile from 
the size exclusion column.  The elution profile of OmpP is nearly identical (data not 
shown).  SDS-PAGE gels of (b) OmpT and (c) OmpP showing protein samples before 
size exclusion and after.  The size in kiloDaltons (kDa) of the protein markers is 
indicated.
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3.2.3 FOLDING SCREENS OF OMPT AND OMPP USING COLD SDS-PAGE 
Following purification, OmpT and OmpP were stored in an unfolded form in 6 M 
GuHCl at -80 °C.  Therefore, conditions for the refolding of these proteins must be 
optimised so that a high yield of native protein can be obtained for further study.  The 
work of Huysmans et al
167; 240
 showed that the choice of LPR is important in influencing 
the folding pathway of HT PagP and also modulates the reversibility of folding.  For 
these reasons a high LPR of 3200:1 was chosen for all subsequent experiments.  For 
both OmpT and OmpP, the final urea concentration was varied from 2–6 M during all 
experiments. 
Based on the protocol described by Burgess et al
162, 4.8 μM OMP was diluted into 
liposomes at an LPR of 3200:1 in varying buffer conditions and allowed to refold for 
16 h.  The reaction was then quenched by the addition of 2 × SDS-PAGE loading buffer 
and loaded on to an SDS-PAGE gel with and without prior boiling (Section 2.5.2).  Due 
to the high stability of OMPs, the folded protein is often resistant to SDS-induced 
denaturation if samples are not boiled and migrates at a different apparent molecular 
weight to the unfolded conformation
140
.  The fraction of folded OMP was estimated 
using densitometry and averaged over three experiments to reduce error.  In most of the 
experiments, some higher molecular weight species are present indicating that under all 
conditions tested the competing process of aggregation is occurring alongside folding.  
Since these aggregated species can be depolymerised by boiling in SDS-PAGE loading 
buffer (Figure 3.16a), the fraction folded was calculated by comparing the intensity of 
the folded band in the unboiled sample with the intensity of the single, unfolded band 
observed in the boiled fraction so that the effects of aggregation are considered.  Values 
of folding efficiency were quite reproducible between replicate samples (± 10 %).  
Possible sources of error could include differing extents of aggregation between 
samples, differences in the efficiency of staining of individual gels and disruption of the 
folded OMP by the presence of SDS in the SDS-PAGE loading buffer.  The latter was 
reduced by running gels immediately after addition of SDS-PAGE loading buffer. 
Using 100 nm LUVs of diC12:0PC, the pH of the reaction buffer was varied from 7–10 
while the temperature was fixed at either 25 °C or 37 °C.  For both OmpT and OmpP, 
the highest yields (70–80 % folded) were seen at pH 8.0, 25 °C (Figure 3.16b, c; Table 
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3.2) so these conditions were kept constant throughout the remaining experiments.  The 
effect of vesicle diameter was next examined using 50 nm SUVs of diC12:0PC as this has 
previously been suggested to improve the folding yield of OmpA in some lipids
147
.  For 
OmpT the decrease in liposome diameter caused little change in the folded fraction, 
however, for OmpP the folded yield was seen to decrease from 69 % to 46 % at 5 M 
urea and so it was decided not to use SUVs in subsequent experiments (Table 3.2). 
Finally, the effect of acyl chain length and saturation on OmpT and OmpP folding 
efficiency was investigated.  The hydrophobic thickness of a diC12:0PC bilayer is 19.5 ± 
1 Å, while that of diC14:0PC is 23.0 ± 1 Å
261
.  Comparing the folded yields of OmpT and 
OmpP at a urea concentration which gave a high yield in diC12:0PC (3 M for OmpT and 
5 M for OmpT), increasing the hydrophobic thickness of the membrane by using 
100 nm LUVs of diC14:0PC for refolding had little effect on yield (Table 3.2).  
Conversely, using LUVs of diC16:1PC lowered the folding efficiency of both proteins, 
from 72 % to 56 % for OmpT in 3 M urea and from 69 % to 32 % for OmpP in 5 M 
urea (Table 3.2), an effect most likely due to the degree of saturation of the acyl chain 
since the hydrophobic thickness of diC16:1PC bilayers is estimated to be 23.5 ± 1 Å
261
 
and hence is not significantly different to that of diC14:0PC. 
Interestingly, the effect of changing the concentration of urea in any given reaction is 
dependent on the other experimental conditions and the OMP.  For example, for OmpT 
folding into 100 nm LUVs of diC12:0PC at pH 8.0, 25 °C the folding yield is increased 
from 46 % in 2 M urea to 82 % in 6 M urea, however, at pH 10.0 the folding yield 
decreases from 62 % in 2 M urea to 48 % in 6 M urea.  Conversely, OmpP folding yield 
in 100 nm diC12:0PC LUVs at either pH 8.0 or pH 10.0 is higher when urea 
concentration is increased from 3 M to 6 M.  The varying effects of urea concentration 
on the folding yield of OmpT and OmpP may be attributable to the delicate balance 
which exists between folding, unfolding and aggregation.  If the urea concentration 
present is too low, insoluble OMPs will aggregate; however, if the urea concentration is 
too high, the unfolded, urea-solubilised state becomes more favourable than the native 
state.  Therefore, optimising the urea concentration for folding in any given set of 
conditions is as important as optimising the membrane and buffer properties to ensure a 
high yield of folded OMP. 
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Figure 3.16 Temperature and pH dependence of folding into 100 nm diC12:0PC LUVs.  (a) Example gel showing higher molecular weight OmpT 
aggregates in the unboiled sample, which are depolymerised upon boiling.  Samples contained 4.8 μM (b) OmpT or (c) OmpP at an LPR of 3200:1 and 
were allowed to refold in the presence of 5 M urea for 16 hours prior to 1:1 dilution with 2 × SDS-PAGE loading buffer. The relative intensities of the 
folded and unfolded monomer bands (indicated by F and U, respectively, in the figure) are given in Table 3.2. The following buffers were used in these 
experiments: 50 mM sodium phosphate, pH 8.0; 50 mM glycine, pH 9.0 and 50 mM sodium borate, pH 10.0.  
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Lipid diC12:0PC diC14:0PC diC16:1PC 
Vesicle Size 50 nm 100 nm 
Temperature 25 °C 37 °C 25 °C 
pH 8.0 7.0 8.0 9.0 10.0 8.0 9.0 10.0 8.0 8.0 
O
m
p
T
 
[U
re
a]
 (
M
) 
2 43 43 46 55 62 49 53 63 75 ND 
3 54 56 72 63 69 66 74 64 73 56 
4 72 75 67 61 57 61 62 60 69 67 
5 71 61 75 73 41 51 47 22 53 60 
6 ND ND 82 53 48 49 51 28 54 50 
O
m
p
P
 
2 16 16 – – – 9 9 11 9 ND 
3 26 33 44 40 48 52 54 51 37 11 
4 47 43 63 55 52 59 56 56 50 – 
5 46 61 69 58 48 63 58 28 60 32 
6 ND ND 74 66 68 56 62 38 54 36 
Table 3.2 Estimated percentage folded yield of OmpT and OmpP into PC liposomes in vitro.  Yield was determined by using densitometry to 
calculate the relative intensities of the folded and unfolded monomer bands following cold SDS-PAGE analysis of the folding reaction.  Yields 
are colour coded as follows: 0–24 % in very pale blue, 25–49 % in pale blue, 50–74 % in mid-blue and ≥ 75 % in deep blue.  – denotes the 
absence of any detectable folded yield, while ND indicates folding conditions which were not tested.   
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3.2.4 OMPT AND OMPP FOLD TO THE NATIVE STATE IN SYNTHETIC LIPOSOMES 
While shifts in apparent molecular weight observed in cold SDS-PAGE assays are often 
indicative of the presence of folded OMPs, these assays provide no structural 
information and do not confirm the presence of correctly folded OmpT or OmpP.  To 
determine if natively folded OMPs are present, tryptophan fluorescence emission 
spectra were first measured for both OmpT and OmpP after folding for 16 h in 100 nm 
LUVs of diC12:0PC, diC14:0PC and diC16:1PC at an LPR of 3200:1 in 50 mM sodium 
phosphate, pH 8.0, 25 °C (Figure 3.17).  Upon folding into PC liposomes, the 
tryptophan fluorescence emission intensity increases in yield and the wavelength 
corresponding to maximal intensity (λmax) is blue shifted, indicating protection of 
tryptophan residues from exposure to solvent.   
 
 
Figure 3.17 Fluorescence emission spectra of OmpT and OmpP folded in PC 
liposomes.  Tryptophan emission spectra of (a) OmpT and (b) OmpP folded into 
100 nm LUVs of diC12:0PC (red line), diC14:0PC (blue line) and diC16:1PC (green line) or 
unfolded in 10 M urea in the presence of 100 nm LUVs of diC12:0PC (black line).  All 
spectra were acquired at a protein concentration of 0.4 μM an LPR of 3200:1 in 50 mM 
sodium phosphate, pH 8.0, 25 °C.  OmpT samples were refolded in buffer containing 
3 M urea and OmpP samples were refolded in buffer containing 5 M urea.  
 
In order to remove the variation in spectral intensity that is inherent to pipetting 
liposomes
167
, the intensity averaged wavelength, <λ>320–370 (Equation 2.4), was 
calculated for each spectrum (Table 3.3).  For OmpT, the spectral <λ> is blue shifted 
upon folding into liposomes compared with the unfolded spectrum with all three lipids 
giving similar values of approximately 342.5 nm.  OmpP folded into either diC12:0PC or 
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diC14:0PC has a similarly low <λ>, however, in diC16:1PC the <λ> is increased to 
343.8 nm and the spectral intensity also appears significantly lower than in the other 
lipids tested.  This could be reflective of the low yield of folded protein in diC16:1PC 
(Table 3.2). 
 
Lipid 
OmpT  
<λ>320–370 (nm) 
OmpP 
<λ>320–370 (nm) 
diC12:0PC 342.6 342.4 
diC14:0PC 342.3 342.1 
diC16:1PC 342.7 343.8 
Unfolded 345.9 345.8 
Table 3.3 Intensity averaged wavelengths (<λ>320–370) of tryptophan fluorescence 
emission spectra of OmpT and OmpP folded in PC liposomes.  All spectra were 
acquired in 100 nm LUVs at an LPR of 3200:1 in 50 mM sodium phosphate, pH 8.0, 
25 °C.  OmpT samples were refolded in buffer containing 3 M urea and OmpP samples 
were refolded in buffer containing 5 M urea.  Unfolded spectra were acquired in 10 M 
urea in the presence of diC12:0PC liposomes. <λ>320–370 was calculated according to 
Equation 2.4.  
 
Following the conclusion that upon folding into PC liposomes, tryptophan residues 
become protected from exposure to solvent, far-UV CD spectra were next measured of 
both OmpT and OmpP after folding for 16 h in 100 nm LUVs of diC12:0PC, diC14:0PC 
and diC16:1PC in 50 mM sodium phosphate, pH 8.0, 25 °C (Figure 3.18).  In all 
experiments, a protein concentration of 40 μM was used with an LPR of 400:1 in order 
to reduce the light scattering caused by the presence of liposomes and maximise the 
signal-to-noise ratio.  The spectra of both OmpT and OmpP in all lipids shows a peak of 
negative ellipticity with a minimum at approximately 218 nm, indicative of β-sheet 
secondary structure.  This peak is not observed in the spectrum of the unfolded state of 
either protein.  In the case of OmpP folded into diC16:1PC LUVs, the negative peak 
observed at 218 nm had a low intensity (Figure 3.18b), which may again be attributed to 
the low folding efficiency of OmpP under these conditions (Table 3.2).  The far-UV CD 
spectra of OmpP were acquired by Remco N. P. Rodenburg (a visiting M.Sc. student 
from the University of Utrecht under the supervision of Lindsay M. McMorran). 
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Figure 3.18 Far-UV CD spectra of OmpT and OmpP folded in PC liposomes.  Spectra 
of (a) OmpT and (b) OmpP folded into 100 nm LUVs of diC12:0PC (red line), diC14:0PC 
(blue line) and diC16:1PC (green line) or unfolded in 10 M urea in the absence of lipid 
(black line).  All spectra were acquired at a protein concentration of 40 μM and an LPR 
of 400:1 in 50 mM sodium phosphate, pH 8.0, 25 °C.  OmpT samples were refolded in 
buffer containing 3 M urea and OmpP samples were refolded in buffer containing 5 M 
urea.  OmpP spectra were acquired by Remco N. P. Rodenburg (University of Utrecht).  
 
The spectral data suggest that both OmpT and OmpP can fold to their native states in 
synthetic PC vesicles in vitro, and this was confirmed using an enzyme assay that was 
designed based on functional assays reported by Kramer et al
138
 and Hagan et al
137
.  
Briefly, OmpT and OmpP were refolded into 100 nm LUVs of diC12:0PC, diC14:0PC and 
diC16:1PC containing 0.8 mg ml
-1
 LPS at an LPR of 3200:1 in 50 mM sodium 
phosphate, pH 8.0, 25 °C.  The protein was rapidly diluted into a 100 μM solution of the 
internally quenched fluorogenic peptide Abz-Ala-Arg-Arg-Ala-Tyr(NO2)-NH2 in 
50 mM sodium phosphate, pH 7.0.  The concentration of the peptide stock was 
measured using absorbance at 428 nm (A428) with a molar extinction coefficient of 
4200 M
-1
 cm
-1
.  Both OmpT and OmpP should cleave the peptide between the two 
arginine residues
245; 262
, releasing the ortho-aminobenzoic acid (Abz) group from the 
nitrotyrosine quenching group. The reaction progress can be monitored by exciting the 
Abz group at 325 nm and measuring the increase in intensity of emission at 430 nm 
over time. 
The increase in fluorescence intensity over time was measured for a variety of OmpT 
and OmpP concentrations using a large excess of substrate (Figure 3.19).  The slope of 
the linear part of the line (0–30 s for OmpT and 0–300 s for OmpP) was used to 
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estimate the initial rate of the reaction and this was used to calculate the specific 
enzyme activity (nmol of substrate processed per μM enzyme per minute, 
nmol.μM-1.min-1) (see Equation 2.1) of each protein in each lipid (Figure 3.20).  OmpP 
activity assays in diC14:0PC and diC16:1PC liposomes were conducted by Remco N. P. 
Rodenburg (University of Utrecht). 
 
 
Figure 3.19 Enzyme activity assays of OmpT and OmpP in 100 nm diC12:0PC LUVs.  
The fluorescence emission increase over time of Abz within an internally quenched 
peptide at 430 nm following excitation at 325 nm was monitored over time in the 
presence of (a) OmpT: 5 nM (red line), 10 nM (blue line), 20 nM (green line) or 25 nM 
in the absence of LPS (black line) and (b) OmpP: 180 nM (red line), 240 nM (blue line), 
320 nM (green line) or 320 nM in the absence of LPS (black line).  Both OmpT and 
OmpP were refolded for 16 h into 100 nm LUVs of diC12:0PC containing 0.8 mg ml
-1
 
LPS (where appropriate) at an LPR of 3200:1 in 50 mM sodium phosphate, pH 8.0, 
25 °C before the reaction was initiated by rapid dilution into a 100 μM solution of Abz-
Ala-Arg-Arg-Ala-Tyr(NO2)-NH2 in 50 mM sodium phosphate, pH 7.0.  
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Figure 3.20 Initial enzymatic rates of OmpT and OmpP folded in PC liposomes.  The 
fluorescence emission increase over time of Abz upon cleavage from an internally 
quenched peptide at 430 nm following excitation at 325 nm was monitored over time in 
the presence of (a) OmpT and (b) OmpP.  The initial rate was calculated from the slope 
of the fluorescence traces according to Equation 2.1.  Error bars indicate the standard 
error of the mean of the enzymatic activity measured over a range of enzyme 
concentrations.  The number above each bar indicates the percentange of folded OMP 
estimated using cold SDS-PAGE.  Both OmpT and OmpP were refolded for 16 h into 
100 nm LUVs of diC12:0PC, diC14:0PC or diC16:1PC containing 0.8 mg ml
-1
 LPS at an 
LPR of 3200:1 in 50 mM sodium phosphate, pH 8.0, 25 °C before the reaction was 
initiated by rapid dilution into a 100 μM solution of Abz-Ala-Arg-Arg-Ala-Tyr(NO2)-
NH2 in 50 mM sodium phosphate, pH 7.0.  The data for OmpP in diC14:0PC and 
diC16:1PC liposomes were acquired by Remco N. P. Rodenburg (University of Utrecht).  
 
OmpT shows similarly high specific activities in the three lipids tested, however, OmpP 
activity was much lower (Figure 3.19b, Figure 3.20b), which is in part due to the 
slightly different substrate specificity of this enzyme
245; 262
.  Comparing the activity of 
OmpP upon changing the liposome environment demonstrates that OmpP shows ten-
fold higher activity in the thicker diC14:0PC and diC16:1PC bilayers (Figure 3.20b), in 
spite of the lower folding efficiency observed in cold SDS-PAGE assays compared with 
diC12:0PC.  These data demonstrate the ability of OmpT and OmpP to fold to their 
native state in synthetic liposomes of varying acyl chain length and saturation.  
Increasing the bilayer thickness (from diC12:0PC to diC14:0PC) does not affect the 
folding yield of either protein under the buffer conditions tested for these assays.  
Additionally, bilayer thickness does not seem to significantly affect OmpT enzyme 
  
139 
 
activity, however, the activity of OmpP increases significantly upon folding into thicker 
bilayers.  Using lipids with unsaturated acyl chains (diC16:1PC) causes a decrease in 
folding yield of both proteins, but has little effect on activity when compared with 
saturated lipids of similar hydrophobic thickness (diC14:0PC). 
 
3.2.5 RELATIVE STABILITY OF OMPT AND OMPP IN SYNTHETIC LIPOSOMES 
The relative stabilities of OmpT and OmpP in 100 nm LUVs of diC12:0PC, diC14:0PC 
and diC16:1PC were determined by using urea denaturation based on the method 
described by Huysmans et al
167.  Briefly, 1.2 μM OmpT or OmpP was allowed to refold 
for 16 h in 50 mM sodium phosphate, pH 8.0, 25 °C at an LPR of 3200:1 before a three-
fold dilution into aliquots of increasing urea concentration (3–10 M).  Refolding was 
carried out in an appropriate concentration of urea, as determined from the results of the 
cold SDS-PAGE screens (Table 3.2).  These samples were allowed to equilibrate for a 
minimum of 8 h before the tryptophan emission spectrum of each sample was 
measured.  The <λ>320-370 nm of each spectrum was calculated and plotted against the 
final urea concentration of that sample to monitor the unfolding transition (Figure 3.21).  
Urea denaturation experiments for OmpP were carried out by Remco N. P. Rodenburg 
(University of Utrecht). 
Unfolding of both proteins from the native state in diC12:0PC and diC14:0PC liposomes 
does not go to completion, even after incubation in 10 M urea, and no post-transition 
baseline is observed (Figure 3.21).  This suggests that these proteins are very stable 
under these conditions, even though the hydrophobic thickness of the two membranes 
differs by approximately 4 Å
261
.  In contrast, unfolding from diC16:1PC liposomes 
occurs much more readily: OmpP is fully unfolded at 5 M urea and OmpT at 
approximately 9 M urea.  OmpP stability in diC16:1PC is so low that no pre-transition 
baseline is observed and coupled with the low folding yields observed in the cold SDS-
PAGE folding screens, these data suggest that although enzyme activity is detectable in 
this lipid only a small proportion of the OmpP in the folding reaction reaches and 
maintains the native state.   
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As OmpT unfolding from diC16:1PC liposomes shows a full unfolding transition over 
the accessible range of urea concentrations, the denaturation midpoint ([D]50%) could be 
estimated.  It should be noted that urea denaturation has thus far only been measured in 
the unfolding direction and it is therefore unknown if OmpT unfolding is fully 
reversible under these conditions.  For this reason, a full thermodynamic analysis of 
OmpT unfolding is not possible; however, this will be addressed in Chapter 4.  The 
apparent denaturant midpoint ([D]50% app) was estimated by first fitting the data to 
Equation 2.6 using a quantum yield correction (QR, Equation 2.5) of 1.25.  The apparent 
values of            
    and          obtained from this fit can be used to calculate the 
apparent [D]50% according to Equation 2.7.  The apparent [D]50% of OmpT unfolding 
from diC16:1PC liposomes is 6.24 M, demonstrating that even though OmpT is 
destabilised in this lipid compared to diC12:0PC or diC14:0PC liposomes it is still 
relatively resistant to unfolding (Figure 3.21a).  Due to the similar hydrophobic 
thickness of diC14:0PC and diC16:1PC bilayers
261
, the markedly lower stability of both 
OmpT and OmpP in this lipid is most likely an effect of the difference in acyl chain 
saturation between these two lipids.   
 
 
Figure 3.21 Urea denaturation curves of OmpT and OmpP in PC lipids.  Urea 
denaturation of (a) OmpT and (b) OmpP in diC12:0PC (red circles), diC14:0PC (blue 
circles) and diC16:1PC (green circles).  All experiments were carried out at a final OMP 
concentration of 0.4 μM, in 100 nm liposomes, LPR 3200:1, 25 ºC, 50 mM sodium 
phosphate, pH 8.0.  OmpP data were acquired by Remco N. P. Rodenburg (University 
of Utrecht). 
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Interestingly, the pre-transition baselines in diC12:0PC and diC14:0PC liposomes overlay 
for OmpP but are offset by approximately 0.4 nm for OmpT.  The baseline for OmpT in 
diC14:0PC liposomes occurs at a lower <λ>320-370 than the other two lipids (Figure 
3.21a), which would likely be caused by lower aggregation or a higher folded yield 
under these conditions.  Interestingly, the results of the cold SDS-PAGE suggest that the 
folding yield of OmpT would be lower in diC14:0PC than diC12:0PC (Table 3.2), perhaps 
indicating that the ability of OMPs to withstand denaturation by SDS when the samples 
are unboiled could vary between individual OMPs and buffer conditions.   
 
3.2.6 OMPT FOLDS TO THE NATIVE STATE IN AN AMPHIPATHIC POLYMER (APOL), A8-35 
The use of liposomes provides a convenient method to examine the folding and stability 
of OMPs in a native-like lipid bilayer.  Liposomes are, however, unsuitable for some 
biophysical techniques including mass spectrometry.  Currently, the most commonly 
used method for the study of membrane proteins by mass spectrometry is solubilisation 
in detergent micelles, but this can lead to inactivation, unfolding and aggregation of the 
membrane protein under study
263; 264
.  To overcome these problems, the use of Apols 
that bind strongly yet non-covalently to the transmembrane region of membrane 
proteins has become more prevalent
264
.  Apol-bound membrane proteins have been 
shown to be more stable than micelle-encapsulated membrane proteins
264
 and recently 
matrix-assisted laser desorption ionisation-mass spectrometry (MALDI-MS) was 
successfully used to determine the molecular mass of bR, OmpA, cytochrome b6f and 
cytochrome bc1 in the Apol A8-35 (Figure 1.18c)
265
.  This approach, however, is limited 
as conformational information cannot be ascertained using this ionisation technique.  
The work described in this section was conducted in collaboration with Aneika C. 
Leney (University of Leeds) and aimed to develop methods for the study of Apol-bound 
membrane proteins by mass spectrometry. 
Unfolded OmpT in 8 M urea was folded into A8-35 by dilution into a solution of Apol 
at a ratio of 1:5 OmpT:A8-35, and refolding was initiated by dialysis against 100 mM 
ammonium bicarbonate, pH 8.0.  After folding had been allowed to proceed for 24 h, 
4 °C, cold SDS-PAGE analysis was used to determine the folding efficiency of OmpT 
in A8-35, revealing that the protein migrates as a single, folded band (Figure 3.22a).  
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This was confirmed using analytical size exclusion chromatography, which also shows 
elution of the OmpT:A8-35 complex as a single peak, demonstrating that a single, 
folded species is present in solution (Figure 3.22b).  Far-UV CD of the complex shows 
a peak of negative ellipticity with a minimum at approximately 218 nm (Figure 3.22c), 
comparable in magnitude to that of OmpT folded in PC liposomes (Figure 3.18a), and 
indicative of the present of β-sheet secondary structure.  Acquisition of the native state 
of OmpT in A8-35 was confirmed using the fluorogenic peptide Abz-Ala-Arg-Arg-Ala-
Tyr(NO2)-NH2 as described in Section 3.2.4, revealing that OmpT specific activity is 
approximately 700 nmol.μM.min-1 (Figure 3.22d) in the presence of LPS, comparable 
with the specific activity measured in PC liposomes (Figure 3.20a).  Interestingly, a 
lower specific activity of approximately 100 nmol.μM.min-1 was measured in the 
absence of LPS (Figure 3.22d), which is not seen in PC liposomes (Figure 3.19a) and 
suggests that the interaction with A8-35 is slightly activating as well as stabilising. 
Analysis of the OmpT:A8-35 complex by ESI-MS coupled with ion mobility 
spectrometry (IMS) by Aneika C. Leney (University of Leeds) revealed that OmpT is 
released from the amphipol complex and can be detected as multiply charged ions 
(Figure 3.23).  A narrow charge state distribution of the 6+, 7+, 8+ and 9+ ions was 
observed, corresponding to a compact structure with a calculated mass of 
33,462 ± 5 Da, which is within 0.01 % of the theoretical mass based on the amino acid 
sequence (33,460 Da).  Analysis of the arrival time distribution of OmpT from ESI-
IMS-MS revealed that the 6+ ion has a collisional cross section of 2601 Å
2
, which is 
consistent with the value of 2718 Å
2 
predicted from the PDB structure using the 
projected superposition approximation method.  The agreement of the experimentally 
derived collisional cross section with the predicted value allows the conclusion that 
OmpT remains in a native-like conformation in the gas phase
266
 and demonstrates the 
utility of amphipols as an alternative to a membrane mimetic for the study of native 
membrane proteins by a variety of techniques. 
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Figure 3.22 Folding of OmpT into A8:35.  (a) SDS-PAGE of OmpT:A8-35 complex 
with and without heat denaturation; (b) size exclusion chromatogram showing a single 
peak corresponding to the OmpT:A8-35 complex. The void (Vo) and total column 
volume (Vt) are highlighted; (c) far-UV CD spectrum of the OmpT:A8-35 complex and 
(d) functional assay showing the fluorescence increase (relative fluorescence units) on 
enzymatic cleavage of the peptide Abz-Ala-Arg-Arg-Ala-Tyr-(NO2)-NH2 on addition of 
0.05 µM (black), 0.10 µM (blue), 0.15 µM (green), 0.20 µM (yellow), and 0.30 µM 
(red) OmpT:A8-35 complex in the presence of LPS. The inset shows the weak catalytic 
activity of OmpT:A8-35 without LPS at OmpT:A8-35 concentrations of 0.05 µM 
(black), 0.15 µM (green) and 0.30 µM (red).  This figure is taken from Leney et al, 
(2012)
267
.  These data were acquired in collaboration with Aneika C. Leney (University 
of Leeds).  
 
 
Figure 3.23 ESI-IMS-MS driftscope plot of the OmpT:A8-35 complex.  The charge 
state of each ion is labelled and the summed m/z spectrum is displayed on the right-hand 
side.  This figure is adapted from Leney et al, (2012)
267
.  These data were acquired by 
Aneika C. Leney (University of Leeds).  
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3.3 DISCUSSION 
Detailed analysis of OMP folding pathways has previously only been achieved for 
OmpA
144; 145; 147; 153; 161
 and PagP
167; 238; 240
, resulting in limited opportunities to compare 
and contrast the folding of different OMPs in the search for generic folding principles.  
In this study, the OM proteases, OmpT and OmpP, from E. coli have been successfully 
cloned, over-expressed, purified and refolded into liposomes composed of PC lipids of 
varying chain length and saturation.  Additionally, protocols for the folding of OmpT 
into the Apol A8-35 have been developed in order to improve methodology for the 
study of functional membrane proteins by mass spectrometry.  The results demonstrate 
the ability of OmpT and OmpP to fold to and maintain their native structure in changing 
membrane environments and the different stabilities of the two proteins suggest a role 
of competing evolutionary constraints in the folding of these two proteins. 
 
3.3.1 ADAPTATION OF OMPT AND OMPP TO DIFFERENT LIPID ENVIRONMENTS 
Cold SDS-PAGE was utilised in order to screen a variety of folding conditions 
assessing the effects of temperature and pH, vesicle size, as well as lipid acyl chain 
length and saturation on the folding efficiencies of OmpT and OmpP.  The highest yield 
of folded protein obtained in diC12:0PC LUVs for both proteins was in 50 mM sodium 
phosphate, pH 8.0, 25 °C, so these conditions were kept constant while the liposome 
composition was varied.  The results demonstrate the ability of these OMPs to fold to 
their native, functional state in all three lipids tested (diC12:0PC, diC14:0PC and 
diC16:1PC) suggesting an ability of the protein to adapt to a changing lipid environment.  
Such adaptation has been observed previously: a combination of X-ray crystallography 
data and MD simulations has shown that during the conformational changes required 
for the function of the sarco(endo)plasmic reticulum Ca
2+–ATPase, a hydrophobic 
mismatch occurs between the protein and the membrane
268
.  This mismatch can be 
overcome by local deformation in the lipid bilayer around the protein as well as small 
rearrangements of the amino acid side chains and helix tilts of the protein
268
.  These, or 
similar effects, could explain how OmpT and OmpP remain functional in synthetic 
liposomes with varying hydrophobic thicknesses. 
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Interactions between membrane proteins and the lipid bilayer have been well 
characterised, demonstrating the importance of individual amino acid side chains in 
stabilising the membrane-spanning regions in the bilayer.  The requirement of LPS in 
the lipid membrane to activate OmpT protease activity is one example
258
.  In general, 
the interactions of the protein, lipid and solvent in the complex interfacial region of the 
membrane are most important for determining placement of transmembrane 
segments
156; 269.  The effect of different residues on the positioning of α-helices in the 
membrane has been studied extensively using the “glycosylation mapping technique” 
(Figure 3.24), in which the active site of a membrane-bound endoplasmic-reticulum 
enzyme, oligosaccharyl transferase, is used as a point of reference to determine the 
relative position of an adjacent transmembrane helix
270
.  Mutations in the 
transmembrane helix which change its position in the membrane will change the 
number of residues between the membrane surface and the glycosylation site of the 
oligosaccharyl enzyme, known as the minimal glycosylation distance
270
.  The 
glycosylation mapping technique showed that the basic residues, arginine and lysine, 
which have long hydrophobic side chains, could reach along the face of the helix to 
position their positively charged groups into the negatively charged head-group region 
of the lipid, an effect called snorkelling
270
.  This could lead to dramatic changes in the 
membrane positioning of the helix, and hence, the minimal glycoslyation distance.  
Aspartate and glutamate residues did not have such a marked effect on glycosylation 
distance, which was suggested to arise from their acidic side chains preventing 
snorkelling though unfavourable electrostatic interactions with the lipid head-groups.  
Instead, the relatively low pH at the membrane interface was proposed to promote the 
protonation of the side chains, allowing them to be buried in the transmembrane 
region
270
. 
The intrafacial region of both α-helical and β-barrel membrane proteins has been 
observed to be enriched with tryptophan and tyrosine residues, and has been dubbed the 
“aromatic girdle”271; 272.  By contrast, phenylalanine prefers to be buried in the 
membrane core
271
.  This was also demonstrated by glycosylation mapping experiments, 
which showed that both tryptophan and phenylalanine would push a transmembrane 
helix further into the membrane if they were positioned in a region normally outside the 
membrane
271
.  When placed in the core of the membrane phenylalanine had no effect on 
membrane position, whereas tryptophan residues repositioned themselves in the 
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intrafacial region, causing the helix to be pushed out of the membrane
271
.  The effect of 
tryptophan and tyrosine on minimal glycosylation distances was observed to be similar 
to that of arginine, suggesting these residues also exhibit snorkelling behaviour
271
.  The 
preference of the polar aromatic residues for the membrane-water interface was studied 
using indole analogues and it was shown that hydrogen bonding and dipole interactions 
had little effect on membrane positioning
272
.  Instead, it was suggested that the 
quadrupole interactions of the aromatic system would give rise to complex electrostatic 
interactions which favour the intrafacial region.  The difference in behaviour of 
phenylalanine compared with tyrosine and tryptophan was attributed to the polar nature 
of the aromatic systems in the latter residues
272
.  While these experiments elegantly 
demonstrate the ability of individual helices to move with respect to the membrane, and 
perhaps each other, the extensive lateral hydrogen bonding network present within the 
β-barrel of OMPs may prevent repositioning of individual secondary structural 
elements. 
The effects of the positioning of tryptophan residues in the β-barrel of OmpA have been 
investigated more recently and begun to shed light on the interactions of individual 
amino acids with the lipid environment within the context of a β-barrel structure273.  All 
residues in strand 1 of the OmpA β-barrel were first mutated to alanine in order to 
minimise interactions between side chains and increase the effect of lipid-exposure of 
the inserted tryptophan residues
273
.  Each residue was in turn mutated to tryptophan and 
the effect on stability measured by carrying out urea denaturation under conditions 
which have previously been reported to yield reversible folding of OmpA
149; 273
.  These 
mutations had little effect on folding efficiency of OmpA but mutants with tryptophan 
residues placed in the centre of the bilayer were shown to be slightly stabilised while 
those with tryptophan residues placed towards the edge of the bilayer were slightly 
destabilised
273
.  The results suggest that while tryptophan residues show a preference for 
the intrafacial region when contained in a transmembrane segment which is free to 
move with respect to the bilayer, the more rigid structure of the OmpA β-barrel may 
limit the ability of tryptophan to reposition favourably within the complex electrostatic 
environment of the intrafacial region. 
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Figure 3.24 The “gylcosylation mapping technique”.  The endopasmic reticulum (ER) 
enzyme, oligosaccharide transferase (OST) is membrane-anchored.  The number of 
residues between the membrane and the active site of OST (yellow star) is the minimum 
glycosylation distance (MGD).  Helix 1 (H1) is a reference transmembrane helix, which 
is unchanged in the experiments.  Mutations in Helix 2 (H2) may alter the position of 
H2 in the membrane, relative to H1, and this will change the MGD. 
  
One mutation which did not follow the observed trend in the tryptophan mutants of 
OmpA was positioned in the periplasmic aromatic girdle of OmpA, and the anomalous 
stability of this mutant was thought to arise from stabilising interactions with nearby 
aromatic residues
273
.  Indeed, the stabilising effects of aromatic residues in the OmpA 
periplasmic aromatic girdle has previously been measured using the same method.  The 
study concluded that individual aromatic residues contribute much less to OmpA 
stability than clusters of residues
155
.  Furthermore, OmpA stability depended more 
strongly on clustering of nearby aromatics than the type of aromatic residues present
155
.  
The clustering of aromatic residues at the intrafacial regions of β-barrel proteins may 
therefore arise not because positioning in this region is particularly stable, but from the 
highly stabilising nature of the side chain interactions of these residues.  The ability of 
these residues to exist at the membrane-solvent interface or to be buried within the 
membrane core may help to explain the adaptability of OmpT and OmpP to membrane 
environments of varying hydrophobic thickness without losing functionality.  Indeed, 
this ability to adapt to changing environments is so pronounced that OmpT can fold to 
and maintain its native state in the non-membrane mimetic environment of an amphipol 
as demonstrated in this study. 
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3.3.2 DIFFERENCES IN OMPT AND OMPP STABILITY: EVIDENCE OF FOLD VERSUS FUNCTION? 
The urea denaturation experiments of OmpT and OmpP demonstrate that both of these 
OMPs are very resistant to urea denaturation in unsaturated diC12:0PC or diC14:0PC 
liposomes, in spite of the 4 Å difference in hydrophobic thickness of these bilayers
261
.  
In contrast, both OmpT and OmpP are destabilised in diC16:1PC bilayers and since the 
hydrophobic thickness of this bilayer is not significantly different to that of diC14:0PC
261
, 
the destabilisation observed is most likely due to the unsaturated acyl chains in 
diC16:1PC bilayers.  Unsaturated lipids have kinks in their hydrocarbon chains causing 
the acyl chains to require more lateral space than the head-group of the lipid
274
.  Within 
a bilayer, it is not possible for the two layers to bend away from each other, but the 
tendency for this to occur gives rise to the stored curvature stress of the membrane and 
is the origin for increased lateral pressure in membranes containing unsaturated 
lipids
274
.  The effects of lateral pressure on the kinetics and thermodynamics of bR 
folding have been investigated and revealed that increased lateral pressure can improve 
the packing of tertiary structure and increase stability of bR, however, the kinetics of 
folding are slowed
275
.  In the case of OmpT and OmpP, the increased lateral pressure in 
diC16:1PC bilayers appears to have the opposite effect and is destabilising.  This is in 
agreement with work that showed increasing lateral pressure in the bilayer by inclusion 
of PE lipids caused a decrease in stability of OmpA
149
.  These differences in the 
response of α-helical and β-barrel membrane proteins to changing lateral pressure most 
likely arise due to the different topologies of these families.  The β-barrel forms a very 
rigid structure, particularly in the region at the bilayer centre
45
, and is unlikely to be able 
to conformationally adapt to relieve lateral pressure.  In contrast, helix packing appears 
to be reinforced in the presence of increased lateral pressure
275
 and the low lateral 
pressure in detergent micelles may explain the reported low stability of α-helical 
proteins in micellar systems
29
.  Accordingly, the bacterial OM has been shown to be 
enriched in lipids with saturated acyl chains
276
 and is thus expected to have a lower 
lateral pressure than the IM. 
Interestingly, OmpP is much more destabilised in diC16:1PC bilayers than OmpT and 
this could be a consequence of the differences in sequence of these homologous 
proteins.  As illustrated in Figure 3.2, residues in OmpP which are not conserved in 
OmpT are clustered in two areas: around the active site and at the intrafacial regions, 
particularly in the periplasmic aromatic girdle.  The differences in amino acid sequence 
  
149 
 
around the active site are presumably necessary in order to achieve the slightly different 
substrate specificities of OmpT and OmpP
245; 262
.  Assuming these mutations cause 
destabilisation of OmpP, the three extra aromatic residues, tryptophan-60, 
phenylalanine-117 and phenylalanine-191 in the periplasmic aromatic girdle which are 
not present in OmpT may have evolved to offset the destabilisation due the mutations in 
the active site residues.  The fact that OmpP remains less stable than OmpT in spite of 
the reinforcement of the periplasmic aromatic girdle highlights the competing 
evolutionary constraints of maintaining a stable fold while optimising function in these 
homologous proteins. 
The concept of “fold versus function” has not previously been highlighted in the context 
of membrane proteins, perhaps due to the lack of detailed information on the folding 
pathways of these proteins or the few comparative studies available.  It is well 
established, however, in the field of soluble protein folding.  One example of this is the 
bacterial immunity protein, Im7, in which formation of non-native interactions has been 
observed in each of the two folding transition states en route to the native state
201; 277
.  
Many of the residues which form these non-native contacts have been shown to be 
functionally important for colicin binding, and so the unusually rugged folding 
landscape arises due to functional constraints
201
.  Another study which uncovered the 
competing relationship of protein fold and function looked at the conserved glycine-48 
residue in the SH3 domain (a domain found in a large number of eukaryotic signalling 
proteins)
278
.  All mutations at residue 48 led to destabilisation of the folded protein but 
also caused a large increase in the folding rate of the protein
278
.  In addition, many of 
the mutants showed decreased binding affinity to a target peptide
278
.  Overall, this 
suggests that glycine-48 is a highly conserved functional residue that actually slows the 
folding of the SH3 domain.  The data presented in this chapter alongside the homology 
model of OmpP suggest that a “fold versus function” tension may affect the folding and 
stability of this protein.  Further work will be required, however, in order to 
conclusively show whether the larger decrease in stability of OmpP in diC16:0PC 
liposomes compared with that of OmpT is a direct consequence of functional 
constraints.   
In this chapter, relative stability of OmpT and OmpP was examined by comparing urea 
denaturation curves in the unfolding direction.  In order to conduct a more rigorous 
thermodynamic analysis and determine the free energy of unfolding of a protein, it is 
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required that the protein must fold reversibly.  Determining conditions under which 
folding of these OMPs is reversible would allow further examination of the “fold versus 
function” tension in OmpT and OmpP and also allow information to be gained on the 
folding mechanism of these proteins.  Accordingly, the work in the next chapter focuses 
on OMP reversibly and the origins of irreversible folding. 
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4 IS THERE A LINK BETWEEN FOLDING REVERSIBILITY AND LIPID 
ADHESION IN THE UNFOLDED STATE? 
4.1 INTRODUCTION 
4.1.1 MEASURING PROTEIN STABILITY 
The relative folding stabilities of OmpT and OmpP were measured in Section 3.2.5 by 
urea titration in the unfolding direction only, that is, folded OMP in liposomes was 
unfolded by adding increasing concentrations of urea.  While this comparative approach 
allowed conclusions on the relative stability of these proteins in liposomes of differing 
composition to be drawn, a more rigorous approach is required in order to determine the 
standard free energy of unfolding (    
 ) of a protein.  In a simple, two-state folding 
mechanism where only the unfolded (U) and native (N) states of the protein are 
significantly populated, the folding and unfolding transitions can be characterised by the 
folding rate and unfolding constants kf and ku, respectively
279
, as shown in the scheme 
below: 
 
When the system is at equilibrium, then the concentration of N and U is described by: 
   [ ]     [ ] Equation 4.1 
And the equilibrium constant for folding,    , can be calculated by: 
      
[ ]
[ ]
  
  
  
 Equation 4.2 
According to the van ’t Hoff equation, the free energy of folding (    
 ) can be 
connected to the equilibrium constant as follows: 
     
                  (
  
  
) Equation 4.3 
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Thus, in a two-state system protein stability can be determined by either kinetic or 
thermodynamic analysis since both approaches yield the same free energy. 
The free energy of unfolding is linearly proportional to the denaturant concentration, 
and so the free energy of unfolding in the absence of denaturant (     
   ) can be 
calculated
280
 according to: 
     
        
        [ ] Equation 4.4 
where     is the m-value for the equilibrium folding transition and [D] is the 
concentration of denaturant. 
Equation 4.3 and Equation 4.4 can be combined with Equation 2.5 to yield Equation 
2.6, which allows the fitting of spectroscopic data describing the unfolding of the 
protein of interest with urea to determine the standard free energy of unfolding. 
 
4.1.2 OVERCOMING HYSTERESIS IN OMP EQUILIBRIUM STUDIES 
The approach outlined in Section 4.1.1 relies on the reversible folding of the protein of 
interest in order to satisfy the definition of a two-state folding mechanism and this has 
resulted in few reports to date on OMP stability (Table 4.1)
149; 150; 151; 165; 167; 174
.  The 
low number of successful applications of this approach to membrane protein folding has 
been attributed to the difficulties in handling unfolded membrane proteins in vitro
152; 164
.  
Hysteresis of denaturation curves in the folding and unfolding directions is commonly 
observed for OMPs (Figure 4.1), which may arise from aggregation funnelling some of 
the protein of interest off the folding pathway and preventing its return to a folding 
competent state as demonstrated by Moon et al
165
.  Another possible explanation is that 
folded OMPs are subject to a very high kinetic barrier to unfolding.  If this is the case, 
hysteresis of the folding and unfolding curves should disappear if the system is given 
sufficient time to equilibrate, as demonstrated for OmpA folding into both LDAO 
micelles and the amphipol, A8-35
151.  The concept of “infinite kinetic stability” is not 
unique to OMPs and has previously been observed as a barrier to dissociation of the 
subunits of the E. coli Type 1 pilus
281
 and as a barrier to unfolding in the meta-stable 
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α-lytic protease202; 203.  Given the range of essential functions carried out by OMPs in 
vivo
46; 64; 282
 it is not unreasonable to assume they are subject to similarly high kinetic 
barriers to unfolding.  From the few successful reports of reversible OMP folding, it is 
clear that no consensus has been reached on conditions which reduce aggregation and 
promote reversibility, reflecting the current lack of understanding of these processes. 
Previously, conditions were found under which a full unfolding transition of OmpT 
could be measured in diC16:1PC liposomes (LPR 3200:1, 50 mM sodium phosphate, 
pH 8.0, 25 °C, see Section 3.2.5).  Here, conditions were screened to attempt to 
establish reversible folding of OmpT, however, this was unsuccessful.  In the process of 
this investigation, a link was established between the unfolding kinetics and two-state 
reversible folding of OMPs, leading to the hypothesis that folding reversibility may be 
achieved where there is adhesion of the OMP to the liposome in the unfolded state.  
This relationship was shown to be upheld for OmpT, PagP and HT PagP under a variety 
of conditions.  The validity of the hypothesis was tested by incorporating dansyl-
labelled guest lipid into liposomes of diC12:0PC and diC16:1PC (Figure 4.2) and using the 
resulting FRET to tryptophan residues in PagP and HT PagP to follow the unfolding 
reaction.  This analysis revealed that residual FRET is observed at the end of a 
reversible folding reaction that is not present at the end of an irreversible folding 
reaction, providing evidence that lipid adhesion in the unfolded state may be one 
mechanism by which folding reversibility is mediated. 
 
  
 
 
1
5
4
  
Protein Membrane Mimetic Buffer Conditions 
Free Energy 
of Folding 
(kJ mol
-1
) 
M-value of 
Folding (kJ 
mol
-1 
M
-1
) 
Reference 
OmpA 
30 nm SUVs, 92.5:7.5 
C16:0C18:1PC:C16:0C18:1PG 
(800:1 excess) 
10 mM glycine, 2 mM EDTA, pH 10.0, 37.5 °C 
Urea denaturant, 16 h 
-14.2 4.60 
Hong and 
Tamm 
(2004)149 
OmpA 
Octyl maltoside micelles  
(100,000:1 excess) 
10 mM glycine, 2 mM EDTA, pH 10.0, 25 °C 
 GuHCl denaturant, 4 days 
-65.2 12.5 
Andersen et al 
(2012)150 
OmpA 
LDAO micelles  
(800:1 excess) 
10 mM sodium borate, 2 mM EDTA, pH 10.0, 40 °C 
Urea denaturant, 52 days 
-59.8 
Not 
Reported 
Pocanschi et al 
(2013)151 
OmpA 
Amphipol A8-35  
(65:1 excess) 
10 mM sodium borate, 2 mM EDTA, pH 10.0, 40 °C 
Urea denaturant, 25 days 
-7.94 
Not 
Reported 
Pocanschi et al 
(2013)151 
HT PagP 
100 nm LUVs, diC12:0PC 
(3200:1 excess) 
50 mM sodium phosphate, pH 8.0, 25 °C 
Urea denaturant, 16 h 
-60.2 6.86 
Huysmans et al 
(2010)167 
OmpLa 
 100 nm LUVs, diC12:0PC* 
(2000:1 excess) 
100 mM sodium citrate, 2 mM EDTA, pH 3.8, 37 °C 
GuHCl denaturant, 5 h 
-136 38.5 
Moon et al 
(2011)165 
PagP 
100 nm LUVs, diC12:0PC* 
(2000:1 excess) 
100 mM sodium citrate, 2 mM EDTA, pH 3.8, 37 °C 
GuHCl denaturant, 5 h 
-102 22.6 
Moon et al 
(2013)174 
OmpW 
100 nm LUVs, diC12:0PC* 
(2000:1 excess) 
100 mM sodium citrate, 2 mM EDTA, pH 3.8, 37 °C 
GuHCl denaturant, 5 h 
-76.5 18.8 
Moon et al 
(2013)174 
Table 4.1 Reported free energies of folding of OMPs to date.  The excess of membrane mimetic in each reaction is expressed as the mol:mol 
ratio of mimetic:OMP.  *Indicates the presence of 1.5 mM 3-(N,N-dimethylmyristyl-ammonio)propanesulfonate during initial dilution from the 
GuHCl unfolded state.  
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Figure 4.1 OMP denaturation curves in the folding and unfolding directions often 
display hysteresis.  Denaturation of (A) OmpX, (B) PagP, (C) OmpW, (D) OmpA, 
(E) OmpT and (F) FadL in the unfolding (open circles) and folding (filled circles) 
directions.  All experiments were performed in 100 mM citrate, 2 mM EDTA, pH 3.8, 
37 °C for 40 h in 100 nm LUVs of diC12:0PC at an LPR of 2000:1 and contained 
1.5 mM 3-(N,N-dimethylmyristyl-ammonio)propanesulfonate during initial dilution 
from the GuHCl unfolded state λmax corresponds to the wavelength at which maximum 
tryptophan fluorescence emission is observed.  This figure is taken from Moon et al 
(2013)
174
.  
 
 
Figure 4.2 Structures of lipids used in this chapter.  (a) 1,2-dilauroyl-sn-glycero-3-
phosphocholine (diC12:0PC); (b) 1,2-dipalmitoleoyl-sn-glycero-3-phosphocholine 
(diC16:1PC) and (c) 1,2-dioleoyl-sn-glycero-3-phospho-L-serine-N-(5-dimethylamino-1-
naphthalenesulfonyl) (diC18:1PS-dansyl).  
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4.2 RESULTS 
4.2.1 TESTING OMPT FOLDING REVERSIBILITY 
The urea denaturation experiments of OmpT and OmpP in the unfolding direction 
(Section 3.2.5) revealed that in 100 nm LUVs of diC12:0PC and diC14:0PC both 
proteins are so stable that they do not fully unfold.  In contrast, in 100 nm diC16:1PC 
LUVs both proteins are destabilised.  The folded yield of OmpP is so low that no 
pre-transition baseline is observed in the denaturation experiments and so its folding 
reversibility could not be analysed under these conditions.  A full transition was 
observed upon unfolding of OmpT from 100 nm diC16:1PC LUVs and so folding 
reversibility was investigated with the aim of calculating the free energy of 
unfolding. 
Reversibility experiments were conducted according to the method described by 
Huysmans et al
167.  For the unfolding direction, 1.2 μM OmpT was allowed to fold 
for 16 h in 3 M urea, 50 mM sodium phosphate, pH 8.0, 25 °C at an LPR of 3200:1 
before a three-fold dilution into aliquots of increasing urea concentration (3.2–
9.2 M).  These samples were allowed to equilibrate for a minimum of 8 h before the 
tryptophan emission spectrum of each sample was measured.  Samples in the 
refolding direction were made by folding 4.8 μM OmpT for 16 h under identical 
buffer conditions before a four-fold dilution into 9.2 M urea for a minimum of 8 h to 
unfold the protein.  A three-fold dilution was then carried out to refold samples at 
urea concentrations of 3.2–9.2 M, which were allowed to equilibrate for a minimum 
of 8 h before the tryptophan emission spectrum of each sample was measured. The 
<λ>320-370 of each spectrum was calculated and plotted against the final urea 
concentration of that sample, revealing that under these conditions OmpT 
denaturation curves display hysteresis (Figure 4.3a).  The observed hysteresis shows 
that in the refolding direction, many samples have a higher value of <λ>320-370 than 
the corresponding sample in the unfolding direction at the same concentration of 
urea.   
OmpT aggregation upon dilution of urea in the refolding step could skew the value 
of <λ>320-370 to higher wavelengths and seems a likely source of hysteresis.  To 
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attempt to reduce aggregation and hence promote reversibility without hysteresis, the 
urea denaturation scheme was amended so that final samples contained 0.1 μM 
OmpT while the LPR was fixed at 3200:1.  All equilibration times and buffer 
conditions were unchanged from the initial experiment.  The resulting denaturation 
curves also exhibit hysteresis and show no improvement on the denaturation 
experiments performed at higher OmpT concentration (Figure 4.3b) suggesting that 
if hysteresis does occur due to aggregation that this effect is not dependent on protein 
concentration in the range of concentrations tested.   
Aggregation may also occur when the unfolded OmpT stock is diluted from 6 M 
GuHCl into 3 M urea to initiate folding at the beginning of the experiments, resulting 
in a population of aggregated protein present in all samples which could affect the 
calculated value of <λ>320-370 in a urea-dependent manner.  A new scheme was 
employed where OmpT unfolded in 6 M GuHCl was first diluted into 10 M urea in 
the presence 100 nm diC16:1PC liposomes at an LPR of 3200:1 and allowed to 
equilibrate overnight.  A four-fold dilution into aliquots of decreasing urea 
concentration (3.2–9.2 M) was then carried out to create samples in the refolding 
direction.  For the unfolding direction, the initial equilibration at 10 M urea in the 
presence of liposomes was identical.  A four-fold dilution into 3 M urea was then 
used to initiate refolding, and following equilibration for at least 8 h, a second four-
fold dilution into aliquots of increasing urea concentration (3.2–9.2 M) was carried 
out.  Buffer conditions were unchanged (50 mM sodium phosphate, pH 8.0) from 
previous experiments and all incubations were at 25 °C.  The resulting curves 
demonstrated the largest discrepancy observed thus far between the folding and 
unfolding directions (Figure 4.3c).  Note that in the folding direction, changing urea 
concentration has little effect on <λ>320-370, in contrast with other conditions.  The 
reasons for this are unclear and it is not known which conformation OmpT is in at 
the start of this reaction. 
Previously, samples made in both the refolding and unfolding directions were 
subjected to an initial folding step such that the starting point for both sets of 
experiments is folded OmpT in diC16:1PC liposomes.  In this scheme, this step was 
omitted and the equilibrium between the initial folding step and unfolding measured.  
Based on the poor results obtained, it was decided to return to the previous 
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experimental method to include the initial folding step, however, the unfolded stock 
of OmpT was first buffer exchanged into 10 M urea by gel filtration using a Zeba 
Spin Column (Thermo Scientific).  All other experimental details were unchanged.  
This method also resulted in hysteresis of the folding and unfolding denaturation 
curves, suggesting that reversibility without hysteresis may not be achievable under 
these conditions. 
 
 
Figure 4.3 OmpT denaturation curves measured in the folding and unfolding 
directions exhibit hysteresis.  Denaturation curves of (a) 0.4 μM OmpT from an 
unfolded stock in 6 M GuHCl, (b) 0.1 μM OmpT from an unfolded stock in 6 M 
GuHCl, (c) 0.1 μM OmpT from an unfolded stock in 6 M GuHCl that was diluted 
into 10 M urea before folding was initiated and (d) 0.1 μM OmpT from an unfolded 
stock in 10 M urea.  The unfolding curve is shown in red and the folding curve is 
shown in blue.  Dilution schemes for each experiment are shown below the 
appropriate panel.  All experiments were carried out in 100 nm diC16:1PC LUVs at an 
LPR of 3200:1, 50 mM sodium phosphate, pH 8.0, 25 °C.  
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Following the study by Moon et al
165
, which reported reversible folding of OmpLa 
without hysteresis at acidic pH, it was decided to test a similar method to see if 
OmpT folding is also reversible without hysteresis under these conditions.  First, a 
cold SDS-PAGE folding screen was carried out to examine the ability of OmpT to 
fold at pH 3.8 in 100 nm diC16:1PC LUVs containing different concentrations of 
GuHCl.  Following 16 h refolding time at 37 °C, the samples were analysed 
revealing folding yields of approximately 50 % under these conditions (Figure 4.4a, 
Table 4.2).  Equilibrium denaturation experiments were then conducted to determine 
whether folding reversibility could be achieved under these conditions.  Unfolded 
OmpT in 6 M GuHCl was mixed with 100 nm diC16:1PC LUVs in 50 mM sodium 
citrate, pH 3.8 in either 6 M GuHCl (refolding direction) or 1.5 M GuHCl (unfolding 
direction) and allowed to equilibrate for 5 h at 37 °C.  These reactions were then 
diluted four-fold into aliquots containing different GuHCl concentrations (1.5–
6.0 M) and allowed to equilibrate for 36 h at 37 °C before the tryptophan 
fluorescence spectrum of each sample was measured.  The resulting denaturation 
curves (Figure 4.4b) demonstrate that this method does not result in folding 
reversibility without hysteresis for OmpT and suggests the observed hysteresis is not 
a pH-dependent effect.  Subsequent, similar experiments by the Fleming group 
concur with this observation (Figure 4.1E)
174
 
 
[GuHCl] (M) Folding Yield (%) 
1.0 40 
1.5 49 
2.0 53 
2.5 50 
Table 4.2 Folding yield of OmpT at acidic pH determined using cold SDS-PAGE.  
All samples contained 100 nm diC12:0PC LUVs at an LPR of 3200:1 and 50 mM 
sodium citrate buffer, pH 3.8, 37 °C.  
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Figure 4.4 Testing OmpT folding and reversibility at acidic pH.  (a) cold SDS-
PAGE folding screen showing the folded (F) and unfolded (U) conformations and 
(b) urea denaturation in the folding (blue) and unfolding (red) directions. A dilution 
scheme is provided in the lower panel.  SDS-PAGE experiments contained 4 μM 
OmpT and denaturation samples contained 0.5 μM OmpT.  SDS-PAGE samples are 
labelled according to the final concentration of GuHCl.  All samples contained 
100 nm diC16:1PC LUVs at an LPR of 3200:1 and 50 mM sodium citrate buffer, 
pH 3.8, 37 °C. 
 
4.2.2 A SHORT UNFOLDING METHOD REVEALS DOUBLE EXPONENTIAL UNFOLDING KINETICS 
OF OMPT 
The results obtained thus far suggest that the hysteresis observed in previous 
equilibrium denaturation experiments could not be overcome by employing methods 
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to reduce aggregation in the urea denaturation samples.  In the work of Huysmans et 
al
167
, folding of HT PagP could be made reversible without hysteresis.  These 
experiments were thought to measure the equilibrium between the folded, 
membrane-inserted form of HT PagP and an unfolded, lipid-adhered form.  
Assuming this to be correct, hysteresis in OmpT folding may occur if some of the 
OmpT does not remain adhered to the liposome in the unfolded state, giving rise to 
two different unfolded populations.  Such a situation would be expected to give rise 
to parallel refolding pathways, and indeed, kinetic analysis of the HT PagP folding 
reaction revealed that at high LPR, where folding is reversible without hysteresis, 
folding kinetics display a burst phase followed by a single exponential phase
240
.  
Lowering the LPR causes hysteresis of folding and unfolding to occur and 
correspondingly, a second, slower exponential phase is observed
240
.  This was 
proposed to arise from a second population of HT PagP which is not initially lipid-
adhered
240
.  If a similar scenario exists upon OmpT refolding, the population which 
is not lipid-adhered may require a long time to adhere and refold, or may never 
refold due to a loss of folding competency.  In the latter case, if loss of folding 
competency were due to aggregation then the extent of aggregation and hence degree 
of hysteresis should be dependent upon protein concentration.  Either situation could 
be expected to result in hysteresis of the folding and unfolding denaturation curves. 
While it is not experimentally feasible to allow very long incubation times in a 
liposome-based folding system due to the lifespan of liposomes in aqueous solution 
being limited to approximately 5 days
158
, it may be possible to circumvent the 
formation of two unfolded OmpT populations.  If unfolding is allowed to proceed to 
an unfolded, lipid-adhered state then refolding is immediately initiated before 
dissociation from the liposome can take place, it may be possible to set up a 
“pseudo-equilibrium” which could be used to measure OmpT stability.  To employ 
this method, the unfolding time of OmpT must first be determined kinetically.  
OmpT was refolded in 3 M urea, 50 mM sodium phosphate, pH 8.0 in 100 nm 
diC16:1PC LUVs for 16 h, before a ten-fold dilution into 9 M urea was used to initiate 
unfolding.  The change in tryptophan fluorescence emission at 335 nm was measured 
to follow the progress of the reaction, revealing that OmpT unfolding occurs rapidly 
and is completed after around 500 s (Figure 4.5a).  A downward slope is observed at 
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the plateau of the reaction, which could be due to photobleaching of the sample or to 
an additional slow unfolding phase. 
Equilibrium denaturation was next carried out using the kinetic data to set the 
unfolding time of the samples accordingly.  For the unfolding direction, 1.2 μM 
OmpT was allowed to fold for 16 h in 3 M urea, 50 mM sodium phosphate, pH 8.0, 
25 °C at an LPR of 3200:1 before a three-fold dilution into aliquots of increasing 
urea concentration (3.2–9.2 M).  These samples were allowed to equilibrate for 500 s 
before the tryptophan emission spectrum of each sample was measured.  Samples in 
the refolding direction were made by folding 4.8 μM OmpT for 16 h under identical 
buffer conditions before a four-fold dilution into 9.2 M urea to unfold the protein.  
After 500 s equilibration, a three-fold dilution was then carried out to refold samples 
at urea concentrations of 3.2–9.2 M, which were allowed to equilibrate for a 
minimum of 8 h before the tryptophan emission spectrum of each sample was 
measured.  The results reveal that even very brief unfolding times give rise to a large 
degree of hysteresis between the folding and unfolding denaturation curves (Figure 
4.5b). 
 
 
Figure 4.5 OmpT equilibrium denaturation using a short unfolding method.  (a) 
OmpT unfolding kinetics in 9 M urea and (b) OmpT urea denaturation in the 
unfolding (red) and refolding (blue) directions.  All experiments contained 0.4 μM 
OmpT and were carried out in 100 nm diC16:1PC LUVs at an LPR of 3200:1, 50 mM 
sodium phosphate, pH 8.0, 25 °C.  
 
Next, it was decided to analyse the unfolding kinetics of the OmpT unfolding 
reaction in more detail.  The unfolding trace was first fitted (see Section 2.5.7) to a 
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single exponential function (Figure 4.6a, top, Table 4.3), with a linear term included 
to account for the slope in the baseline.  Visual inspection of the fit and analysis of 
the fitting residuals (Figure 4.6a, bottom) show that the data are not well described 
by this function, and so a fitting to a double exponential function including a linear 
term was carried out instead (Figure 4.6b, top, Table 4.3).  This fit was found to 
satisfactorily describe the data as judged by the fitting residuals (Figure 4.6b, 
bottom) and resulted in a large, ten-fold difference in the two unfolding rate 
constants obtained (Table 4.3). 
 
Fit k1 (×10
-2
 s
-1
) 
Fitting Error  
(×10
-2
 s
-1
) 
k2 (×10
-3
 s
-1
) 
Fitting Error  
(×10
-3
 s
-1
) 
Single 
exponential 
– – 3.85 0.12 
Double 
exponential 
2.63 0.08 1.88 0.04 
Table 4.3 OmpT rate constants obtained from exponential fits of unfolding data in 
diC16:1PC LUVs, 50 mM sodium phosphate, pH 8.0.   All exponential fits included a 
linear term to account for the downward slope in the plateau of the data. 
 
Figure 4.6 OmpT unfolding kinetics are best described by a double exponential 
function.  (a) OmpT unfolding (red line) fitted to a single exponential function with a 
linear term (black, dashed line) and (b) OmpT unfolding (green line) fitted to a 
double exponential function with a linear term (black, dashed line).  The fitting 
residuals are shown in the lower panels of the figure.  Experiments contained 0.4 μM 
OmpT and were carried out in 100 nm diC16:1PC LUVs at an LPR of 3200:1, 9 M 
urea, 50 mM sodium phosphate, pH 8.0, 25 °C.  
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The reproducibility of the unfolding rate constants was tested by measuring replicate 
unfolding samples using a four-cell changer and comparing the rate constants 
obtained from a minimum of three different liposome batches.  The results 
demonstrate that OmpT consistently unfolds through two exponential phases at 
pH 8.0 (Figure 4.7) and reproducible rate constants are obtained (summarised in 
Table 4.4, Figure 4.16).  In order to determine if OmpT unfolding under acidic 
conditions is also described by two unfolding phases, kinetic measurements of 
OmpT unfolding were next investigated at pH 3.8.  OmpT was refolded in 1.5 M 
GuHCl, 50 mM sodium citrate, pH 3.8 in 100 nm diC16:1PC LUVs for 16 h, before a 
ten-fold dilution into 6 M GuHCl was used to initiate unfolding and the tryptophan 
fluorescence emission at 335 nm was recorded.  The resulting transients were fitted 
globally to both single (Figure 4.8a) and double (Figure 4.8b) exponential functions 
and the suitability of the fit determined using the fitting residuals (Figure 4.8, 
bottom). These experiments revealed that a double exponential function is required 
to satisfactorily describe the data (summarised in Table 4.4, Figure 4.16).  This result 
is in contrast with the single exponential unfolding kinetics previously reported by 
Huysmans et al for HT PagP
167; 240
 under conditions where folding is reversible 
without hysteresis (see Section 4.2.3) and led to the hypothesis that the second phase 
in the unfolding kinetics of OmpT may correspond to the OmpT detachment from 
the lipid surface. 
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Figure 4.7 OmpT unfolding kinetics are reproducible.  (a) OmpT unfolding (red 
lines) fitted to a single exponential function with a linear term (black, dashed lines) 
and (b) OmpT unfolding (green lines) fitted to a double exponential function with a 
linear term (black, dashed lines).  Typical fitting residuals are shown in the lower 
panels of the figure.  Experiments contained 0.4 μM OmpT and were carried out in 
100 nm diC16:1PC LUVs at an LPR of 3200:1, 9 M urea, 50 mM sodium phosphate, 
pH 8.0, 25 °C.  Four replicate unfolding transients are shown in the top panels.  
 
 
Figure 4.8 OmpT unfolding kinetics under acidic conditions are best described by a 
double exponential function.  (a) OmpT unfolding (red lines) fitted to a single 
exponential function (black, dashed lines) and (b) OmpT unfolding (green lines) 
fitted to a double exponential function (black, dashed lines).  Typical fitting residuals 
are shown in the lower panels of the figure.  Experiments contained 0.4 μM OmpT 
and were carried out in 100 nm diC16:1PC LUVs at an LPR of 3200:1, 6 M GuHCl, 
50 mM sodium citrate, pH 3.8, 25 °C.  Four replicate unfolding transients are shown 
in the top panels. 
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4.2.3 HIS-TAGGED PAGP FOLDS REVERSIBLY AND UNFOLDS BY SINGLE EXPONENTIAL KINETICS 
The validity of the hypothesis that unfolding kinetics described by a double 
exponential could be indicative of lipid-detachment and hence hysteresis of folding 
and unfolding was tested further using HT PagP as a model system of reversible 
folding.  The free energy of unfolding and the unfolding kinetics of HT PagP have 
been characterised previously
167; 240
.  It was decided to test if these results could be 
replicated and ensure the resulting thermodynamic and kinetic parameters agreed 
with the published values.  HT PagP was over-expressed in E. coli BL21 (DE3) cells 
as insoluble inclusion bodies and purified by nickel affinity chromatography 
according to the method of Huysmans et al
238
, which is described in detail in 
Sections 2.4.1, 2.4.2 and 2.4.4).  The resulting HT PagP was greater than 95 % in 
purity and, although a faint second band that may be attributed to the presence of a 
small amount of dimerised protein is observed by SDS-PAGE, was sufficiently pure 
for biophysical analysis.  A typical yield of 50 mg pure protein per litre of culture 
was obtained. 
 
 
Figure 4.9 Purification of HT PagP using nickel affinity chromatography.  Samples 
of the solubilised inclusion bodies before purification and the resulting protein after 
purification are shown.  The second band in the pure sample is most likely due to the 
presence of a small amount of dimer.  The size in kiloDaltons (kDa) of the protein 
markers is indicated.A detailed description of the purification strategy can be found 
in Sections 2.4.1, 2.4.2 and 2.4.4.  
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Folding reversibility was tested following the method of Huysmans et al
167
, in which 
1.2 μM HT PagP in 7 M urea was allowed to fold for 16 h in 50 mM sodium 
phosphate, pH 8.0, 25 °C in 100 nm diC12:0PC LUVs at an LPR of 3200:1 before a 
three-fold dilution into aliquots of increasing urea concentration (7–10 M).  These 
unfolding samples were allowed to equilibrate for a minimum of 8 h before the 
tryptophan emission spectrum of each sample was measured.  Samples in the 
refolding direction were made by folding 3.6 μM HT PagP for 16 h under identical 
buffer conditions before a three-fold dilution into 10 M urea to unfold the protein.  
After 8 h equilibration, a three-fold dilution was then carried out to refold samples at 
urea concentrations of 7–10 M, which were allowed to equilibrate for a minimum of 
8 h before the tryptophan emission spectrum of each sample was measured.  The 
resulting denaturation curves could be overlaid (Figure 4.10) demonstrating that 
folding of HT PagP under these conditions is reversible without hysteresis.  Fitting 
the resulting data to a two-state model as described in Section 2.5.6 yielded fit 
parameters (      
    = -60.3 ± 6.24 kJ mol
-1
 and     = 6.92 ± 0.74 kJ mol
-1 
M
-1
) 
that are in good agreement with those previously reported 
(      
    = -60.2 ± 0.3 kJ mol
-1
 and    = 6.86 ± 0.20 kJ mol
-1 
M
-1
)
240
. 
 
 
Figure 4.10 Folding of HT PagP is reversible without hysteresis.  HT PagP urea 
denaturation in the unfolding (red) and refolding (blue) directions.  All experiments 
contained 0.4 μM HT PagP and were carried out in 100 nm diC12:0PC LUVs at an 
LPR of 3200:1, 50 mM sodium phosphate, pH 8.0, 25 °C.  Black dashed lines 
indicate fits to a two-state folding model using a quantum yield correction factor of 
1.65 (see Section 2.5.6).  
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The unfolding kinetics of HT PagP were next measured by allowing the protein to 
refold in 7 M urea, 50 mM sodium phosphate, pH 8.0 in 100 nm diC12:0PC LUVs for 
16 h, before a ten-fold dilution into 10 M urea was used to initiate unfolding.  The 
change in tryptophan fluorescence emission at 335 nm was measured to follow the 
progress of the reaction and the resulting traces were globally fit to exponential 
functions as described in Section 2.5.7.  The data were globally fit to both a single 
exponential function (Figure 4.11a, top) and a double exponential function (Figure 
4.11b, top) revealing that the fitting residuals are not significantly improved in the 
double exponential fit (Figure 4.11, bottom panels).  Additionally, although a 
relatively large difference in the two folding rate constants was observed 
(k1 = 8.59×10
-3 
± 8.95×10
-4 
s
-1 
and k2 = 9.84×10
-4 
± 6.79×10
-6 
s
-1
), the amplitude of k1 
is less than 10 % of that of k2 (8253 counts and 90361 counts, respectively), 
suggesting that a single exponential fit is sufficient to describe the data. 
 
 
Figure 4.11 HT PagP unfolding kinetics are best described by a single exponential 
function.  (a) HT PagP unfolding (red lines) fitted to a single exponential function 
(black, dashed lines) and (b) HT PagP unfolding (green lines) fitted to a double 
exponential function (black, dashed lines).  Typical fitting residuals are shown in the 
lower panels of the figure.  Experiments contained 0.4 μM HT PagP and were 
carried out in 100 nm diC12:0PC LUVs at an LPR of 3200:1, 10 M urea, 50 mM 
sodium phosphate, pH 8.0, 25 °C.  Four replicate unfolding transients are shown in 
the top panels.  
  
169 
 
 
Unfolding kinetics were measured in replicates of four in a total of four different 
batches of liposomes, and the obtained rate constant averaged.  The measured rate 
constant (k = 1.08×10
-3 
± 8.25×10
-5 
s
-1
, summarised in Table 4.4, Figure 4.16) is 
comparable to the previously reported value
240
 of 0.14 min
-1
, which corresponds to 
approximately 2.2 ×10
-3 
s
-1
.  These results confirm that under reversible folding 
conditions, this protein unfolds via a single exponential process and is consistent 
with the hypothesis that lipid-adhesion in the unfolded state is linked to folding 
reversibility. 
 
4.2.4 THE RELATIONSHIP BETWEEN FOLDING REVERSIBILITY AND UNFOLDING KINETICS IN 
UNTAGGED PAGP 
Analysis of OmpT and HT PagP suggest a possible link between unfolding kinetics 
and folding reversibility.  This may arise, however, due to the different proteins used 
as models for irreversible and reversible folding systems.  The validity of the 
hypothesis that unfolding kinetics and folding reversibility are linked was further 
examined using the untagged construct of PagP first reported by Burgess et al
162
.  
PagP was over-expressed in E. coli BL21 (DE3) cells as insoluble inclusion bodies, 
which were isolated according to the method of Burgess et al
162
 (described in 
Sections 2.4.1 and 2.4.2).  Further purification of PagP was achieved by gel filtration 
using a Superdex 75 HiLoad 26/60 column (GE Healthcare) in 6 M GuHCl, 25 mM 
Tris-HCl, pH 8.0 as described in Section 2.4.5.  The resulting protein was greater 
than 95 % pure (Figure 4.12) and was typically obtained in yields of 70 mg pure 
protein per litre of culture. 
Previous work by Dr Alice I. Bartlett (University of Leeds) on the reversibility of 
PagP folding in 100 nm diC12:0PC LUVs revealed that under conditions in which HT 
PagP folding is reversible without hysteresis (50 mM sodium phosphate, pH 8.0, 
25 °C in 100 nm diC12:0PC LUVs at an LPR of 3200:1), the folding of PagP shows 
hysteresis (Figure 4.13a).  In contrast, under similar conditions to those reported by 
Moon et al
165
 for the reversible folding of OmpLa (50 mM sodium citrate buffer, 
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pH 3.8, 37 °C in 100 nm diC12:0PC LUVs at an LPR of 3200:1), PagP folding is 
reversible without hysteresis (Figure 4.13b).  The PagP reversibility experiments 
were performed according to the protocols described by Huysmans et al
167
 and Moon 
et al
165
, however, the 3-(N,N-dimethylmyristyl-ammonio)propanesulfonate was 
excluded from the dilution steps in the latter protocol as this did not affect whether 
hysteresis was observed in PagP folding.  In spite of this omission, the parameters 
obtained following fitting to a two-state folding model as described in Section 2.5.6 
(      
    = -89.5 ± 5.55 kJ mol
-1
 and     = 20.9 ± 1.3 kJ mol
-1 
M
-1
) were 
comparable to those that have since been reported by Moon et al
174
 (Table 4.1). 
 
 
Figure 4.12 Purification of PagP.  (a) Typical elution profile from the size exclusion 
column.  (b) SDS-PAGE gel showing a PagP sample after purification.  The size in 
kiloDaltons (kDa) of the protein markers is indicated.  A detailed description of the 
purification strategy can be found in Sections 2.4.1, 2.4.2 and 2.4.5.  
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Figure 4.13 Folding reversibility of PagP is dependent on buffer conditions.  PagP 
urea denaturation in the unfolding (red) and refolding (blue) directions in (a) 50 mM 
sodium phosphate, pH 8.0, 25 °C and (b) 50 mM sodium citrate, pH 3.8, 37 °C.  All 
experiments contained 0.4 μM PagP and were carried out in 100 nm diC12:0PC LUVs 
at an LPR of 3200:1.  Black dashed lines indicate fits to a two-state folding model 
using a quantum yield correction factor of 2.39 (see Section 2.5.6).  The fit 
parameters obtained were       
    = -89.5 ± 5.55 kJ mol-1 and 
    = 20.9 ± 1.3 kJ mol
-1 M-1.  These data were acquired by Dr Alice I. Bartlett 
(University of Leeds). 
  
The ability to modulate hysteresis of PagP folding by changing buffer conditions 
allows the unfolding kinetics of PagP to be compared under conditions which favour 
either folding with or without hysteresis.  The unfolding kinetics of PagP were 
measured by allowing the protein to refold in 100 nm diC12:0PC LUVs for 16 h in 
either 7 M urea, 50 mM sodium phosphate, pH 8.0 or 3 M GuHCl, 50 mM sodium 
citrate, pH 3.8.  Ten-fold dilutions into either 10 M urea or 6 M GuHCl were then 
used to initiate unfolding.  Unfolding kinetic data were measured and fitted to 
exponential functions as before (Section 4.2.3).  At pH 8.0, where PagP folding 
shows hysteresis, the unfolding kinetics are found to be poorly described by a single 
exponential function (Figure 4.14a) and a double exponential function (Figure 4.14b) 
is required to give a satisfactory fit, as judged by the fitting residuals (Figure 4.14, 
bottom).  Conversely, at pH 3.8 a single exponential function provides a good fit to 
the experimental data (Figure 4.15a) and fitting the same data to a double 
exponential function (Figure 4.15b) yields no improvement in the fitting residuals 
(Figure 4.15, bottom).  Additionally, the two rate constants obtained from the double 
exponential fit are almost identical (k1 = 4.4×10
-3 
± 1.4×10
-4 
s
-1 
and 
k2 = 8.1×10
-3 
± 5.4×10
-4 
s
-1
), indicating that this is truly a single exponential process.  
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Replicate unfolding kinetics measured in different liposome batches showed good 
reproducibility under both conditions (summarised in Figure 4.16). 
Overall, these data suggest that the previously identified relationship between 
hysteresis in urea denaturation experiments and unfolding kinetics is not a protein-
dependent effect but is observed for the three different OMPs tested thus far.  The 
second phase observed in the unfolding kinetics of the OMPs under conditions 
which favour hysteresis in urea denaturation experiments is hypothesised to 
correspond to the unfolded protein becoming detached from the liposome.  This 
second unfolding phase is not observed for folding systems which fold reversibly 
without hysteresis as these exist in a two-state equilibrium between the folded, 
membrane-inserted state and the unfolded, lipid-adsorbed state.  These data suggest 
the ability to predict the presence of hysteresis in folding and unfolding experiments 
based on the unfolding kinetics of an OMP, however, they do not provide evidence 
that the second phase is indeed due to lipid detachment. 
 
 
Figure 4.14 PagP unfolding kinetics are best described by a double exponential 
function at pH 8.0.  (a) PagP unfolding (red lines) fitted to a single exponential 
function (black, dashed lines) and (b) PagP unfolding (green lines) fitted to a double 
exponential function (black, dashed lines).  Typical fitting residuals are shown in the 
lower panels of the figure.  Experiments contained 0.4 μM PagP and were carried out 
in 100 nm diC12:0PC LUVs at an LPR of 3200:1, 10 M urea, 50 mM sodium 
phosphate, pH 8.0, 25 °C.  Four replicate unfolding transients are shown in the top 
panels.  
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Figure 4.15 PagP unfolding kinetics are best described by a single exponential 
function at pH 3.8.  (a) PagP unfolding (red lines) fitted to a single exponential 
function (black, dashed lines) and (b) PagP unfolding (green lines) fitted to a double 
exponential function (black, dashed lines).  Typical fitting residuals are shown in the 
lower panels of the figure.  Experiments contained 0.4 μM PagP and were carried out 
in 100 nm diC12:0PC LUVs at an LPR of 3200:1, 6 M GuHCl, 50 mM sodium citrate, 
pH 3.8, 37 °C.  Four replicate unfolding transients are shown in the top panels.  
 
 
Figure 4.16 Summary of unfolding rate constants of HT PagP, PagP and OmpT.  
The rate constants obtained from exponential fits of the unfolding transients, k1 and 
k2, are shown by white and grey bars, respectively.  Where no value of k2 is shown, 
data were best described by a single exponential process.  Error bars depict the 
standard deviations of the rate constants.  All samples contained 0.4 μM OMP with 
100 nm LUVs (diC12:0PC for HT PagP and PagP, diC16:1PC for OmpT) at an LPR of 
3200:1 and 50 mM buffer (sodium phosphate, pH 8.0 or sodium citrate, pH 3.8).  
Rate constants and their associated errors are also provided in Table 4.4. 
  
 
 
1
7
4
  
Protein Lipid pH Hysteresis 
Exponential 
Fit 
k1  
(×10
-3
 s
-1
) 
Mean k1 
(×10
-3
 s
-1
) 
Std Dev 
k1 (×10
-3
 s
-1
) 
k2  
(×10
-4
 s
-1
) 
Mean k2 
(×10
-4
 s
-1
) 
Std Dev 
k2 (×10
-4
 s
-1
) 
HT PagP diC12:0PC 8.0 No Single 
1.05 
1.08 0.07 – – – 
1.14 
1.15 
0.98 
PagP diC12:0PC 
8.0 Yes Double 
2.17 
2.18 0.20 
4.29 
3.95 0.48 
2.07 4.36 
1.97 3.16 
2.50 3.99 
3.8 No Single 
5.41 
5.40 0.48 – – – 
4.65 
5.98 
5.56 
OmpT diC16:1PC 
8.0 Yes Double 
27.1 
16.7 6.3 
25.5 
13.5 7.2 
10.2 6.40 
14.2 10.0 
15.5 12.0 
3.8 Yes Double 
17.6 
19.8 3.4 
22.2 
17.9 3.2 24.6 14.4 
17.3 17.2 
Table 4.4 Summary of unfolding kinetic data.  Std Dev is an abbreviation of standard deviation.  Each rate constant was obtained by fitting four 
replicate unfolding transients to exponential functions as described in Section 2.5.7.  
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4.2.5 USE OF DANSYL-LABELLED LIPID TO DETECT DIFFERENCES IN THE UNFOLDING KINETICS OF 
PAGP CONSTRUCTS 
Under conditions where hysteresis is observed in urea denaturation experiments, the 
second phase observed in the unfolding kinetics of OMPs is hypothesised to arise from 
the unfolded protein becoming detached from the lipid.  This hypothesis was 
investigated using FRET studies.  For this, it was decided to compare HT PagP and 
PagP unfolding so that models both with and without observed hysteresis could be 
examined without changing buffer conditions between experiments.  Both constructs of 
PagP have twelve tryptophan residues throughout the protein structure (Figure 1.24a), 
whose fluorescence emission is used to report on folding and unfolding of the proteins 
throughout this thesis.  These residues, however, can also be utilised as FRET donors.  
5-(Dimethylamino)naphthalene-1-sulfonyl (dansyl) labelled diC18:1PS was chosen as a 
suitable FRET acceptor as the excitation maximum of dansyl occurs at approximately 
335 nm
283
, the emission wavelength used in the unfolding kinetic studies of PagP due to 
the large fluorescence emission of tryptophan at this wavelength.  Since FRET is 
strongly distance-dependent
284
, if the OMP remains lipid bound in the unfolded state, it 
would be expected to display higher FRET efficiency between tryptophan residues and 
dansyl than if the OMP is not lipid-adhered.  Higher FRET efficiency between the 
donor and acceptor groups would cause a higher fluorescence emission from the dansyl 
group at the end of the reaction, and so the unfolded state of the two proteins can be 
compared. 
Before FRET measurements were made, the unfolding kinetics of both HT PagP and 
PagP were measured to ensure the presence of the dansyl labelled diC18:1PS does not 
affect the unfolding kinetics.  The unfolding kinetics of HT PagP and PagP were 
measured by allowing the protein to refold in 7 M urea, 50 mM sodium phosphate, 
pH 8.0 in 100 nm diC12:0PC LUVs doped with 1 % diC18:1PS-dansyl for 16 h, before a 
ten-fold dilution into 10 M urea was used to initiate unfolding.  The change in 
tryptophan fluorescence emission at 335 nm was measured to follow the progress of the 
reaction as before and the resulting traces were globally fit to both single and double 
exponential functions as described in Section 2.5.7.  The low fluorescence amplitude of 
the resulting traces is a result of the FRET between tryptophan and dansyl, causing a 
reduction in the tryptophan fluorescence emission intensity, and makes the data more 
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difficult to fit with confidence.  In spite of this, the resulting rate constants were found 
to be in reasonable agreement with those measured previously in 100 nm diC12:0PC 
LUVs (Table 4.5), with HT PagP unfolding via single exponential kinetics (Figure 4.17) 
and PagP unfolding via double exponential kinetics (Figure 4.18).  All unfolding rate 
constants obtained in 100 nm diC12:0PC LUVs doped with 1 % diC18:1PS-dansyl are 
slower than the corresponding rate constants measured in 100 nm diC12:0PC LUVs, and 
this may perhaps be attributed to FRET effects altering the rate of change of 
fluorescence intensity at 335 nm. 
 
Construct Lipid 
k1  
(×10
-3
 s
-1
) 
Std Dev 
k1 (×10
-3
 s
-1
) 
k2  
(×10
-4
 s
-1
) 
Std Dev 
k2 (×10
-4
 s
-1
) 
HT PagP diC12:0PC 1.08 0.07 – – 
HT PagP 
diC12:0PC 
+ dansyl 
0.72 0.08 – – 
PagP diC12:0PC 2.18 0.20 3.95 0.48 
PagP 
diC12:0PC 
+ dansyl 
1.67 0.11 2.30 0.20 
Table 4.5 Comparison of unfolding rate constants of PagP and HT PagP in 100 nm 
LUVs of diC12:0PC in the presence or absence of 1 % diC18:1PS-dansyl.  Std Dev is an 
abbreviation of standard deviation.  Each rate constant is obtained by averaging the 
calculated rate constants from a minimum of three different liposomes batches.  
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Figure 4.17 Unfolding kinetics of HT PagP in 100 nm diC12:0PC LUVs are not affected 
by the presence of 1 % diC18:1PS-dansyl.  (a) HT PagP unfolding (red lines) fitted to a 
single exponential function (black, dashed lines) and (b) HT PagP unfolding (green 
lines) fitted to a double exponential function (black, dashed lines).  Typical fitting 
residuals are shown in the lower panels of the figure.  Experiments contained 0.4 μM 
HT PagP and were carried out in 100 nm diC12:0PC LUVs doped with 1 % 
diC18:1PS-dansyl at an LPR of 3200:1, 10 M urea, 50 mM sodium phosphate, pH 8.0, 
25 °C.  Three replicate unfolding transients are shown in the top panels.  
 
 
Figure 4.18 Unfolding kinetics of PagP in 100 nm diC12:0PC LUVs are not affected by 
the presence of 1 % diC18:1PS-dansyl.  (a) PagP unfolding (red lines) fitted to a single 
exponential function (black, dashed lines) and (b) PagP unfolding (green lines) fitted to 
a double exponential function (black, dashed lines).  Typical fitting residuals are shown 
in the lower panels of the figure.  All experiments contained 0.4 μM PagP and were 
carried out in 100 nm diC12:0PC LUVs doped with 1 % diC18:1PS-dansyl at an LPR of 
3200:1, 10 M urea, 50 mM sodium phosphate, pH 8.0, 25 °C.  Three replicate unfolding 
transients are shown in the top panels.  
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To monitor changes in FRET between tryptophan residues in the PagP constructs and 
lipid-attached dansyl, unfolding reactions were initiated as described previously; 
however, following excitation of tryptophan residues at 280 nm the fluorescence 
emission spectrum from 300–500 nm was recorded at regular intervals.  By following 
the entire spectrum over these wavelengths and time, changes in both tryptophan 
emission and dansyl emission can be measured.  Protein unfolding was monitored by 
following the change in <λ>320-370 over time as this follows changes in spectral shape 
and should not be affected by low intensity changes caused by tryptophan quenching.    
Dansyl emission was monitored by following the change in the area under the intensity 
versus wavelength curve (A460-540) between 460 and 540 nm.  The relative emission at 
any time-point was calculated by normalising the A460-540 at the relevant time-point 
between the maximum A460-540 (that when folded protein is present) and the minimum 
A460-540 (that of the dansyl-doped liposomes alone). 
For both PagP and HT PagP, the unfolding rate constants measured by the change in 
<λ>320-370 (Table 4.6) were similar to those measured by following changes in the 
intensity of tryptophan emission at 335 nm (Table 4.5).  It should be noted that the 
former method contains fewer data points and hence yields rate constants with lower 
accuracy than the latter method, particularly for the fast rate (k1) of PagP unfolding.  
Additionally, unfolding rate constants obtained by monitoring changes in relative dansyl 
emission are also similar to those measured by the change in <λ>320-370 (Table 4.6).  
This indicates that changes in dansyl emission arise due to changes in the FRET 
between tryptophan residues and dansyl as the PagP constructs unfold.  Unfolding of 
HT PagP was highly reproducible when monitored using either <λ>320-370 or A460-540, 
and FRET at the end of the unfolding reaction was evident through the elevated dansyl 
emission intensity compared with dansyl-doped liposomes in the absence of protein 
(Figure 4.19).  Unfolding of PagP by both methods showed more variability between 
samples, but was overall reproducible.  At the end of the unfolding reaction, the dansyl 
emission was equal to that of dansyl-doped liposomes in the absence of protein, 
suggesting that no FRET is occurring (Figure 4.20). 
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Construct Method 
k1  
(×10
-3
 s
-1
) 
Fitting Error 
k1 (×10
-3
 s
-1
) 
k2  
(×10
-4
 s
-1
) 
Fitting Error 
k2 (×10
-4
 s
-1
) 
HT PagP <λ>320-370 0.90 0.02 – – 
HT PagP A460-540 1.90 0.12 – – 
PagP <λ>320-370 7.80 0.69 3.05 0.24 
PagP A460-540 8.33 0.26 4.33 0.30 
Table 4.6 Comparison of unfolding rate constants of PagP and HT PagP in 100 nm 
LUVs of diC12:0PC in the 1 % diC18:1PS-Dansyl by two spectral methods.  <λ>320-370 
refers to the intensity averaged wavelength of tryptophan emission, the calculation of 
which is described in Section 2.5.6. A460-540 refers to the area under the dansyl emission 
curve, the calculation of which is described in Section 2.5.8.  
 
 
Figure 4.19 Unfolding kinetics of HT PagP in 100 nm diC12:0PC LUVs doped with 1 % 
diC18:1PS-dansyl.  (a) Unfolding of HT PagP monitored using <λ>320-370, (b) emission of 
dansyl following excitation tryptophan residues in HT PagP at 280 nm (red line 
indicates folded HT PagP present, violet line indicates diC12:0PC LUVs doped with 1 % 
diC18:1PS-dansyl in the absence of protein, other solid lines show changes in dansyl 
emission over time with orange indicating the start of the unfolding reaction and blue 
indicating the end of the unfolding reaction) and (c) unfolding of HT PagP monitored 
using A460-540.  In (a) and (c), four replicate experiments are depicted (circle, square, 
triangle and diamond markers), while fits to single exponential functions are shown as 
black dashed lines.  In (b) black dashed lines indicate the range of wavelengths used to 
calculate efficiency of energy transfer.  All experiments contained 0.4 μM HT PagP and 
were carried out in 100 nm diC12:0PC LUVs doped with 1 % diC18:1PS-dansyl at an LPR 
of 3200:1, 10 M urea, 50 mM sodium phosphate, pH 8.0, 25 °C. 
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Figure 4.20 Unfolding kinetics of PagP in 100 nm diC12:0PC LUVs doped with 1 % 
diC18:1PS-dansyl.  (a) Unfolding of PagP monitored using <λ>320-370, (b) emission of 
dansyl following excitation tryptophan residues in HT PagP at 280 nm (red line 
indicates folded PagP present, violet line indicates diC12:0PC LUVs doped with 1 % 
diC18:1PS-dansyl in the absence of protein, other solid lines show changes in dansyl 
emission over time with orange indicating the start of the unfolding reaction and blue 
indicating the end of the unfolding reaction) and (c) unfolding of PagP monitored using 
A460-540.  In (a) and (c), four replicate experiments are depicted using differently shaped 
markers (circle, square, triangle and diamond), while fits to double exponential 
functions are shown as black dashed lines.  In (b) black dashed lines indicate the range 
of wavelengths used to calculate efficiency of energy transfer.  All experiments 
contained 0.4 μM PagP and were carried out in 100 nm diC12:0PC LUVs doped with 
1 % diC18:1PS-dansyl at an LPR of 3200:1, 10 M urea, 50 mM sodium phosphate, 
pH 8.0, 25 °C.   
  
A total of eight replicate unfolding reactions were carried out for both PagP and HT 
PagP and the relative dansyl fluorescence at the end of the reaction was compared to 
give a measure of the residual FRET between tryptophan residues and the dansyl groups 
(Figure 4.21).  The amount of residual FRET at the end of each reaction was highly 
reproducible over all eight replicates for both HT PagP and PagP.  Although the 
absolute difference between the blue and violet spectra in Figure 4.19 is small, it was 
consistent over all replicates.  The average residual FRET is shown to be approximately 
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20 % for HT PagP and 0 % for PagP compared with dansyl-doped liposomes in the 
absence of protein.  This difference was found to be highly significant using a t-test (p < 
0.01).  These data suggest that the unfolded state of HT PagP is sufficiently close to the 
liposome surface for measurable FRET to occur between tryptophan residues and 
dansyl, but this is not the case for PagP. 
 
Figure 4.21 Relative dansyl fluorescence remaining at the end point of unfolding 
reactions of PagP and HT PagP in 100 nm diC12:0PC LUVs doped with 1 % 
diC18:1PS-dansyl.  Data are the average of eight replicate unfolding samples, with error 
bars depicting the standard error.  All experiments contained 0.4 μM PagP or HT PagP 
and were carried out in 100 nm diC12:0PC LUVs doped with 1 % diC18:1PS-dansyl at an 
LPR of 3200:1, 10 M urea, 50 mM sodium phosphate, pH 8.0, 25 °C.  
 
4.3 DISCUSSION 
Measurement of the free energy of unfolding of OMPs in vitro has proved to be difficult 
due to the necessity of identifying experimental conditions under which folding is 
completely reversible without hysteresis.  Hysteresis between the folding and unfolding 
denaturation curves is commonly reported
150; 151; 165; 174
 and, as a result, there are few 
studies which have been successful in determining free energies of unfolding of OMPs 
(Table 4.1).  Two main approaches for overcoming hysteresis have been employed in 
these studies.  The first is to allow the samples to equilibrate for very long times prior to 
measurements, which has been successful in achieving OmpA reversibility in both 
detergent micelles and amphipols
150; 151
.  Measurement of samples repeatedly over up to 
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52 days results in the shift of the refolding denaturation curve until it overlays with the 
unfolding denaturation curve
151
, and this effect is typical in systems with extremely high 
kinetic barriers to unfolding.  Very high kinetic stability has been observed in 
dissociation of subunits of the E. coli Type 1 pilus
281
.  The extrapolated half-life of this 
process is 3×10
9
 years and this results in stable pili with subunits that never dissociate 
under physiological conditions
281.  Additionally, unfolding of the prokaryotic α-lytic 
protease has been shown to be inhibited by high kinetic barriers as the native state of 
this protein is actually thermodynamically unstable compared with the unfolded state
202
.  
Upon denaturation, α-lytic protease would require millennia to refold unaided, however, 
folding is catalysed by the “pro-region”, an N-terminal domain which is degraded after 
folding occurs in vivo
203.  The high kinetic stability of α-lytic protease has been 
attributed to a conserved β-hairpin in the C-terminal domain204.  Protein engineering 
experiments to alter the conformation of this β-hairpin to a more favourable one were 
successful in increasing the kinetic stability of α-lytic protease but gave rise to impaired 
proteolytic function
204.  The experiments on both pilis subunits and α-lytic protease 
demonstrate the advantages of large kinetic barriers to unfolding in vivo, but also 
highlight the limitations on protein stability imposed by functional constraints
202; 203; 204; 
281
.  Such extremely high kinetic barriers may act to inhibit OMP unfolding and ensure 
no disruption to the essential functions carried out by OMPs in vivo
46; 64; 282
.  For studies 
of OMP folding in liposomes, it is not possible to incubate samples for more than a few 
days
158
 to allow full equilibration of kinetically stable samples and so conditions must 
be found under which folding reversibility without hysteresis is achievable on shorter 
timescales.  While this has been achieved for two different PagP constructs, OmpW, 
OmpLa and OmpA
149; 165; 167; 174
, problems with aggregation led to hysteresis under 
many conditions and continues to hamper work in this area.   
Following the work described in Chapter 3, folding of OmpT in diC16:1PC liposomes 
was carried out in different conditions with the aim of achieving reversible folding 
without hysteresis.  Changing buffer conditions, protein concentration, denaturant and 
equilibration time with the aim of preventing aggregation all failed to improve the large 
degree of observed hysteresis.  With so many examples of this phenomenon apparent in 
the literature, it is perhaps surprising that no previous studies have attempted to 
ascertain which factors control OMP folding reversibility in vitro.  Following the 
problems experienced in achieving folding reversibility without hysteresis, the focus of 
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this study shifted to examine possible causes of hysteresis in unfolding and folding 
equilibration. 
During the course of the reversibility studies of OmpT, a short unfolding time was 
employed and this revealed that OmpT unfolds via double exponential kinetics.  This is 
notable as studies on the folding kinetics of HT PagP reported single exponential 
unfolding kinetics of this protein under conditions where folding is reversible without 
hysteresis
167; 240
.  Additionally, these studies suggested that the measured reversible 
equilibrium was between the folded, membrane-inserted state of HT PagP and the 
unfolded, lipid-adsorbed state
167
.  Together these observations led to the hypothesis that 
if OmpT becomes detached from the liposome in the unfolded state, it could then refold 
via parallel pathways with different kinetics.  Folding of OmpT from a lipid-detached 
state could give rise to aggregation of unfolded OmpT, or a loss of folding competency, 
leading to the observed hysteresis in the folding and unfolding equilibrium. 
This hypothesis was first tested by examining the folding equilibria for the presence of 
hysteresis and the unfolding kinetics of HT PagP, PagP and OmpT under different 
conditions to establish whether single exponential unfolding kinetics are indeed linked 
to folding reversibility.  The results show that for the OMP constructs tested, double 
exponential unfolding kinetics are observed when the folding equilibrium exhibits 
hysteresis.  To examine whether the second exponential phase observed when the 
folding equilibrium shows hysteresis arises due to the unfolded protein becoming 
detached from the membrane surface, liposomes were doped with dansyl-labelled lipid 
as this moiety acts as a FRET acceptor to tryptophan
283
.  Unfolding kinetics of PagP and 
HT PagP were then measured in these dansyl-doped liposomes under identical 
conditions where HT PagP folds reversibly without hysteresis and PagP folds and 
unfolds with hysteresis.  The results obtained suggest that FRET between dansyl and 
tryptophan still occurs in the unfolded state of HT PagP but not in the unfolded state of 
PagP.  The Förster distance (R0) of the dansyl-tryptophan FRET pair has been estimated 
to be 21 Å
283
.  Assuming that there should be observable FRET between 0.5–2 R0
284
, it 
can be concluded that for no FRET to be detectable in the unfolded state of PagP, all 
tryptophan residues in the protein must be further than 42 Å from the liposome in the 
unfolded state.  This leads to the conclusion that it is unlikely that PagP remains 
adhered to the liposome in the unfolded state.  Conversely, residual FRET in the 
unfolded state of HT PagP suggests that the unfolded protein is further from the dansyl 
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on the liposome surfaces than the folded protein, but close enough for FRET to occur.  
This could arise from the HT PagP remaining lipid-bound in the unfolded state.   
The large decrease in FRET as HT PagP unfolds could be explained by the fact that 
dansyl groups will be present on both the inner and outer surfaces of the liposome.  In 
the presence of folded HT PagP, tryptophan residues in both aromatic girdles of this 
OMP (Figure 1.24a) will allow FRET to occur with dansyl groups on both surfaces of 
the bilayers.  In contrast, upon unfolding HT PagP will cease to be membrane inserted 
and the lipid-adhered unfolded state will only facilitate FRET with the dansyl groups on 
the surface of the liposome nearest the unfolded protein.  Additionally, the FRET 
efficiency with the dansyl groups on the outer surface of the bilayer could be expected 
to be lower in the unfolded than the folded state due to the effects of different 
orientations of the donor and acceptor with respect to each other
284
.  Together these data 
provide evidence that hysteresis in the folding equilibria of PagP and HT PagP is 
dependent on lipid adsorption of the unfolded state.  These experiments, however, 
provide an indirect measurement of the adsorption state of the unfolded protein.  One 
possible experimental method to directly measure if the unfolded states of HT PagP and 
PagP are lipid-attached or free in solution would be to dope the liposomes with 
biotinylated lipid and use streptavidin beads to separate the lipid-adhered and lipid-
inserted protein from protein free in solution.  Alternatively, sucrose density gradient 
centrifugation could be used to separate lipid-bound OMP species from those free in 
solution.  In both of the suggested experiments, fractions could then be analysed using 
cold SDS-PAGE and thus the folded state of the protein could also be assessed.  
Additionally, the subset of OMPs examined could be expanded to include all of the 
proteins whose folding equilibria have been previously examined
174
. 
While the work presented in this chapter suggests that lipid adhesion in the unfolded 
state could be important for folding reversibility without hysteresis of different PagP 
constructs, this cannot be stated conclusively.  Additionally, it is not yet known whether 
this effect is generic for all OMPs under all conditions, or if other factors could be at 
play.  The recent study by Moon et al compared fluorescence emission spectra of 
unfolded PagP and OmpW, under conditions where folding of both proteins was 
reversible without hysteresis, to that of N-acetyl-L-tryptophanamide under identical 
buffer conditions
174
. This led to the conclusion that both proteins were likely to be 
completely solvated in aqueous solution and not bound to the membrane surface
174
.  
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These data suggest that it is also possible that folding reversibility without hysteresis is 
not determined by lipid adhesion in the unfolded state, but by the ability of the unfolded 
protein to re-adsorb to the liposome upon dilution of denaturant.  This would imply that 
folding reversibility without hysteresis depends on the delicate balance of lipid 
adsorption and aggregation of the denatured state in low concentrations of urea.  If this 
is true in the case of all OMPs, it is perhaps surprising that HT PagP folding is 
reversible under conditions where very high urea concentrations are required to ensure 
solubility
238
, while PagP folding is irreversible even though this construct remains 
soluble at much lower concentrations of urea
162
.  It is apparent that much more work 
needs to be done on the unfolded states of OMPs under conditions where the folding 
equilibrium has been characterised in order to fully understand the factors which govern 
reversible folding.   
In vivo, large numbers of chaperones have been identified in the E. coli periplasm which 
are thought to be involved in OMP folding and membrane insertion
76; 83; 107
.  The 
presence of these proteins in the OMP folding pathway is essential in preventing the 
misfolding and aggregation of these insoluble proteins in vivo, and their absence in 
studies in vitro must be compensated for by use of carefully designed experimental 
conditions.  The understanding of exactly which requirements must be fulfilled to 
achieve reversible folding of an OMP in vitro will be invaluable in aiding future studies 
of OMP folding, stability and function. 
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5 DISSECTING THE EFFECTS OF PERIPLASMIC CHAPERONES ON THE 
FOLDING OF OUTER MEMBRANE PROTEINS 
5.1 INTRODUCTION 
The folding pathway of a C-terminally His-tagged construct of PagP (the mature PagP 
sequence followed by leucine, glutamic acid and (histidine)6, referred to as HT PagP 
herein) in the absence of chaperones has been described in detail in Section 1.8.2.  The 
work in this chapter aims to establish conditions under which the folding of an OMP 
can be studied in the presence of periplasmic chaperones and shed light on the 
mechanism of action of these chaperones. 
Previous analysis on HT PagP revealed that high concentrations of urea are required in 
order to maintain this construct in a soluble, folding competent state
167; 238; 240
 (see 
Section 1.8.2).  This is in stark contrast with the OMP folding screen reported by 
Burgess et al
162
, which showed the folding of nine different OMPs, including an 
untagged construct of PagP, into a range of synthetic lipid vesicles at urea 
concentrations as low as 1 M using the cold SDS-PAGE method.  Although the 
different OMPs studied folded with different efficiencies under each condition, in 
general, folding at high pH into vesicles comprised of lipids with shorter acyl chains 
favoured the highest yields (Figure 5.1)
162
.  These results suggest that the development 
of an OMP folding assay in the presence of soluble periplasmic chaperones enabling the 
examination of the effects of these proteins on folding rate and yield is possible. 
Although many proteins thought to act as periplasmic chaperones have been identified 
(see Section 1.5.2), the mechanisms by which they interact with unfolded OMPs to 
promote correct folding and membrane insertion remain poorly understood
76; 83
.  In this 
chapter, the effect of two chaperones, SurA and Skp (discussed in detail in Sections 
1.5.2.1 and 1.5.2.2, respectively), on the folding kinetics of OMPs are investigated.  
Following analysis of the folding kinetics of PagP, OmpT and OmpP in low 
concentrations of urea, only PagP was taken forward for study in the presence of 
chaperones based on highly reproducible folding kinetics that are well described by an 
exponential function.   
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Figure 5.1 Effect of lipid acyl chain length and pH on the efficiency of OMP folding.  
(a) Fraction of folded OMP observed in the presence of phosphocholine (PC) lipids of 
different chain lengths.  OMPs were incubated with 100 nm large unilamellar vesicles 
(LUVs) at a lipid to protein ratio (LPR) of 800:1 for 15 h at 38.3 °C in 10 mM sodium 
borate, pH 10.0 containing 1 M urea and 2 mM EDTA. (b) Effect of pH on the observed 
fraction folded of each OMP.  OMPs were incubated with 100 nm diC12:0PC LUVs at an 
LPR of 800:1 for 15 h in 10 mM buffer at the appropriate pH containing 1 M urea and 
2 mM EDTA.  SDS-PAGE loading buffer was added to quench the folding reactions 
and the samples were analysed by cold SDS-PAGE (i.e. not boiled prior to loading onto 
the gel).  The fraction folded for each reaction was determined by quantifying the 
relative intensities of the folded and unfolded bands by densitometry.  This figure has 
been adapted from Burgess et al, 2008
162
.  
 
Folding kinetics of PagP into both zwitterionic diC12:0PC liposomes and negatively 
charged 80:20 diC12:0PC:diC12:0PG liposomes (for lipid structures see Figure 5.2) were 
investigated using a combination of spectroscopic and SDS-PAGE assays.  The results 
presented show that the membrane composition and ionic strength of the buffer strongly 
influence the effect of Skp on PagP folding, suggesting that electrostatic interactions 
play an important role in the mechanism of action of Skp.  In contrast, SurA did not 
affect the observed folding rates of PagP, consistent with the view that these chaperones 
act by distinct mechanisms in partially redundant chaperone pathways.  The ability of 
Skp to prevent OMP aggregation was also investigated, revealing that even in 
conditions where aggregation is strongly favoured, Skp can rescue the folding and 
membrane insertion of HT PagP.  These results demonstrate the use of minimalist in 
vitro assays for investigating the complex folding environment of the periplasm and 
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demonstrate the key role of Skp in holding unfolded and aggregation-prone OMPs prior 
to their delivery, directly or indirectly, to the membrane where folding can be initiated. 
 
 
Figure 5.2 Structures of C12 lipids used in this chapter.  (a) 1,2-dilauroyl-sn-glycero-3-
phosphocholine (diC12:0PC) and (b) 1,2-dilauroyl-sn-glycero-3-phospho-(1'-rac-
glycerol) (diC12:0PG).  
 
5.2 RESULTS 
5.2.1 DEVELOPMENT OF KINETIC FOLDING ASSAYS IN LOW CONCENTRATIONS OF UREA 
To facilitate biophysical studies of folding in the presence of periplasmic chaperones, it 
is necessary to establish conditions under which the OMP is in a soluble, folding-
competent state while simultaneously maintaining the chaperone in a folded and 
functional state.  Satisfying this criterion allows direct comparison between the folding 
reactions in the presence and absence of chaperones, giving insights into the 
mechanisms of chaperone action.  To characterise the folding of OmpT, OmpP and 
PagP (expressed and purified as shown in Sections 3.2.2.2, 3.2.2.3 and 4.2.4), an 
unfolded stock of OMP in 10 M urea was diluted directly into 100 nm LUVs at an LPR 
of 3200:1 and folding was monitored using tryptophan fluorescence emission.  The 
enrichment of tryptophan residues in the membrane intrafacial region of membrane 
proteins
271; 272
 makes tryptophan fluorescence a sensitive probe of folding and 
membrane insertion. 
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The folding parameters tested were chosen based on the results of the screens described 
in Section 3.2.3 and also the work described by Huysmans et al
167; 238; 240
 and Burgess et 
al
162
.  Two lipid compositions were tested: zwitterionic diC12:0PC and negatively 
charged 80:20 diC12:0PC:diC12:0PG.  The former was chosen based on the observation 
that lipids with shorter acyl chains favour higher folding yields and the previous success 
of folding studies of HT PagP in this lipid
162; 167; 238; 240
, while the latter was chosen to 
give a negative surface charge similar to that observed in the OM of Gram-negative 
bacteria in vivo
66
.  Data were fitted to exponential functions as described in Section 
2.6.1. 
 
5.2.1.1 OmpT 
OmpT was over-expressed and purified as described in Sections 3.2.2.2 and 3.2.2.3. 
OmpT folding was initiated by dilution from a concentrated stock of protein (100 μM) 
in 10 M urea to 0.4 μM OmpT into 100 nm LUVs and the fluorescence emission at 
335 nm (following excitation at 280 nm) monitored for up to 2 h.  The lipid 
composition, LPR, temperature and pH were varied.  The final concentration of urea in 
the folding samples ranged from 1–2 M. 
Folding of OmpT into 100 nm diC12:0PC LUVs at an LPR of 3200:1 was carried out in a 
final concentration of 2 M urea, 50 mM sodium phosphate, pH 8.0 at 25 °C (Figure 5.3).  
Kinetic folding traces were not well described by either a single exponential function 
(Figure 5.3a) or a double exponential function (Figure 5.3b).  Increasing the temperature 
to 37 °C resulted in a faster folding reaction, as judged by the time taken to reach 
plateau, however, the kinetic folding traces were once again not well described by either 
a single (Figure 5.3c) or double (Figure 5.3d) exponential function.  The origin of the 
complex folding kinetics appears to be from a short “lag” phase at the beginning of the 
transient, which was hypothesised to arise from the initial association of the unfolded 
protein with the liposome surface.  This association has been shown for HT PagP to 
occur in the dead-time of manual-mixing experiments and manifests as a burst-phase in 
fluorescence folding transients
167; 240
.  If this occurs on a slower time-scale for OmpT 
folding into diC12:0PC liposomes, it may give rise to the observed lag-phase.   
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Figure 5.3 Kinetics of OmpT folding into 100 nm diC12:0PC LUVs at pH 8.0.  
Fluorescence kinetic traces are shown as red lines, with the exponential fit as black 
dashed lines. Folding was measured at 25 °C and fitted to (a) a single exponential 
function and (b) a double exponential function.  Folding was also measured at 37 °C 
and fitted to (c) a single exponential function and (d) a double exponential function.  All 
experiments contained 0.4 μM OmpT at an LPR of 3200:1 in 2 M urea, 50 mM sodium 
phosphate, pH 8.0.  Four replicate transients are shown in each panel. 
 
To investigate if the lag-phase does in fact originate from association of the unfolded 
OmpT to the lipid, the folding reaction was repeated in 100 nm diC12:0PC LUVs in 
50 mM sodium phosphate, pH 8.0 containing 2 M urea and monitored for up to 2 h at 
25 °C.  The LPR was varied from 400:1 to 6400:1 under the assumption that lipid 
adsorption is a bimolecular reaction dependent on both the protein and lipid 
concentrations, as suggested by the results reported for HT PagP
240
.  The data show that 
decreasing LPR overall lowers the folding rate, as judged by the time taken to reach 
plateau, and increases the length of the lag-phase, but in all cases the lag-phase is still 
present (Figure 5.4).   
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Figure 5.4 Effect of changing the LPR on kinetics of OmpT folding into 100 nm 
diC12:0PC LUVs.  The LPR was varied between 6400:1 (red lines), 3200:1 (black lines) 
and 400:1 (blue lines).  Kinetic traces have been normalised to the final fluorescence 
signal to highlight differences.  All experiments were carried out at 25 °C and contained 
0.4 μM OmpT in 2 M urea, 50 mM sodium phosphate, pH 8.0.  2–3 replicate transients 
are shown for each LPR. 
 
Changing the buffer conditions from 50 mM sodium phosphate, pH 8.0 to 50 mM 
glycine, pH 9.5, but keeping all other conditions identical, also failed to eliminate the 
lag-phase in 100 nm diC12:0PC LUVs (Figure 5.5a), suggesting that this phenomenon 
may arise due to the properties of the lipid surface itself rather than the buffer 
conditions or lipid concentration.  When the folding experiment in 50 mM glycine, 
pH 9.5 was repeated with 100 nm 80:20 diC12:0PC:diC12:0PG LUVs, which changes the 
charge at the surface of the lipid from zwitterionic to negatively charged, the lag-phase 
was no longer observed in the time-course of the experiment and the refolding transients 
were well described by a single exponential function with a rate constant of 
6.61×10
-3
 ± 8.61×10-4 s-1 (Figure 5.5b, Table 5.1).  Together these data suggest that the 
lag-phase does indeed correspond to adsorption of the unfolded OmpT to the liposome 
surface, and the presence of this effect make the data difficult to analyse quantitatively. 
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Figure 5.5 Effect of changing lipid surface charge on kinetics of OmpT folding into 
100 nm LUVs.  Fluorescence folding transients of OmpT into (a) diC12:0PC and 
(b) 80:20 diC12:0PC:diC12:0PG.  Fits to single exponential functions are shown as black 
dashed lines, with typical fitting residuals for the 80:20 diC12:0PC:diC12:0PG data shown 
in the inset of panel (b).  All experiments were carried out at 37 °C and contained 
0.4 μM OmpT in 2 M urea, 50 mM glycine, pH 9.5 with an LPR of 3200:1.  3–4 
replicate transients are shown in each panel. 
 
The final strategy employed to find simple, reproducible folding kinetics in 100 nm 
diC12:0PC LUVs was to reduce the urea concentration.  Folding reactions were carried 
out in 50 mM sodium phosphate, pH 8.0 at 25 °C and an LPR of 3200:1 with urea 
concentrations of 1.5 M and 1 M (Figure 5.6).  At a urea concentration of 1.5 M, the lag 
phase is no longer visible in the folding transient (Figure 5.6a), however, the data are 
not satisfactorily described by a single exponential function as determined by the fitting 
residuals (Figure 5.6b).  Conversely, in 1 M urea the folding reaction is well described 
by a single exponential function (Figure 5.6c), as determined by the fit residuals (Figure 
5.6d), yielding a rate constant of 1.51×10
-2
 ± 9.34×10-5 s-1 (Table 5.1). 
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Figure 5.6 Effect of changing final urea concentration on kinetics of OmpT folding into 
100 nm diC12:0PC LUVs.  Fluorescence folding transients in (a) 1.5 M urea and (c) 1 M 
urea, with fits to a single exponential function shown as black dashed lines.  Typical 
fitting residuals (b) for the 1.5 M urea data and (d) the 1 M urea data are shown.  All 
experiments contained 0.4 μM OmpT at an LPR of 3200:1 in 50 mM sodium phosphate, 
pH 8.0 and were measured at 25 °C.  Four replicate transients are shown in the top 
panels. 
 
Conditions Ave. Rate 
Constant (×10
-3
) s
-1
 
Standard Error 
(×10
-3
) s
-1
 
100 nm diC12:0PC LUVs, LPR 3200:1,  
50 mM sodium phosphate, pH 8.0,  
1 M urea, 25 °C 
15.1 0.1 
100 nm 80:20 diC12:0PC:diC12:0PG LUVs, 
LPR 3200:1, 50 mM glycine, pH 9.5,  
2 M urea, 37 °C 
6.61 0.86 
Table 5.1 Summary of OmpT folding rate constants.  Rate constants were obtained by 
measuring tryptophan fluorescence emission at 335 nm over time, and fitting the 
observed transients to a single exponential function.  Global fits were obtained over four 
replicates from a single batch of liposomes, and the average of the global fits from 
folding reactions into three batches of liposomes calculated.  The standard error of the 
mean was calculated by taking the number of liposome replicates to be 3.  
 
Taken together, these results suggest OmpT folding kinetics are not well suited to study 
with chaperones as the folding kinetics obtained are mostly complex.  While 
reproducible and exponential kinetics are observed under two conditions (100 nm 
diC12:0PC LUVs at an LPR of 3200:1 in 1 M urea, 50 mM sodium phosphate, pH 8.0, 
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25 °C; and 100 nm 80:20 diC12:0PC:diC12:0PG LUVs at an LPR of 3200:1 in 2 M urea, 
50 mM glycine, pH 9.5, 37 °C), these two sets of conditions are not directly comparable 
excluding the possibility of investigating the effect of lipid surface charge on chaperone 
activity.  Additionally, the rate constant obtained in 100 nm diC12:0PC LUVs at an LPR 
of 3200:1 in 1 M urea, 50 mM sodium phosphate, pH 8.0, 25 °C shows OmpT folding 
occurs very rapidly under these conditions and if chaperone activity were to further 
increase the rate of folding it would no longer be possible to measure the folding 
transient using this manual mixing technique.  For these reasons, it was decided not to 
use OmpT as a model protein to investigate the mechanism of action of periplasmic 
chaperones. 
 
5.2.1.2 OmpP 
OmpP was over-expressed and purified as described in Sections 3.2.2.2 and 3.2.2.3.  
OmpP folding kinetics were first measured by dilution from a 100 μM stock unfolded in 
10 M urea into 100 nm diC12:0PC LUVs at an LPR of 3200:1 in 2 M urea, 50 mM 
sodium phosphate, pH 8.0, 37 °C.  Tryptophan fluorescence emission was measured at 
335 nm (following excitation at 280 nm) and monitored for up to 2 h.  The resulting 
kinetic transients were well described by a single exponential function yielding an 
average rate constant of 1.82×10
-2
 ± 3.92×10-3 s-1 (Figure 5.7a, Table 5.2).  Folding into 
100 nm 80:20 diC12:0PC:diC12:0PG LUVs under the same conditions occurred too 
quickly to be measured by this technique (data not shown), however, increasing the 
final urea concentration to 3 M was sufficient to slow the folding rate and gave an 
average rate constant of 2.93×10
-3
 ± 8.91×10-4 s-1 (Figure 5.7b, Table 5.2).   
OmpP folding kinetics into both 100 nm diC12:0PC LUVs (Figure 5.8a) and 100 nm 
80:20 diC12:0PC:diC12:0PG LUVs (Figure 5.8b) were also measured in 2 M urea, 50 mM 
glycine buffer, pH 9.5, which revealed single exponential transients in both lipids under 
these buffer conditions.  Average rate constants obtained under these conditions were 
8.52×10
-3
 ± 7.73×10-4 s-1 and 1.02×10-2 ± 2.70×10-3 s-1 for diC12:0PC and 80:20 
diC12:0PC:diC12:0PG LUVs, respectively (Table 5.2).   
  
195 
 
 
Figure 5.7 OmpP folding kinetics into 100 nm LUVs at pH 8.0.  (a) OmpP folding into 
diC12:0PC in 2 M urea and (b) OmpP folding into 80:20 diC12:0PC:diC12:0PG in 3 M urea 
measured using tryptophan fluorescence emission.  Fits to single exponential functions 
are shown as black dashed lines.  All experiments contained 0.4 μM OmpP at an LPR of 
3200:1 in 50 mM sodium phosphate, pH 8.0 and were measured at 37 °C.  Four 
replicate transients are shown in each panel. 
  
 
Figure 5.8 OmpP folding kinetics into 100 nm LUVs at pH 9.5. OmpP folding into (a) 
diC12:0PC and (b) 80:20 diC12:0PC:diC12:0PG liposomes measured using tryptophan 
fluorescence emission.  Fits to single exponential functions are shown as black dashed 
lines.  All experiments contained 0.4 μM OmpP at an LPR of 3200:1 in 2 M urea, 50 
mM sodium phosphate, pH 8.0 and were measured at 37 °C.  Four replicate transients 
are shown in each panel.  
 
Using OmpP as a model protein, conditions have been established under which 
reproducible folding kinetics can be measured in low concentrations of urea in two 
different lipid environments.  These conditions allow the possibility of studying folding 
in the presence of periplasmic chaperones.  The folding rate constant in 80:20 
diC12:0PC:diC12:0PG LUVs, however, may be too fast to assess any increase in folding 
rate conferred unless a stopped-flow mixing assay could be developed successfully and 
the folding rate accelerated sufficiently for measurement by this technique. 
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Conditions Average Rate 
Constant (×10
-2
) s
-1
 
Standard Error 
(×10
-2
) s
-1
 
100 nm diC12:0PC LUVs, LPR 3200:1,  
50 mM sodium phosphate, pH 8.0,  
2 M urea, 37 °C 
1.82 0.39 
100 nm 80:20 diC12:0PC:diC12:0PG LUVs, 
LPR 3200:1, 50 mM sodium phosphate, pH 
8.0, 3 M urea, 37 °C 
0.29 0.09 
100 nm diC12:0PC LUVs, LPR 3200:1,  
50 mM glycine, pH 9.5,  
2 M urea, 37 °C 
0.85 0.07 
100 nm 80:20 diC12:0PC:diC12:0PG LUVs, 
LPR 3200:1, 50 mM glycine, pH 9.5,  
2 M urea, 37 °C 
1.02 0.27 
Table 5.2 Summary of OmpP folding rate constants.  Rate constants were obtained by 
measuring tryptophan fluorescence emission at 335 nm over time and fitting the 
observed transients to a single exponential function.  Global fits were obtained over four 
replicates from a single batch of liposomes, and the average of the global fits from 
folding reactions into three batches of liposomes calculated.  The standard error of the 
mean was calculated by taking the number of liposome replicates to be 3.  
 
For the introduction of soluble chaperones into the assay, it was decided to add an 
addition dilution step such that the unfolded OmpP stock in 10 M urea was first diluted 
to 0.24 M urea for 5 min in the absence of lipid, either with or without chaperone.  This 
low urea incubation was used to promote binding to the chaperone as the presence of 2–
3 M urea required for efficient liposome insertion may disrupt interaction with the 
unfolded OMP.  Following incubation, the mixture was then added to liposomes at the 
appropriate final concentration of urea.  This protocol was first carried out in the 
absence of chaperones to determine whether low urea incubation would change the 
observed folding kinetics.  While direct dilution into diC12:0PC LUVs from an unfolded 
stock in 10 M urea yielded exponential folding kinetics, pre-incubation at 0.24 M urea 
before addition to liposomes did not result in a folding transient (Figure 5.9).  These 
data suggest that OmpP does not remain folding-competent at 0.24 M urea and this 
additional step to promote binding would have to be omitted from the assay, which may 
disrupt chaperone binding.   
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Figure 5.9 Effect of incubation at 0.24 M urea on OmpP folding into 100 nm diC12:0PC 
LUVs.  Unfolded OmpP solubilised in 10 M urea was added to 100 nm diC12:0PC LUVs 
at a final concentration of 0.4 μM OmpP, 2 M urea either by direct dilution (red lines) 
or via a pre-incubation step of 2.4 μM OmpP in 0.24 M urea for 5 min in the absence of 
lipid (green lines).  Fits to a single exponential function are shown as black dashed 
lines.  All reactions were carried out at an LPR of 3200:1 in 50 mM sodium phosphate, 
pH 8.0, 37 °C.  The replicate transients of each experiment are shown. 
  
5.2.1.3 PagP 
The work described in Section 5.2.1.3 was carried out by Dr. Alice I. Bartlett, 
University of Leeds.  It is included here as the prelude to the work carried out in this 
thesis.  This work, including the work in the remainder of this chapter, has been 
published in: McMorran L. M.; Bartlett A. I.; Huysmans G. H. M.; Radford S. E. & 
Brockwell D. J. (2013) Dissecting the effects of periplasmic chaperones on the in vitro 
folding of the outer membrane protein PagP. J. Mol. Biol. 425, 3178-3191 
PagP was over-expressed and purified as described in Section 4.2.4.  To characterise the 
folding of untagged PagP, an unfolded stock in 10 M urea was diluted into 100 nm 
diC12:0PC LUVs at an LPR of 3200:1 in 50 mM glycine, pH 9.5 and folding was 
monitored using tryptophan fluorescence emission at 335 nm (following excitation at 
280 nm).  The observed transients were well described by single exponential functions 
over the time-course of the experiment when the final urea concentration was varied 
between 2 M and 4 M (Figure 5.10a).  Interestingly, the observed folding rate constant 
increased approximately five-fold between 2 M and 4 M urea (Table 5.3), suggesting 
that increasing the concentration of urea is able to change the balance between folding 
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and aggregation such that folding is favoured.  PagP has been reported to be particularly 
aggregation-prone when compared with other OMPs
164; 238
 and when PagP folding is 
monitored using cold SDS-PAGE, higher urea concentrations result in fewer observable 
aggregates (Figure 5.11).  Under these conditions, however, the reported folding rate 
constants in 2 M urea were independent of protein concentration between 0.4 μM and 
0.04 μM PagP (Table 5.4, Figure 5.12), suggesting that the explanation for this 
phenomenon may be more complex. 
 
 
Figure 5.10 Effect of urea concentration and lipid composition on PagP folding 
kinetics.  Kinetic traces have been normalised to the final fluorescence signal to 
highlight the changes in kobs in 2 M (blue lines), 3 M (green lines) and 4 M (red lines) 
urea for PagP folding into (a) diC12:0PC LUVs and (b) 80:20 diC12:0PC:diC12:0PG LUVs.  
Fits to single exponential functions are shown as black dashed lines.  All kinetic 
samples contained 0.4 µM PagP, LPR 3200:1, 50 mM glycine, pH 9.5 and were 
measured at 37 °C.  These data were acquired by Dr Alice I. Bartlett (University of 
Leeds).  
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Lipid 
[Urea] 
(M) 
Rate Constant 
(×10
-3
 s
-1
) 
Error in Global Fit 
(×10
-3
 s
-1)
 
diC12:0PC 
2.0 1.37 0.01 
3.0 2.90 0.01 
4.0 7.02 0.06 
80:20 
diC12:0PC: 
diC12:0PG 
2.0 0.32 0.00 
3.0 0.92 0.01 
4.0 1.20 0.01 
Table 5.3 Urea dependence of PagP folding into diC12:0PC and 80:20 
diC12:0PC:diC12:0PG liposomes.  Rate constants were obtained by measuring tryptophan 
fluorescence emission at 335 nm over time and globally fitting the observed transients 
to a single exponential function.  All kinetic samples contained 0.4 µM PagP, LPR 
3200:1, 50 mM glycine, pH 9.5 and were measured at 37 °C.  These data were acquired 
by Dr Alice I. Bartlett (University of Leeds).  
 
 
Figure 5.11 Urea-dependence of PagP folding monitored using cold SDS-PAGE.  All 
samples contained 4 μM PagP and 100 nm diC12:0PC LUVs at an LPR of 3200:1 in 
10 mM glycine buffer, pH 9.5, 2 mM EDTA and were refolded at 37 ºC for 15 hours 
prior to 1:1 dilution with 2 × SDS-PAGE loading buffer. Lanes on the SDS-PAGE gel 
are numbered to indicate the final concentration of urea (M) in each sample.  The 
unfolded and folded forms of PagP are denoted by U and F, respectively.  These data 
were acquired by Dr Alice I. Bartlett (University of Leeds).  
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Figure 5.12 Protein concentration dependence of PagP folding into 100 nm diC12:0PC 
LUVs.  Kinetic traces are normalised to the final fluorescence signal.  Samples 
contained 0.4 µM PagP (red lines), 0.1 µM (blue lines) or 0.04 µM PagP (green lines).  
All samples contained 50 mM glycine, pH 9.5, 2 M urea and were measured at 37 °C at 
an LPR of 3200:1.  Note that an additional slow phase visible for 0.04 M PagP was not 
observed reproducibly in replicate experiments and is not considered further.  These 
data were acquired by Dr Alice I. Bartlett (University of Leeds). 
 
PagP Concentration 
(μM) 
Average Rate 
Constant (×10
-3
 s
-1
) 
Standard Error 
(×10
-3
 s
-1
) 
0.4 1.61 0.37 
0.1 2.35 0.40 
0.04 1.56 0.60 
Table 5.4 Protein concentration dependence of PagP folding into 100 nm diC12:0PC 
LUVs.  Rate constants were obtained by measuring tryptophan fluorescence emission at 
335 nm over time, and fitting the observed transients to a single exponential function.  
The mean of four transients was calculated and standard error (n = 4) was calculated.  
All kinetic samples contained LPR 3200:1, 50 mM glycine, pH 9.5 and were measured 
at 37 °C.  These data were acquired by Dr Alice I. Bartlett (University of Leeds).  
 
When these experiments were repeated using 100 nm 80:20 diC12:0PC:diC12:0PG LUVs, 
the obtained folding transients were similarly well described by a single exponential 
function over the time-course of the experiments (Figure 5.10b).  The resulting rate 
constants were lower than those measured in diC12:0PC LUVs, however, the same 
overall trend was observed with the rate constant increasing approximately four-fold 
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between 2 M and 4 M urea (Table 5.3).  The lower folding rate constants in 80:20 
diC12:0PC:diC12:0PG LUVs may reflect a less favourable folding reaction as these 
liposomes carry an overall negative surface charge and PagP, with a theoretical pI of 5.5 
calculated using the ExPASy ProtParam Tool
251
, will also be negatively charged under 
the conditions of the assay. 
Folding of PagP into both diC12:0PC and 80:20 diC12:0PC:diC12:0PG LUVs was 
successful, with reproducible exponential folding kinetics being observed in urea 
concentrations as low as 2 M.  Folding in 50 mM glycine, pH 9.5, 37 °C was carried out 
either by direct dilution into liposomes from an unfolded stock in 10 M urea or by first 
incubating unfolded PagP at 0.24 M urea for 5 min before the addition to lipid and the 
resulting rate constants were compared.  Direct dilution to 0.4 μM PagP in 100 nm 
diC12:0PC LUVs at a final concentration of 2 M urea yielded a rate constant of 
1.34×10
-3 
± 7.7×10
-5 
s
-1.  When 2.4 μM PagP was incubated in 0.24 M urea prior to six-
fold dilution into 100 nm diC12:0PC LUVs, a similar rate constant of 
1.52×10
-3 
± 9.8×10
-6 
s
-1
 was observed, suggesting that PagP remains folding-competent 
in these conditions.  Taken together, these results indicate PagP as an excellent model 
protein for the study of the effects of periplasmic chaperones on the folding of an OMP. 
 
5.2.2 PAGP POPULATES A COLLAPSED, FOLDING-COMPETENT STATE IN VERY LOW 
CONCENTRATIONS OF UREA 
The conformation adopted by PagP in 0.24 M urea, pH 9.5, 37 °C in the absence of lipid 
was further characterised using spectroscopic methods as it represents an early species 
in the folding pathway that could be recognised by chaperones before liposome 
insertion occurs.  Analytical gel filtration of PagP in 0.24 M urea, 50 mM glycine, 
pH 9.5 showed that PagP elutes as a single peak with an elution volume of 
approximately 8 ml (Figure 5.13), suggesting that PagP populates a single non-
aggregated species under these conditions. 
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Figure 5.13 PagP populates a single, non-aggregated conformation in 0.24 M urea.  
2 μM PagP in 50 mM glycine, pH 9.5 containing 0.24 M urea was incubated for 5 min 
at room temperature before injection on to a Superdex 75 10/300 GL column.  Elution 
volumes of calibrant proteins are indicated with arrows. 
  
The far-UV CD spectrum of PagP in 0.24 M urea is distinct from both the spectrum of 
PagP folded in diC12:0PC LUVs and the spectrum of PagP unfolded in 10 M urea 
(Figure 5.14a).  The spectrum of PagP folded in diC12:0PC LUVs (Figure 5.14a) shows a 
negative peak at 218 nm, indicative of β-sheet secondary structure, and a Cotton band at 
232 nm, which has been shown to arise from interactions between Tyr-26 and Trp-66 
and is characteristic of natively folded PagP
235; 238
.  The Cotton band is not observed in 
the spectrum of the folding-competent PagP species in 0.24 M urea (Figure 5.14a), 
however, the negative ellipticity around 215 nm suggests the presence of β-sheet 
structure.  By contrast, the fluorescence emission spectra of the folding-competent state 
in 0.24 M urea and the native state in diC12:0PC LUVs have identical intensity-averaged 
wavelength (< λ >) values of 342.9 nm but differ in signal intensity (Figure 5.14b).  
Both spectra show a higher fluorescence yield and were blue-shifted when compared 
with that of unfolded PagP in 10 M urea (Figure 5.14), suggesting the folding-
competent state is collapsed in 0.24 M urea such that the tryptophan residues are 
partially protected from exposure to the solvent.   
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Figure 5.14 PagP in 0.24 M urea populates a collapsed state with residual structure as 
assessed by far UV-CD and tryptophan fluorescence emission spectroscopy.  (a) The 
far-UV CD spectra of 10 µM PagP refolded in 50 mM glycine, pH 9.5 in diC12:0PC 
liposomes (red circles); 10 µM PagP in 0.24 M urea, 50 mM glycine, pH 9.5 (blue 
circles) and 10 µM PagP unfolded in 10 M urea, 50 mM glycine, pH 9.5 (black circles). 
(b) The fluorescence emission spectra of 0.4 µM PagP folded in diC12:0PC liposomes, 
50 mM glycine, pH 9.5  (red line); 0.4 µM PagP in 0.24 M urea, 50 mM glycine, pH 9.5 
(blue line) and 0.4 µM PagP unfolded in 10 M urea, 50 mM glycine, pH 9.5 (black 
line).  The <λ320-370nm> calculated for the unfolded spectrum in 10 M urea is 346.3 nm.  
The <λ320-370nm> values for the folded spectrum and spectrum in 0.24 M urea are 
342.9 nm.  All spectra were acquired at 37 °C.   
 
The fluorescent molecule 8-anilinonaphthalene-1-sulfonic acid (ANS), binds to the 
exposed hydrophobic areas on the surface of partially folded proteins, causing a 
characteristic large increase in the fluorescence emission of the ANS and also a blue-
shift in the peak emission wavelength (λmax)
285; 286
.  Fluorescence emission spectra of 
ANS were acquired in both the presence and absence of 1 μM PagP in 0.24 M urea to 
probe the conformation of the protein.  In 10 M urea the emission spectrum of ANS had 
a λmax of 509 nm and was unchanged by the addition of PagP (Figure 5.15), suggesting 
that the protein is in a fully unfolded conformation under these conditions.  In contrast, 
the emission spectrum of ANS in 0.24 M urea shows a shift in λmax to 476 nm in the 
presence of 1 μM PagP, with an associated three-fold increase in intensity (Figure 5.15).  
These data show that in 0.24 M urea, PagP adopts a soluble, molten globule
287
 like 
conformation with residual secondary structure, as observed by far-UV CD, but with 
loosely defined tertiary structure and exposed hydrophobic amino acid side chains.  
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Figure 5.15 ANS binding to PagP reveals a molten globule like state in 0.24 M urea.  
The fluorescence spectrum of 250 μM ANS in 10 M urea in the absence (red) and 
presence (black) of 1 μM PagP and in 0.24 M urea in the absence (green) and presence 
(blue) of 1 μM PagP.  All samples contained 50 mM glycine, pH 9.5 and were measured 
at 37 °C.  
 
5.2.3 SURA DOES NOT AFFECT PAGP FOLDING IN VITRO 
SurA is a periplasmic chaperone from E. coli which contains two PPIase domains
86
.  
Deletion of these domains showed that SurA can still function in vivo and exhibits a 
chaperone activity which is not dependent on PPIase activity
87
.  The observation that 
SurA can be cross-linked to BamA in vivo
94
, the ability of SurA to assist the BAM 
complex in the folding of OmpT in vitro
137
 and proteomics experiments on SurA 
depletion strains of E. coli
85; 98
 have all led to the hypothesis that SurA is the primary 
chaperone involved in transport of unfolded OMPs across the periplasm, making it an 
obvious choice for study. 
SurA was over-expressed in BL21 (DE3) cells and purified according to the method of 
Hagan et al
137
 as described in Section 2.4.6.  Briefly, purification from whole cell lysate 
was achieved by nickel affinity chromatography in 20 mM Tris-HCl, 5 mM imidazole, 
pH 8.0.  SurA was eluted using a stepwise gradient against 20 mM Tris-HCl, 500 mM 
imidazole, pH 8.0 (Figure 5.16a).  The N-terminal His-tag was removed by thrombin 
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cleavage and the cleaved protein purified using a second nickel affinity chromatography 
purification step.  The resulting protein was greater than 95 % pure (Figure 5.16b) and 
was typically obtained in yields of 6 mg pure protein per litre of culture. 
Prior to inclusion in PagP folding assays, the stability of SurA was assessed using 
equilibrium denaturation experiments.  Tryptophan fluorescence emission was chosen 
as a suitable probe since SurA contains four tryptophan residues which are located 
throughout the structure in the P1, P2 and C-terminal domains (Figure 1.11).  The 
resulting denaturation curves indicate that SurA remains natively folded in buffer 
containing 2 M or 3 M urea (Figure 5.17) suggesting it could be added directly into 
folding assays at these concentrations of denaturant.  Equilibrium denaturation 
experiments of SurA were conducted by Dr. Alice I. Bartlett, University of Leeds. 
Folding assays were carried out by diluting unfolded PagP in 10 M urea into a three-
fold molar excess of SurA in 50 mM glycine, pH 9.5 containing a final concentration of 
0.24 M urea and 2.4 μM PagP and incubating for 5 min.  This mixture was then diluted 
six-fold into either 100 nm diC12:0PC or 100 nm 80:20 diC12:0PC:diC12:0PG LUVs at a 
final urea concentration of 2–3 M and the folding reaction followed using tryptophan 
fluorescence as a probe. 
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Figure 5.16 Purification of SurA.  (a) Typical elution profile of SurA during the first 
nickel affinity purification showing the A280nm (blue line), solution conductivity (red 
line) and percentage of imidazole-containing buffer (green line).  The step gradient of 
imidazole-containing buffer and SurA elution peak are indicated with arrows.  (b) SDS-
PAGE of SurA-containing fraction (1) after first nickel affinity chromatography 
purification and (2) after second nickel affinity chromatography purification following 
thrombin cleavage of the His-tag. The size in kiloDaltons (kDa) of the protein markers 
is indicated. 
 
 
Figure 5.17 Equilibrium unfolding of SurA monitored using tryptophan fluorescence 
emission.  SurA dissolved in 50 mM glycine buffer, pH 9.5 was diluted into separate 
aliquots of 50 mM glycine buffer containing different concentrations of urea (0–8 M in 
0.2 M increments).  The final concentration of protein was 2.5 μM.  The aliquots were 
equilibrated overnight (16 h) at 37 °C before measurement.  The fluorescence emission 
intensity was measured at 335 nm (following excitation at 280 nm) for 60 s and the 
average signal calculated.  These data were acquired by Dr Alice I. Bartlett (University 
of Leeds). 
 
Inclusion of SurA in the PagP folding assay had no effect on the observed folding rate 
constants in either 100 nm diC12:0PC (kobs = 1.34×10
-3
 ± 4.5×10
-5
 s
-1
 for PagP alone and 
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kobs = 1.41×10
-3
 ± 1.3×10
-4
 s
-1
 with SurA in buffer containing 2 M urea) (Figure 5.18a, 
top panel, Figure 5.31, Table 5.5) or 100 nm 80:20 diC12:0PC:diC12:0PG LUVs 
(kobs = 7.9×10
-4
 ± 1.4×10
-4
 s
-1
 for PagP alone and kobs = 6.3×10
-4
 ± 1.7×10
-4
 s
-1
 with 
SurA) (Figure 5.18b, top panel, Figure 5.31, Table 5.5).  Cold SDS-PAGE analysis at 
the endpoint of the reaction revealed no change in folding yield when SurA was added 
to the assay in either lipid composition (Figure 5.18a, b; bottom panels).  These results 
indicate that under these conditions, the presence of SurA has no effect on either the rate 
or yield of PagP folding into liposomes, regardless of the net charge carried on the lipid 
surface.  Kinetic folding assays and endpoint cold SDS-PAGE assays were carried out 
by Dr. Alice I. Bartlett, University of Leeds. 
The lack of any influence of SurA on the folding kinetics or yield of PagP raised the 
question of whether these two proteins interact in vitro.  This was first investigated by 
immobilising HT PagP (10 μM) on nickel Sepharose resin, then washing over SurA in 
50 mM glycine, pH 9.5.  Any protein remaining bound to the resin was then eluted 
using a mixture of 5 M urea and 500 mM imidazole.  Analysis of the fractions by SDS-
PAGE showed that SurA remained in the unbound fraction, suggesting it forms no 
interaction with HT PagP (Figure 5.19).  Additionally, analytical gel filtration of PagP 
in 50 mM glycine, pH 9.5, 0.24 M urea showed no change in peak size or elution 
volume upon addition of a six-fold molar excess of SurA suggesting there is no 
interaction between these two proteins (Figure 5.20).  This was confirmed by SDS-
PAGE analysis of the eluted fractions (Figure 5.20).   
 
 
  
208 
 
 
Figure 5.18 Kinetic traces for PagP folding into (a) diC12:0PC and (b) 80:20 
diC12:0PC:diC12:0PG liposomes in the presence (blue lines) or absence (red lines) of a 
three-fold molar excess of SurA. Dashed grey lines represent the fits of the data to a 
single exponential function. Three replicate samples of each assay are shown.  The 
differences in the final fluorescence signal arise from very small PagP concentration 
differences between samples, which appear due to the large molar extinction coefficient 
(82390 M
-1
 cm
-1
) of PagP.  Note, however, that each sample refolded successfully with 
a similar folding yield.   The lower panels show cold SDS-PAGE analysis of PagP 
samples allowed to fold overnight in the presence of a six-fold molar excess of SurA.  
The folded and unfolded forms of PagP are denoted by F and U, respectively. Kinetic 
samples contained 0.4 µM PagP and 2–3 M urea. SDS-PAGE gel samples contained 
4 µM PagP and 1 M urea. All samples had an LPR of 3200:1, contained 50 mM glycine, 
pH 9.5 and were measured at 37 °C.  These data were acquired by Dr Alice I. Bartlett 
(University of Leeds).  
 
 
Figure 5.19 SurA does not bind to HT PagP under the conditions used for the PagP 
folding kinetic assays.  10 μM HT PagP was immobilised on nickel Sepharose resin 
before incubation with 10 μM SurA in 50 mM glycine buffer, pH 9.5.  Bound and 
unbound fractions were analysed by SDS-PAGE.  SurA remains in the unbound (U) 
fraction, while HT PagP is bound (B) to the resin until eluted with 500 mM imidazole.  
Control experiments containing HT PagP or SurA only were conducted under identical 
conditions for comparison. 
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Figure 5.20 PagP and SurA do not interact under the conditions used in the kinetic 
folding assays.  (a) 10 μM PagP was added to 60 μM SurA in 50 mM glycine, pH 9.5 
containing 0.24 M urea and incubated for 5 min at room temperature before injection on 
to a Superdex 75 10/300 GL column (black dashed line).  Samples containing either 
10 μM PagP (red line) or 60 μM SurA (blue line) in 50 mM glycine, pH 9.5 containing 
0.24 M urea were also analysed.  Elution volumes of calibrant proteins are indicated 
with arrows.  (b) Fractions were collected and analysed by SDS-PAGE. 
  
5.2.4 SKP HAS A DRAMATIC EFFECT ON PAGP FOLDING 
Skp is a trimeric chaperone from E. coli, which has been suggested to have a role in 
rescuing OMPs which deviate from the main folding pathway in the periplasm
94; 98
.  Skp 
has been shown by NMR to bind to both OmpX
92
 and OmpA
102
 in vitro, forming stable 
complexes which maintain the transmembrane domains of the OMPs in unfolded 
conformations.  Additionally, fluorescence spectroscopy revealed that Skp could bind to 
bacterial OMPs with dissociation constants in the nanomolar range but binding to the 
human mitochondrial OMP, VDAC1, was not observed
101; 174
.  Using cold SDS-PAGE 
analysis, it has been suggested that Skp impedes the folding of OmpA into zwitterionic 
bilayers while accelerating folding into negatively charged bilayers
161
.  Exactly how 
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these observations relate to the role of Skp in vivo remains poorly understood, making 
Skp an attractive target of study. 
Skp was over-expressed in BL21 (DE3) cells and purified as described in Section 2.4.7.  
Briefly, following overnight expression of Skp, polymyxin B sulphate was used to 
extract the periplasmic proteins from the harvested cells.  The periplasmic extract was 
then purified first by using anion exchange in 20 mM Tris-HCl, 100 mM NaCl, pH 8.0 
and then by further purifying the flow-through by cation exchange in the same buffer.  
Skp was eluted from the cation exchange column using a continuous gradient of 
increasing NaCl in 20 mM Tris-HCl, pH 8.0 (Figure 5.21a) and the purest fractions, as 
judged by SDS-PAGE, were retained.  The resulting protein was greater than 95 % pure 
(Figure 5.21b) and was typically obtained in yields of 3 mg pure protein per litre of 
culture. 
Prior to inclusion in the PagP folding assay, equilibrium denaturation experiments were 
carried out to determine the stability of Skp.  Far-UV CD was chosen as an appropriate 
probe to follow unfolding since Skp contains no tryptophan residues and thus is only 
weakly excited by UV light at a wavelength of 280 nm.  In 50 mM glycine, pH 9.5, Skp 
is seen to be unfolded by the addition of urea with the unfolding midpoint ([urea]50%) 
occurring at approximately 1.4 M urea (Figure 5.22).  In spite of the low stability of 
Skp, kinetic assays were carried out at a final urea concentration of 2 M under the 
assumption that first allowing Skp to bind to PagP in 0.24 M urea may stabilise the Skp 
trimer sufficiently such that any effect on PagP folding could still be observed.  Binding 
of Skp to OMPs has been observed to occur with a stoichiometry of one Skp trimer per 
OMP monomer
101; 159
, so a two-fold molar excess of Skp trimers were added to the PagP 
kinetic assay to ensure complete PagP binding. 
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Figure 5.21 Purification of Skp.  (a) Typical elution profile of Skp from a cation 
exchange column showing the A280nm (blue line), solution conductivity (red line) and 
gradient of salt-containing buffer (green line).  Eluted fraction numbers are indicated on 
the graph.  Fractions 9–12 were typically retained.  (b) SDS-PAGE of Skp-containing 
fractions after cation exchange.  Lanes on the gel are labelled using the same fraction 
numbers as in (a).  The size in kiloDaltons (kDa) of the protein markers (M) is 
indicated. 
  
Inclusion of Skp trimers in the PagP folding assay showed a dramatic impact on the 
kinetics of PagP folding into 100 nm diC12:0PC or 100 nm 80:20 diC12:0PC:diC12:0PG 
LUVs in a manner which is dependent on liposome composition (Figure 5.23).  The 
folding of PagP into zwitterionic diC12:0PC LUVs in the presence of Skp is inhibited 
such that no fluorescence change is observed over the 2 h time-course (Figure 5.23a, top 
and middle, Figure 5.31, Table 5.5).  This finding was verified using cold SDS-PAGE 
to follow the folding of PagP in the presence and absence of Skp (Figure 5.24).  When 
the folding reaction was allowed to proceed for 16 h, the final folded yield of PagP was 
unchanged in the presence of Skp as determined by cold SDS-PAGE (Figure 5.23a, 
bottom).  By contrast, in 80:20 diC12:0PC:diC12:0PG LUVs, which are negatively 
  
212 
 
charged, Skp increased the observed rate constant of PagP folding by approximately 
nine-fold (kobs PagP folding alone = 2.8×10
-4
 ± 1.8×10
-5 
s
-1
, kobs PagP folding in the 
presence of Skp = 2.4×10
-3
 ± 4.3×10
-4 
s
-1
) (Figure 5.23b, top and middle, Figure 5.31, 
Table 5.5).  Cold SDS-PAGE analysis of the folding reaction after 16 h revealed that in 
spite of the order of magnitude increase in PagP folding rate constant, the folding yield 
remains unchanged in the presence of Skp (Figure 5.23b, bottom).  Skp is a very basic 
protein with a pI around 9.5 and a large macrodipole moment on the chaperone 
surface
105
.  Together with the data described above, this suggests that electrostatics play 
an important role in the modulation of Skp-mediated membrane delivery as has been 
previously suggested
105
.  Kinetic folding assays and endpoint cold SDS-PAGE assays 
(but not the cold SDS-PAGE time-course experiments) were carried out by Dr. Alice I. 
Bartlett, University of Leeds. 
 
 
Figure 5.22 Equilibrium unfolding of Skp monitored using far-UV CD.  Skp dissolved 
in 50 mM glycine buffer, pH 9.5 was diluted into separate aliquots of 50 mM glycine 
buffer containing different concentrations of urea (0–8 M in 0.2 M increments).  The 
final concentration of Skp was 15 μM.  Aliquots were equilibrated for 16 h at 37 °C 
then the ellipticity at 222 nm was recorded for 60 s and the average signal calculated.  
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Figure 5.23 Kinetic traces of PagP folding into (a) diC12:0PC and (b) 80:20 
diC12:0PC:diC12:0PG liposomes in the presence (blue lines) or absence (red lines) of a 
two-fold molar excess of Skp trimers.  Dashed black lines represent the fits of the data 
to a single exponential function.  The differences in the final fluorescence signal arise 
from small PagP concentration differences between samples, which appear due to the 
large molar extinction coefficient (82390 M
-1
 cm
-1
) of PagP.  Note, however, that each 
sample refolded successfully with a similar folding yield. The lower panels show cold 
SDS-PAGE analysis of PagP samples allowed to fold overnight in the presence of a 
two-fold molar excess of Skp trimers. The folded and unfolded forms of PagP are 
denoted by F and U, respectively.  Kinetic samples contained 0.4 µM PagP and 2 M 
urea in 50 mM glycine, pH 9.5.  SDS-PAGE gel samples contained 4 µM PagP and 1 M 
urea in 50 mM glycine, pH 9.5. All samples had an LPR of 3200:1 and were measured 
at 37 °C.  These data were acquired by Dr Alice I. Bartlett (University of Leeds). 
  
Skp has recently been shown to form a tightly bound complex with PagP, having a 
measured dissociation constant of 11.8 nM at pH 8.0
174
.  To confirm Skp binding under 
the experimental conditions described here, HT PagP (10 μM) was immobilised on 
nickel Sepharose resin as described in Section 2.6.5 then incubated with an equal 
concentration of Skp trimers in 50 mM glycine, pH 9.5 (Figure 5.25).  In the presence 
of HT PagP, Skp co-elutes from the resin with HT PagP, as observed in SDS-PAGE 
experiments, when 500 mM imidazole is added suggesting that, in contrast with SurA, 
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Skp readily binds to HT PagP (Figure 5.25a).  This result was confirmed by Western 
blotting with an anti-Histag antibody, as the apparent molecular weights of Skp and HT 
PagP are very similar and hence are difficult to resolve on a Coomassie Blue stained gel 
(Figure 5.25b). 
 
 
Figure 5.24 Skp retards the folding of PagP into diC12:0PC liposomes over a 2 h time-
course.  (a) PagP folding into diC12:0PC liposomes in the absence of Skp.  (b) PagP 
folding into diC12:0PC liposomes in the presence of Skp.  12 μM PagP was incubated 
(with a two-fold excess of Skp trimers, if appropriate) for 5 min at room temperature in 
50 mM glycine, pH 9.5 containing 0.24 M urea before a three-fold dilution into 
diC12:0PC liposomes (LPR 3200:1) in 50 mM glycine, pH 9.5 containing 2 M urea at 
37 °C.  Samples were removed at 0, 2 and 16 hours and analysed by cold SDS-PAGE 
immediately.  
 
 
Figure 5.25 Skp binds to HT PagP under the conditions used for the PagP folding 
kinetic assays as analysed by (a) SDS-PAGE and (b) Western blot analysis with an anti-
Histag antibody.  10 μM HT PagP was immobilised on nickel Sepharose resin before 
incubation with 10 μM Skp in 50 mM glycine buffer, pH 9.5.  Control experiments 
containing HT PagP or Skp only were conducted under identical conditions for 
comparison.  Skp alone does not bind to the resin and is present in the unbound (U) 
fraction, while in the presence of HT PagP, Skp co-elutes in the bound (B) fraction. 
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5.2.5 SKP ACTIVITY IS INFLUENCED BY ELECTROSTATIC INTERACTIONS 
To further investigate the extent to which the modulation of Skp-mediated delivery of 
PagP to zwitterionic and negatively charged liposomes occurs by electrostatic 
interactions, another highly basic protein was added to the folding assay in place of Skp.  
Hen egg-white lysozyme was added at a three-fold molar excess over PagP to assays 
examining folding into both 100 nm diC12:0PC or 100 nm 80:20 diC12:0PC:diC12:0PG 
LUVs (Figure 5.26).  In diC12:0PC LUVs, lysozyme showed a similar inhibition of PagP 
folding over the 2 h fluorescence time-course to that of PagP incubated with an excess 
of Skp (Figure 5.26a, Figure 5.31, Table 5.5).  This finding could not be verified using a 
cold SDS-PAGE time-course due to the folded conformation of untagged PagP and 
lysozyme running at the same apparent molecular weight (for example, see Figure 
5.32).  Inclusion of lysozyme in 80:20 diC12:0PC:diC12:0PG LUVs gave rise to a small, 
approximately two-fold increase in observed rate constant for PagP folding 
(kobs = 7.9×10
-4
 ± 1.4×10
-4
 s
-1
 for PagP alone and kobs = 1.5×10
-3
 ± 1.8×10
-4
 s
-1
 with 
lysozyme) (Figure 5.26b, Figure 5.31, Table 5.5).  This small increase is in stark 
contrast with the order of magnitude increase observed in the presence of Skp.  The data 
in 80:20 diC12:0PC:diC12:0PG LUVs were acquired by Dr. Alice I. Bartlett (University of 
Leeds). 
Binding of lysozyme to PagP was investigated using both analytical gel filtration and 
nickel affinity chromatography (Figure 5.27).  Analytical gel filtration in 50 mM 
glycine, pH 9.5 showed that the elution peak of PagP is shifted in the presence of 
lysozyme, indicating an interaction between these two proteins (Figure 5.27a).  The 
atypical elution profile in the presence of lysozyme arises from the interaction of 
lysozyme with the Superdex resin, as evidenced by lack of an elution profile of 
lysozyme alone under the same buffer conditions.  The manufacturer’s literature also 
indicates that very basic proteins interact with the resin in the absence of salt
288
.  As a 
result of the interaction of lysozyme with Superdex resin, low (2–6 μM) protein 
concentrations were used for this assay, excluding the possibility of SDS-PAGE 
analysis of the eluted fractions.  Binding was additionally testing by immobilising HT 
PagP on nickel Sepharose beads followed by incubation with an equal concentration 
(10 μM) of lysozyme in 50 mM glycine, pH 9.5 (Figure 5.27b).  When the eluent was 
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analysed by SDS-PAGE, lysozyme was seen to have co-eluted with HT PagP 
demonstrating the ability of these two proteins to interact. 
 
 
Figure 5.26 Kinetic traces of PagP folding into (a) diC12:0PC and (b) 80:20 
diC12:0PC:diC12:0PG liposomes in the presence (blue lines) or absence (red lines) of a 
three-fold molar excess of lysozyme.  Dashed black lines represent the fits of the data to 
a single exponential function.  The differences in the final fluorescence signal arise from 
small PagP concentration differences between samples, which appear due to the large 
molar extinction coefficient (82390 M
-1
 cm
-1
) of PagP.  All samples contained 0.4 µM 
PagP and 2–3 M urea in 50 mM glycine, pH 9.5, had an LPR of 3200:1 and were 
measured at 37 °C.  The data shown in panel (b) were acquired by Dr Alice I. Bartlett 
(University of Leeds). 
  
The ability of lysozyme, a basic protein which does not function as a chaperone, to 
partially mimic the activity of Skp provides further evidence that electrostatic 
interactions are important in the mechanism of action of Skp.  To investigate whether 
the changes in rate constant observed when PagP folds in the presence of Skp are 
dependent on complementary electrostatic interactions between the protein and 
membrane, the kinetic refolding assays were repeated in the presence of NaCl.  
Inclusion of 200 mM NaCl in the folding buffer caused relief of Skp-mediated 
inhibition of PagP folding into 100 nm diC12:0PC LUVs and resulted in similar PagP 
folding rate constants in the presence and absence of Skp (kobs = 8.1×10
-4
 ± 9.6×10
-5
 s
-1
 
and kobs = 1.2×10
-3
 ± 1.4×10
-4 
s
-1
, respectively) (Figure 5.28a, Figure 5.31, Table 5.5).  
In 100 nm 80:20 diC12:0PC:diC12:0PG LUVs, data could not be acquired in 200 mM 
NaCl as the resulting traces were too noisy to fit with confidence.  The presence of salt 
has been reported previously to increase the aggregation propensity of OMPs in vitro
164
 
and this, coupled with the slow folding rate constants observed for PagP folding in 
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80:20 diC12:0PC:diC12:0PG liposomes (Figure 5.10, Table 5.3), could account for the 
difficulties encountered.  Reduction of the final NaCl concentration to 100 mM, 
however, was sufficient to yield reproducible kinetic transients with 
kobs = 5.6×10
-4
 ± 6.2×10
-5
 s
-1
 for PagP alone and kobs = 1.5×10
-3
 ± 9.4×10
-5
 s
-1 
with Skp 
(Figure 5.28b, Figure 5.31, Table 5.5).  These data show that the presence of NaCl 
reduces the rate enhancement of PagP folding by Skp from nine-fold in the absence of 
salt to three-fold in the presence of salt.  These data, together with the relative effects of 
Skp and lysozyme, suggest that while electrostatic interactions play a role in the action 
of Skp, they cannot fully account for the observed changes.  The data in diC12:0PC 
LUVs were acquired by Dr. Alice I. Bartlett (University of Leeds). 
 
 
Figure 5.27 Lysozyme interacts with PagP under the conditions used in the kinetic 
folding assays as shown by (a) analytical gel filtration and (b) nickel affinity 
chromatography.  For analytical gel filtration, 2 μM PagP was added to 6 μM lysozyme 
in 50 mM glycine, pH 9.5 containing 0.24 M urea and incubated for 5 min at room 
temperature before injection on to a Superdex 75 10/300 GL column (black line).  
Samples containing either 2 μM PagP (red line) or 6 μM lysozyme (blue line) in 50 mM 
glycine, pH 9.5 containing 0.24 M urea were also analysed.  Note that the lysozyme 
interacts with the Superdex resin under these conditions, preventing its elution when 
injected alone and causing the atypical elution profile when injected with PagP.  For the 
nickel affinity assay, 10 μM HT PagP was immobilised on nickel Sepharose resin 
before incubation with 10 μM lysozyme in 50 mM glycine buffer, pH 9.5.  Control 
experiments containing HT PagP or lysozyme only were conducted under identical 
conditions for comparison.  Lysozyme alone does not bind to the resin and is present in 
the unbound (U) fraction, while in the presence of HT PagP, lysozyme co-elutes in the 
bound (B) fraction. 
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Figure 5.28 Effect of NaCl on Skp-mediated refolding of PagP.  Kinetic traces of PagP 
folding into (a) diC12:0PC liposomes in 200 mM NaCl and (b) 80:20 
diC12:0PC:diC12:0PG liposomes in 100 mM NaCl in the presence (blue lines) or absence 
(red lines) of a two-fold molar excess of Skp trimers.  Dashed black lines represent the 
fits of the data to a single exponential function.  The differences in the final 
fluorescence signal arise from small PagP concentration differences between samples, 
which appear due to the large molar extinction coefficient (82390 M
-1
 cm
-1
) of PagP.  
All samples contained 0.4 µM PagP and 2 M urea in 50 mM glycine, pH 9.5, had an 
LPR of 3200:1 and were measured at 37 °C.  The data in panel (a) were acquired by Dr 
Alice I. Bartlett (University of Leeds). 
  
One possible explanation for the ability of NaCl to influence Skp-mediated delivery of 
PagP to membranes is that electrostatic interactions are important for binding of Skp to 
its substrates and the presence of NaCl could therefore be disrupting binding rather than 
delivery to the membrane surface.  To determine whether Skp is able to bind PagP in 
NaCl, the nickel affinity chromatography assay was repeated in the presence of 200 mM 
NaCl.  As described previously, HT PagP (10 μM) was immobilised on nickel 
Sepharose resin and then incubated with an equal concentration of Skp trimers in 
50 mM glycine, pH 9.5 containing 200 mM NaCl.  The data show the co-elution of Skp 
with HT PagP (Figure 5.29), indicating that the addition of salt does not influence the 
binding of HT PagP to Skp.  The results observed in the kinetic assays (Figure 5.28) 
suggest that NaCl disrupts electrostatic interactions between Skp and the target 
membrane, and hence retards the rate of PagP folding. 
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Figure 5.29 Skp binding to HT PagP is not disrupted by the presence of 200 mM NaCl.  
10 μM HT PagP was immobilised on nickel Sepharose resin before incubation with 
10 μM Skp in 50 mM glycine buffer, pH 9.5 containing 200 mM NaCl.  Control 
experiments containing HT PagP or Skp only were conducted under identical conditions 
for comparison.  Skp alone does not bind to the resin and is present in the unbound (U) 
fraction, while in the presence of HT PagP, Skp co-elutes in the bound (B) fraction. 
  
5.2.6 INTERACTION WITH LPS-CONTAINING BILAYERS HAS A LIMITED EFFECT ON SKP-MEDIATED 
PAGP FOLDING 
Based on the results of cross-linking experiments, Skp has previously been suggested to 
interact with unfolded OMPs soon after their translocation into the periplasm
289
.  
However, under normal growth conditions, it has been hypothesised that Skp is not part 
of the major pathway of OMP assembly
107
.  The crystal structure of Skp revealed a 
putative lipopolysaccharide (LPS) binding site on the surface of the protein
106
 and this 
coupled with the observation that LPS could modulate the Skp-mediated refolding of 
OmpA
159; 161; 290
 has led to the hypothesis that Skp may act to deliver OMPs to the OM 
under conditions of stress
107
. 
This hypothesis was tested by measuring the PagP folding rate constant in the presence 
and absence of a two-fold molar excess of Skp trimers following incorporation of 20 % 
(w/w) LPS into both 100 nm diC12:0PC and 100 nm 80:20 diC12:0PC:diC12:0PG LUVs.  
Analysis of the resulting kinetic transients revealed that the folding rate constant of 
PagP into LPS-containing diC12:0PC LUVs was doubled in the presence of Skp 
(kobs = 8.9×10
-4
 ± 6.7×10
-5
 s
-1
 for PagP alone and kobs = 1.9×10
-3
 ± 3.3×10
-4
 s
-1
 with 
Skp) (Figure 5.30a, Figure 5.31, Table 5.5).  The folding rate constant in LPS-
containing 80:20 diC12:0PC:diC12:0PG LUVs was increased by a smaller amount 
(approximately 50 %) in the presence of Skp (kobs = 6.8×10
-4
 ± 7.1×10
-6
 s
-1
 for PagP 
alone and kobs = 1.0×10
-3
 ± 1.5×10
-4
 s
-1
 with Skp) (Figure 5.30b, Figure 5.31, Table 5.5).  
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These data show that LPS, a negatively charged glycolipid, causes an increase in rate of 
Skp-mediated PagP folding into bilayers which are not already negatively charged, 
however, this increase is smaller than the increase observed when Skp is added to the 
folding reaction in negatively charged liposomes in the absence of LPS.  Together, these 
results suggest that the presence of LPS may actually impede delivery of PagP to the 
membrane surface in the presence of Skp. 
 
 
Figure 5.30 Effect of LPS on Skp-mediated refolding of PagP.  Kinetic traces of PagP 
folding into (a) diC12:0PC liposomes containing 20 % (w/w) LPS (b) 80:20 
diC12:0PC:diC12:0PG liposomes containing 20 % (w/w) LPS in the presence (blue lines) 
or absence (red lines) of a two-fold molar excess of Skp trimers. Dashed black lines 
represent the fits of the data to a single exponential function.  The differences in the 
final fluorescence signal arise from small PagP concentration differences between 
samples, which appear due to the large molar extinction coefficient (82390 M
-1
 cm
-1
) of 
PagP.  All samples contained 0.4 µM PagP and 2 M urea in 50 mM glycine, pH 9.5, had 
an LPR of 3200:1 and were measured at 37 °C. 
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Figure 5.31 Relative rates of PagP folding under different conditions in diC12:0PC 
(white) and 80:20 diC12:0PC:diC12:0PG (grey) liposomes.  Each rate is normalised to the 
rate of PagP folding alone in the same lipid.  Error bars depict the standard deviation of 
the average rate for each condition, propagated through the normalisation.  All kinetic 
samples contained 0.4 µM PagP, LPR of 3200:1, 50 mM glycine, pH 9.5 and were 
measured at 37 °C.  Unnormalised rate constants and their associated errors are 
provided in Table 5.5. 
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Lipid Experiment 
Average 
Rate 
Constant 
 (×10
-3
 s
-1
) 
Standard 
Deviation  
(×10
-3
 s
-1
) 
Standard 
Error of the 
Mean  
(×10
-3
 s
-1
) 
diC12:0PC  
PagP alone (2 M urea) 1.34 0.08 0.05 
PagP & SurA (2 M urea) 1.41 0.23 0.13 
PagP & Skp (2 M urea) 0 N/A N/A 
PagP & Lysozyme (2 M urea) 0 N/A N/A 
PagP & NaCl (2 M urea) 1.20 0.25 0.14 
PagP, NaCl & Skp (2 M urea) 0.81 0.14 0.10 
PagP & LPS (2 M urea) 0.89 0.12 0.07 
PagP, LPS & Skp (2 M urea) 1.89 0.58 0.33 
80:20  
diC12:0PC: 
diC12:0PG  
PagP alone (3 M urea) 0.79 0.20 0.14 
PagP alone (2 M urea) 0.28 0.03 0.02 
PagP & SurA (3 M urea) 0.63 0.25 0.17 
PagP & Skp (2 M urea) 2.41 0.60 0.43 
PagP & Lysozyme (3 M urea) 1.52 0.26 0.18 
PagP & NaCl (2 M urea) 0.56 0.11 0.06 
PagP, NaCl & Skp (2 M urea) 1.53 0.16 0.09 
PagP & LPS (2 M urea) 0.68 0.01 0.01 
PagP, LPS & Skp (2 M urea) 1.00 0.26 0.15 
Table 5.5 Measured rate constants of PagP folding into liposomes in vitro.  Rate 
constants were obtained by measuring changes in tryptophan fluorescence emission at 
335 nm (following excitation at 280 nm) over time, and fitting the observed transients to 
a single exponential function.  Global fits were obtained over four replicates from a 
single batch of liposomes, and the average of the global fits from folding reactions into 
three batches of liposomes calculated.  The standard error of the mean was calculated by 
taking the number of liposome replicates to be 3. 
  
5.2.7 SKP DISPLAYS HOLDASE ACTIVITY AGAINST A HIGHLY AGGREGATION-PRONE PAGP 
CONSTRUCT 
The data described herein and elsewhere
174
 show that Skp binds to unfolded or partially 
folded PagP species.  Although this interaction is inhibitory to folding and membrane 
insertion in diC12:0PC LUVs, sequestration of PagP by Skp should decrease the local 
concentration of unfolded and partially folded PagP and hence decrease the aggregation 
propensity of these species.  To probe this hypothesis, the ability of both Skp and 
lysozyme to reduce aggregation of HT PagP was tested.  This construct was chosen as it 
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is particularly aggregation prone, having been shown to require high concentrations of 
urea (> 4 M) to remain soluble
231; 238
.  HT PagP was diluted to 1 M urea in 50 mM 
glycine, pH 9.5 and incubated in these conditions for 5 min before dilution into 100 nm 
diC12:0PC LUVs.  Under these conditions, all of the HT PagP precipitated, leaving none 
detectable in the supernatant by either SDS-PAGE or Western blotting with an anti-
Histag antibody (Figure 5.32).  Conversely, when HT PagP was diluted to 1 M urea in 
the presence of a two-fold molar excess of Skp trimers, a significant proportion of the 
HT PagP was rescued from aggregation and retained in a folding-competent state as 
evidenced by the heat modifiability of the HT PagP band, a characteristic of folded 
OMPs
140
 (Figure 5.32).  Using densitometry, the amount of HT PagP which was aided 
in folding and membrane insertion by Skp was estimated to be 14 %.  When the assay 
was repeated in the presence of a six-fold molar excess of lysozyme, none of the HT 
PagP was prevented from aggregation (Figure 5.32).  These data suggest that Skp is 
able to sequester HT PagP, preventing its aggregation even under conditions which 
strongly disfavour folding, and then release the protein in a folding-competent state.  By 
contrast, lysozyme was not able to prevent the aggregation of HT PagP under these 
conditions despite being shown to interact with PagP under conditions which favour 
folding (Figure 5.27).  These data support the conclusions of other studies which have 
suggested that Skp acts as a holdase chaperone
102; 104; 108; 161
, preventing the aggregation 
of unfolded OMPs even under conditions which strongly favour aggregation. 
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Figure 5.32 The holdase activity of Skp against His-tagged PagP (HT PagP), a highly 
aggregation-prone construct, demonstrated by (a) SDS-PAGE and (b) Western blot 
analysis using an anti-Histag antibody.  21.6 µM HT PagP in 1 M urea, 50 mM glycine, 
pH 9.5 was incubated in the presence of a two-fold molar excess of Skp trimers or a six-
fold molar excess of hen egg white lysozyme before a six-fold dilution into diC12:0PC 
liposomes (final HT PagP concentration = 3.6 µM; LPR 3200:1) at 37 °C.  Any 
precipitate was removed by centrifugation and the supernatant analysed for the presence 
of HT PagP.  The folded and unfolded forms of HT PagP are denoted by F and U, 
respectively.  Control experiments containing Skp and lysozyme incubated alone were 
also conducted under identical conditions.  Lysozyme runs at the same apparent 
molecular weight as folded HT PagP.  The ability of Skp to divert HT PagP from 
aggregation was quantified by densitometry measurements. 
  
5.3 DISCUSSION  
Biophysical analysis of the folding pathway of PagP in vitro has been carried out 
previously, utilising a highly aggregation prone C-terminally His-tagged construct (HT 
PagP) which requires high concentrations of urea to remain in a soluble and folding-
competent conformation
167; 238; 240
.  The requirement for high concentrations of 
denaturant in the folding buffer excludes the possibility of investigating the effects of 
soluble, periplasmic chaperones on the folding mechanism of PagP.  However, an 
untagged PagP construct reported by Burgess et al was recently shown to fold in a 
variety of lipid and buffer conditions in as little as 1 M urea
162
.  In this study, a real-time 
spectroscopic assay has been developed to directly monitor the folding of the untagged 
PagP construct into liposomes in the presence and absence of periplasmic folding 
factors. 
Inclusion of SurA in the PagP folding assay was shown to have no effect on the rate 
constant or yield of PagP folding into either zwitterionic diC12:0PC or negatively 
charged 80:20 diC12:0PC:diC12:0PG liposomes.  Furthermore, SurA was not observed to 
interact with PagP under the conditions tested, suggesting that SurA does not play a 
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direct role in assisting PagP folding in vitro.  In seeming contrast with these 
observations, the work of Sklar et al
94
 shows that depletion of SurA led to a loss of OM 
density and defects in OMP assembly.  Additionally, differential proteomics 
experiments show that depletion of SurA causes a reduction in the abundance of some 
OMPs in E. coli
85
, an effect exacerbated when Skp is also depleted
98
.  Together, these 
results have led to the hypothesis that SurA is the primary chaperone involved in OMP 
transport and assembly in the periplasm
85; 94; 98
.  In accordance with this view, SurA is 
the only soluble chaperone which has successfully been cross-linked to BamA in vivo
94; 
291
 and has been shown to increase the rate of BAM-mediated OmpT refolding in 
vitro
137
 suggesting a role for SurA in delivery of unfolded OMPs to the BAM complex.  
However, while SurA has been shown to bind to OMP-derived peptides with affinities 
in the μM range89 and a preference for Ar-X-Ar motifs89; 90, few studies report binding 
of SurA to full length OMPs in vitro
92; 292
.  Taken together with the data presented 
herein, these results suggest that SurA does not influence OMP folding in vitro in the 
absence of the BAM complex and as such its role may be in delivery of unfolded OMPs 
to the BAM complex to initiate folding and membrane insertion. 
Inclusion of Skp in the PagP folding assay demonstrated that this chaperone results in 
striking changes in the rates of PagP folding, which are dependent on both bilayer 
charge and the ionic strength of the folding buffer.  PagP folding into zwitterionic 
diC12:0PC liposomes was strongly inhibited by Skp such that no folding was observed 
over a 2 h time-course.  When the folding time-course was increased to 16 h, however, 
the yield of folded PagP at the end of the reaction was unchanged by the presence of 
Skp, as judged by cold SDS-PAGE.  In stark contrast with these observations, folding of 
PagP into 80:20 diC12:0PC:diC12:0PG liposomes was accelerated almost ten-fold in the 
presence of Skp, suggesting that electrostatic interactions with the head-groups of the 
lipids in the bilayer may have an important role to play in Skp-mediated membrane 
delivery.  Accordingly, the crystal structure of Skp reveals that the trimer has a 
“jellyfish” topology with long α-helical “tentacles” which define a central cavity and a 
notable positive charge distribution at the tips of the helices, resulting in an extremely 
large dipole moment (Figure 1.12)
105; 106
 through which interaction with a negatively 
charged membrane would be favourable.  The kinetic data presented herein are in 
agreement with data concerning the Skp-mediated folding of OmpA
161
, which was 
monitored using cold SDS-PAGE methods and showed that Skp inhibits folding of 
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OmpA into zwitterionic 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) liposomes 
and reduces the folded yield over a 4 h time-course.  In the same study, folding of 
OmpA into negatively charged liposomes at neutral or basic pH was shown to be 
facilitated by Skp
161
.  
The role of electrostatic interactions in Skp function was verified by the inclusion of 
NaCl in the folding assays, which partially reversed the effects of Skp in both lipid 
mixtures without disrupting substrate binding.  Furthermore, the inclusion of negatively 
charged LPS was able to increase the rate of Skp-mediated refolding by a greater extent 
in zwitterionic liposomes compared with negatively charged liposomes.  The ability of 
lysozyme to partially mimic the action of Skp provides further support for this idea, as it 
is also a highly basic protein.  However, lysozyme was unable to achieve the dramatic 
acceleration of PagP folding observed in the presence of Skp, suggesting that other 
factors such as hydrophobic interactions and substrate orientation may play roles in Skp 
activity.  Indeed, a recent study on the interaction of Skp with soluble proteins 
concluded that hydrophobic interactions were important for binding to these 
substrates
108
.  While lysozyme was observed to bind to PagP and alter folding rate 
constants, it was unable to prevent the aggregation of HT PagP, in contrast with Skp.  
This difference may arise from the difference in structures of Skp and lysozyme.  Skp 
has been shown to be able to bind to and sequester unfolded OMPs in its central cavity, 
a feature absent in lysozyme
293
, by both fluorescence
101; 104; 292
 and NMR 
spectroscopy
92; 102
.  It could be assumed that interaction of Skp with the membrane 
surface would bring the client protein, bound within the cavity, in close to the 
membrane surface while excluding the solvent, hence promoting folding and membrane 
insertion. 
The presence of a putative LPS binding site identified in the Skp structure
106
 has 
contributed to the hypothesis that Skp may act in times of stress to recover OMPs which 
fall off the main folding pathway
107
.  LPS is normally only present in the outer leaflet of 
the OM, and would not come into contact with Skp under normal growth conditions
64; 
65; 107
.  Previous analysis of the effect of LPS on the Skp-mediated refolding of 
OmpA
159; 161
 reported that LPS increased the folding rate into liposomes irrespective of 
membrane charge, in contrast with the results presented herein.  One possible reason for 
these seemingly contradictory results is that while the kinetic assays described in this 
study used LPS-containing bilayers, the work on OmpA allowed pre-binding of the 
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Skp:OMP complex to LPS before addition to lipid
159
.  LPS has been shown to be able to 
spontaneously insert into bilayers from aqueous solution
294
, suggesting that even a non-
specific electrostatic interaction between Skp and LPS may bring the Skp:OMP 
complex in contact with the membrane during LPS insertion and trigger faster OMP 
folding.  While it is not known which of these experimental designs closer mimics the 
possible LPS-Skp interaction under stress conditions in vivo, it is reasonable to assume 
that LPS biogenesis would also be affected
107
 and result in LPS accumulation along the 
transport pathway
65
.  Regardless of whether Skp encountered LPS contained within 
bilayers or free in the periplasm, it could be assumed that this Skp:LPS interaction may 
result in non-specific delivery of OMPs to either membrane and its importance in vivo 
remains to be elucidated. 
The current prevailing model of OMP biogenesis suggests that SurA is the primary 
chaperone for OMP transport, with Skp acting on a separate minor pathway in 
cooperation with the dual protease-chaperone, DegP
107; 111
.  This model has arisen from 
genetic
94; 95
 and proteomic
85; 98
 data showing that depletion of Skp alone has little effect 
on the composition of OMPs in the OM, while SurA depletion and simultaneous SurA 
and Skp depletion cause increasingly serious OMP assembly defects.  While this model 
appears to fit the data, it is based on the assumption that only the three chaperones 
SurA, Skp and DegP play a notable role in OMP assembly.  Very recently, it has been 
reported that depletion of both Skp and another periplasmic chaperone FkpA
110
 causes 
impairment of the assembly of the essential OMP LptD
100
.  Overexpression of SurA 
failed to compensate for this defect in the OMP assembly pathway, while 
overexpression of either Skp or FkpA failed to compensate for SurA depletion
100
.  
These new data are not easily explained by the current OMP folding model and add 
weight to the previously disfavoured hypothesis that Skp interacts with newly-
translocated OMPs and passes them to other chaperones to initiate folding
295
.  It has 
been previously observed using MD simulation data that Skp binding is initiated by the 
OMP N-terminal residues
104
 and that the OMP PhoE interacts with Skp soon after 
translocation in a manner that is impeded by removal of N-terminal segments
103
.  
Overall this suggests that Skp and FkpA may serve the redundant function of interacting 
with unfolded OMPs as they emerge from the translocon, preventing their aggregation.  
Following completion of translocation, the unfolded OMP may then interact with other 
chaperones which are involved in promoting folding and membrane insertion, such as 
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SurA and the BAM complex. This model would provide an explanation for the 
difficulty in binding SurA to full-length OMPs in vitro as shown by the data presented 
in this study and the few studies which report binding elsewhere
92; 292
, as well as the 
lack of SurA participation in OMP folding in vitro in the absence of other chaperones. 
While it remains unclear which of the proposed models accurately describes the 
chaperone pathways encountered by unfolded OMPs in the E. coli periplasm, the data 
presented herein demonstrate the utility of simplified in vitro systems in dissecting this 
complex folding environment.  This work paves the way for studies of PagP folding in 
the presence of other periplasmic chaperones and BAM complex components in future, 
allowing further insights to be gained about the interactions made by unfolded OMPs 
during their transit to the OM.  Additionally, the ability of Skp to sequester an 
extremely aggregation prone OMP and promote its folding and membrane insertion in 
vitro is shown, suggesting a potential role for this chaperone in holding unfolded OMPs 
prior to their delivery, either directly or indirectly, to the membrane in vivo. 
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6 CONCLUDING REMARKS AND FUTURE DIRECTIONS 
Since the realisation by Anfinsen that the primary amino acid sequence encodes the 
native, three-dimensional structure of a protein 
4
, the field of protein folding has seen 
phenomenal progress.  Over the past fifty years, increases in computing power coupled 
with improvements in experimental techniques have led to elucidation of the folding 
pathways of small, soluble proteins at near-atomistic detail
17
.  In stark contrast, 
however, elucidation of the folding mechanisms of membrane proteins has lagged 
significantly behind
27
.  Development of suitable membrane mimetic systems that allow 
the folding of membrane proteins to be studied in vitro has resulted in more research 
being focussed in this area in recent years
27; 29; 46; 48; 296
. 
Integral membrane proteins with a β-barrel structure are found in mitochondria, 
chloroplasts and the OM of Gram-negative bacteria.  Those of the bacterial OM carry 
out a diverse range of essential functions including (non)specific transport of small and 
large ligands
46; 64; 282
, proteolytic and synthetic reactions
46; 282
 and cellular recognition 
and adhesion
64; 282
.  Accordingly, while the β-barrel transmembrane domain forms a 
common structural motif, the number, length and tilt angle of the β-strands, as well as 
the presence of non-membrane incorporated domains is highly variable
46; 48
.  To date, 
detailed information on the folding pathways of only two OMPs, HT PagP
167; 238; 240
 and 
OmpA
144; 145; 147; 149; 153; 161
, has been elucidated, making it difficult to draw generic 
conclusions about the folding of this diverse family of proteins.  In the field of soluble 
protein folding, the “fold approach” of studying the folding mechanisms of homologous 
proteins has been very successful in determining features of protein folding 
landscapes
175; 177
.  This approach is now finding utility in the field of OMP folding, with 
the Fleming group studying the folding of nine different OMPs simultaneously, 
allowing the behaviour of these proteins to be compared and contrasted
162; 164; 165; 174
.  
While informative, these studies have not yet been able to achieve the level of detail 
acquired in comparative studies of soluble protein folding (Sections 1.1 and 1.7).  The 
work described herein aims to expand current knowledge on OMP folding by striking a 
balance between the high levels of detail attained on the folding pathway of HT PagP 
and the utility of comparative folding studies by focussing on a small subset of OMPs. 
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In Chapter 3 the homologous E. coli OM proteases, OmpT and OmpP, were cloned 
from bacterial DNA and protocols for their over-expression and purification from 
inclusion bodies were developed.  Refolding to the native state was achieved for both 
proteins into synthetics PC liposomes of both different hydrophobic thickness and 
different acyl chain saturation, demonstrating the structural malleability of both these 
OMPs and the surrounding lipid environment.  The ability of OmpT and OmpP to 
successfully fold in different lipid environments without significantly perturbing the 
final protein structure suggests that local rearrangements of amino acid side chains, 
local membrane deformation or a combination of both must be occurring.  These effects 
have previously been documented for an α-helical membrane protein using a 
combination of crystallography and MD simulations which studied the conformational 
changes of the sarco(endo)plasmic reticulum Ca
2+–ATPase268.  Additionally, the effect 
of specific side-chains on the positioning of transmembrane helices has been well 
documented
156; 269; 270; 271; 272
.  In contrast, the role of individual side chains in membrane 
positioning and OMP stability is much less characterised.  Work to date on OmpA
155; 273
 
and OmpLa
297
 has begun to examine the role of the energetic cost of burying amino acid 
side chains in the membrane interior and the energetic contributions of aromatic side 
chains in the intrafacial regions of the bilayer.  So far this work has not uncovered any 
evidence for the repositioning of transmembrane regions due to side chain-lipid 
interactions in OMPs, and this may be attributable to the rigidity of the β-barrel 
structure.  Assuming this to be the case, local membrane deformations are likely to be 
mostly responsible for the ability of OmpT and OmpP to remain natively folded and 
functional in lipid environments of varying hydrophobic thickness. 
Examination of the relative stabilities of OmpT and OmpP reveal that in liposomes 
composed of lipids with saturated acyl chains, both proteins appear similarly stable.  In 
contrast, when lipids with unsaturated acyl chains are present, leading to an increase in 
lateral pressure within the membrane, OmpP is much more destabilised than OmpT.  
These two OMPs have approximately 87 % sequence homology
244
 and the homology 
model of OmpP based on the crystal structure of OmpT (Figure 3.2) reveals that 
residues which are not conserved in the two proteins  are clustered in two areas: around 
the active site and the aromatic girdles.  The differences in the active site are 
presumably necessary to alter the substrate specificity of the enzyme, while those in the 
aromatic girdles, in particular the three extra aromatic residues at the periplasmic 
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intrafacial region of OmpP, may act to increase the stability of the protein.  Why, then, 
is OmpP less stable in liposomes comprised of lipids with unsaturated acyl chains if it 
has extra aromatic clusters in the intrafacial region?  This presumably arises as the 
sequence required to confer the substrate specificity of OmpP is very destabilising and 
these extra residues are required to partly offset this destabilisation and ensure a stable 
fold is still attainable.  This fold versus function relationship is well documented in 
soluble proteins
201; 277; 278
; however, this is the first reported example of evidence for its 
existence in OMPs. 
The large destabilisation of OmpP in diC16:1PC liposomes makes this OMP unsuitable 
for rigorous thermodynamic analysis as a full unfolding transition could not be 
measured.  OmpT, however, was less destabilised and accordingly it was attempted to 
find conditions which promoted folding reversibility of this protein.  Even after 
systematically testing a variety of conditions, fully reversible folding of OmpT without 
hysteresis between the folding and unfolding urea denaturation curves was not achieved.  
This phenomenon has been widely reported in the literature for different OMPs
150; 151; 
165; 174
.  Kinetic analysis of OmpT, PagP and HT PagP revealed a link between folding 
reversibility and unfolding kinetics wherein an extra exponential phase is observed in 
the unfolding of OMPs which fold irreversibly.  It was hypothesised, based on previous 
work on the folding mechanisms of HT PagP
167; 240
, that this additional phase may arise 
due to lipid detachment of the unfolded ensemble leading to aggregation.  Evidence 
from the FRET studies presented in Chapter 4 support this view.  Recent work by the 
Fleming group on OmpW, OmpLa and PagP at pH 3.8 suggested that the unfolded 
states of these proteins under conditions which promote reversible folding without 
hysteresis is completed solvated and cannot therefore be membrane-associated
174
.  It 
should be noted that neither the tryptophan fluorescence emission technique used by the 
Fleming group
174
 nor the FRET studies described in Chapter 4 provide direct evidence 
for the membrane-association or dissociation of these OMPs and as such it is difficult to 
draw firm conclusions on the behaviour of the unfolded ensemble in reversible folding.   
Following the kinetic analysis of the unfolding of OmpT, PagP and HT PagP, refolding 
kinetics of these proteins, as well as those of OmpP, were next examined in low urea.  
Conditions were established under which PagP could refold reproducibly with good 
yield in 2–4 M urea, and these were used to facilitate the study of folding in the 
presence of the periplasmic chaperones, Skp and SurA.  The unexpectedly slow folding 
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of PagP in 2 M urea compared with that in 4 M urea was attributed to a possible 
increase in PagP aggregation at lower urea concentrations, although the protein 
concentration independence of the rate constants do not fit well with this hypothesis.  
Studying refolding kinetics at higher PagP concentrations than those addressed in this 
work may show protein concentration dependence of the folding rate constants as 
expected in an aggregating system and should be examined.  While work on SurA in 
vivo has suggested this is the main chaperone for OMP biogenesis
85; 94; 98; 291
, the work 
presented herein alongside a lack of data implicating binding of SurA to full-length 
OMPs
89; 90; 92; 292
 suggests that the situation in vivo may not be so clear cut as previously 
thought.  Indeed, the complexity of the chaperone network in the periplasm
76; 83
 makes 
the results of in vivo knock-out experiments difficult to interpret with confidence and 
highlights the importance for minimalistic in vitro assays to understand OMP:chaperone 
interactions.   
The ability of Skp to sequester PagP and modulate PagP refolding rate in a manner 
dependent on electrostatic interactions is in accordance with previous data on the 
folding of OmpA in the presence of Skp
101; 102; 159; 161
.  These data allow generic 
conclusions about the mechanism of action of this chaperone to be drawn, but 
additionally the use of a real-time spectroscopic assay allows a much higher time 
resolution of the refolding experiments than has been achieved previously using cold 
SDS-PAGE
159; 161
.  A higher time-resolution not only allows more accurate 
determination of folding rates but also facilitates analysis of kinetic transients where 
multiple exponential phases may be occurring, as these processes can be difficult to 
identify unambiguously, especially in limited data sets.  The development of this assay 
allows the effects of individual chaperones on OMP folding to be examined and paves 
the way for experiments to investigate the interactions between chaperones at different 
phases in the OMP biogenesis pathway.  Interestingly, the results presented suggested 
that the presence of a holdase chaperone did not increase PagP folding efficiency over a 
16 h time-course as might be expected.  To address this, further work is needed to 
establish if this reaction has reached completion in the time-course of the experiment 
and if longer incubation times would yield an increase in folding efficiency.  Work on 
this project is on-going the laboratory and aims to dissect the complex mechanisms by 
which OMPs traverse the periplasm in vivo.  Additionally, the opportunity to compare 
the periplasmic chaperone network, which operates in an ATP-devoid environment, to 
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that of the cytosolic chaperone network could provide valuable insights into the 
similarities and differences between the folding of soluble and insoluble proteins in 
vivo. 
Overall, the work in this thesis provides insight into the folding mechanisms of several 
OMPs in both the presence and absence of periplasmic chaperones.  What is apparent is 
that the interaction of unfolded OMPs with the membrane environment plays a critical 
role in folding irrespective of whether the OMP is solubilised by a chaperone or 
chaotrope.  Characterising and understanding these protein:lipid interactions in vitro 
will be critical for further progress in this field.  Without knowledge of the role of the 
membrane in modulating the folding efficiency, aggregation propensity and stability of 
OMPs we cannot hope to fully understand the folding mechanisms of membrane 
proteins.  It is apparent that there is much still to be learned about the folding of 
membrane proteins but the increasing rate of progress in recent years suggests that the 
gap in understanding between soluble proteins and membrane proteins is growing ever 
smaller.  Closing this gap will allow detailed comparisons between the folding of 
soluble and insoluble proteins to be drawn, providing insights which may be invaluable 
in addressing one of the fundamental questions in biochemistry: just how does a 
protein’s sequence confer its native structure? 
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APPENDIX 
The full DNA sequence of the cloned His-tagged OmpT gene (plasmid pLMM01) is 
given below: 
 
GCTACATATG CATCATCACC ATCACCACGA AAATCTGTAC TTCCAGGGTT CTACCGAGA  
CTTTATCGTT TACTCCTGAC AACATAAATG CGGACATTAG TCTTGGAACT CTGAGCGGAA 
AAACAAAAGA GCGTGTTTAT CTAGCCGAAG AAGGAGGCCG AAAAGTCAGT CAACTCGACT 
GGAAATTCAA TAACGCTGCA ATTATTAAAG GTGCAATTAA TTGGGATTTG ATGCCCCAGA 
TATCTATCGG GGCTGCTGGC TGGACAACTC TCGGCAGCCG AGGTGGCAAT ATGGTCGATC 
AGGACTGGAT GGATTCCAGT AACCCCGGAA CCTGGACGGA TGAAAGTAGA CACCCTGATA 
CACAACTCAA TTATGCCAAC GAATTTGATC TGAATATCAA AGGCTGGCTC CTCAACGAAC 
CCAATTACCG CCTGGGACTC ATGGCCGGAT ATCAGGAAAG CCGTTATAGC TTTACAGCCA 
GAGGTGGTTC CTATATCTAC AGTTCTGAGG AGGGATTCAG AGATGATATC GGCTCCTTCC 
CGAATGGAGA AAGAGCAATC GGCTACAAAC AACGTTTTAA AATGCCCTAC ATTGGCTTGA 
CTGGAAGTTA TCGTTATGAA GATTTTGAAC TCGGTGGCAC ATTTAAATAC AGCGGCTGGG 
TGGAATCATC TGATAACGAT GAACACTATG ACCCGGGAAA AAGAATCACT TATCGCAGTA 
AGGTCAAAGA CCAAAATTAC TATTCTGTTG CAGTCAATGC AGGTTATTAC GTCACACCTA 
ACGCAAAAGT TTATGTTGAA GGCGCATGGA ATCGGGTTAC GAATAAAAAA GGTAATACTT 
CACTTTATGA TCACAATAAT AACACTTCAG ACTACAGCAA AAATGGAGCA GGTATAGAAA 
ACTATAACTT CATCACTACT GCTGGTCTTA AGTACACATT TTAAGGATCC GCC 
 
The start codon (located within the NdeI site) is shown in green and the stop codon is 
shown in red.  The restriction enzyme recognition sites are underlined. 
 
The full protein sequence of His-tagged OmpT is given below: 
 
MHHHHHHENL YFQGSTETLS FTPDNINADI SLGTLSGKTK ERVYLAEEGG RKVSQLDWKF 
NNAAIIKGAI NWDLMPQISI GAAGWTTLGS RGGNMVDQDW MDSSNPGTWT DESRHPDTQL 
NYANEFDLNI KGWLLNEPNY RLGLMAGYQE SRYSFTARGG SYIYSSEEGF RDDIGSFPNG 
ERAIGYKQRF KMPYIGLTGS YRYEDFELGG TFKYSGWVES SDNDEHYDPG KRITYRSKVK 
DQNYYSVAVN AGYYVTPNAK VYVEGAWNRV TNKKGNTSLY DHNNNTSDYS KNGAGIENYN 
FITTAGLKYT F 
The His-tag is shown in blue, the TEV recognition site in purple, and the cut site 
marked by an arrow. 
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The full DNA sequence of the cloned His-tagged OmpP gene (plasmid pLMM02) is 
given below: 
 
GCTACATATG CATCATCACC ATCACCACGA AAATCTGTAC TTCCAGGGTT 
CTGATTTCTT CGGCCCGGAG AAAATAAGTA CAGAGATTAA TTTAGGTACA 
CTGAGTGGCA AAACAAAAGA ACGGGTTTAT GAGCCTGAAG AAGGTGGACG 
TAAAGTCAGC CAACTGGACT GGAAATACAG TAACGCCGCC ATTCTTAAAG 
GCGCCGTTAA CTGGGAGCTG AATCCATGGT TATCTGTTGG TGCAGCTGGC 
TGGACCACTC TCAATAGTCG GGGGGGGAAT ATGGTTGATC AGGACTGGAT 
GGATTCCGGG ACTCCCGGAA CATGGACAGA TGAAAGCAGG CATCCTGATA 
CACGTCTTAA TTATGCCAAC GAATTTGATT TGAACGTTAA AGGCTGGTTT 
TTAAAAGAAT CTGATTATCG CCTTGCTATT ATGGCAGGTT ATCAGGAAAG 
CCGTTACAGT TTTAATGCTA CAGGAGGAAC TTATATTTAT AGTGAGAATG 
GTGGTTTCCG GAATGAAACG GGAGCGTTAC CTGATAAAAT AAAAGTGATT 
GGTTATAAAC AACATTTTAA AATTCCTTAT GTCGGTCTGA CAGGAAACTA 
CCGTTACGAT AATTTTGAGT TTGGTGGTGC ATTTAAATAC AGCGGGTGGG 
TCAGGGGATC TGATAATGAT GAGCATTATG TAAGACAAAC TACATTCCGA 
AGCAAAGTAA TAAACCAGAA TTACTATTCT GTTGCAGTTA ATGCCGGTTA 
CTATATTACC CCAGAGGCAA AAGTGTACAT CGAGGGTGTA TGGAGTCGTC 
TCACAAATAA AAAAGGGGAT ACATCTCTTT ACGACCGTAG TGATAATACT 
TCGGAGCATA ATAATAACGG GGCTGGAATT GAAAATTACA ACTTCATTAC 
GACGGCCGGT CTGAAGTACA CGTTTTAAGG ATCC GCC 
The start codon (located within the NdeI site) is shown in green and the stop codon is 
shown in red.  The restriction enzyme recognition sites are underlined. 
 
The full protein sequence of His-tagged OmpP is given below: 
 
MHHHHHHENL YFQGSDFFGP EKISTEINLG TLSGKTKERV YEPEEGGRKV SQLDWKYSNA 
AILKGAVNWE LNPWLSVGAA GWTTLNSRGG NMVDQDWMDS GTPGTWTDES RHPDTRLNYA 
NEFDLNVKGW FLKESDYRLA IMAGYQESRY SFNATGGTYI YSENGGFRNE TGALPDKIKV 
IGYKQHFKIP YVGLTGNYRY DNFEFGGAFK YSGWVRGSDN DEHYVRQTTF RSKVINQNYY 
SVAVNAGYYI TPEAKVYIEG VWSRLTNKKG DTSLYDRSDN TSEHNNNGAG IENYNFITTA  
GLKYTF 
The His-tag is shown in blue, the TEV recognition site in purple, and the cut site 
marked by an arrow. 
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The full DNA sequence of the cloned untagged OmpT gene (plasmid pLMM03) is 
given below: 
 
GGAGACACAT ATACATATG  TCTACCGAGA CTTTATCGTT  TACTCCTGAC AACATAAATG 
CGGACATTAG TCTTGGAACT CTGAGCGGAA AAACAAAAGA GCGTGTTTAT CTAGCCGAAG 
AAGGAGGCCG AAAAGTCAGT CAACTCGACT GGAAATTCAA TAACGCTGCA ATTATTAAAG 
GTGCAATTAA TTGGGATTTG ATGCCCCAGA TATCTATCGG GGCTGCTGGC TGGACAACTC 
TCGGCAGCCG AGGTGGCAAT ATGGTCGATC AGGACTGGAT GGATTCCAGT AACCCCGGAA 
CCTGGACGGA TGAAAGTAGA CACCCTGATA CACAACTCAA TTATGCCAAC GAATTTGATC 
TGAATATCAA AGGCTGGCTC CTCAACGAAC CCAATTACCG CCTGGGACTC ATGGCCGGAT 
ATCAGGAAAG CCGTTATAGC TTTACAGCCA GAGGTGGTTC CTATATCTAC AGTTCTGAGG 
AGGGATTCAG AGATGATATC GGCTCCTTCC CGAATGGAGA AAGAGCAATC GGCTACAAAC 
AACGTTTTAA AATGCCCTAC ATTGGCTTGA CTGGAAGTTA TCGTTATGAA GATTTTGAAC 
TCGGTGGCAC ATTTAAATAC AGCGGCTGGG TGGAATCATC TGATAACGAT GAACACTATG 
ACCCGGGAAA AAGAATCACT TATCGCAGTA AGGTCAAAGA CCAAAATTAC TATTCTGTTG 
CAGTCAATGC AGGTTATTAC GTCACACCTA ACGCAAAAGT TTATGTTGAA GGCGCATGGA 
ATCGGGTTAC GAATAAAAAA GGTAATACTT CACTTTATGA TCACAATAAT AACACTTCAG 
ACTACAGCAA AAATGGAGCA GGTATAGAAA ACTATAACTT CATCACTACT GCTGGTCTTA 
AGTACACATT TTAAGGATCC GCTAACAAAG CCCGAAAGGA 
The start codon (located within the NdeI site) is shown in green and the stop codon is 
shown in red.  The restriction enzyme recognition sites are underlined. 
 
The full protein sequence of untagged OmpT is given below: 
 
MSTETLSFTP DNINADISLG TLSGKTKERV YLAEEGGRKV SQLDWKFNNA AIIKGAINWD 
LMPQISIGAA GWTTLGSRGG NMVDQDWMDS SNPGTWTDES RHPDTQLNYA NEFDLNIKGW 
LLNEPNYRLG LMAGYQESRY SFTARGGSYI YSSEEGFRDD IGSFPNGERA IGYKQRFKMP 
YIGLTGSYRY EDFELGGTFK YSGWVESSDN DEHYDPGKRI TYRSKVKDQN YYSVAVNAGY 
YVTPNAKVYV EGAWNRVTNK KGNTSLYDHN NNTSDYSKNG AGIENYNFIT TAGLKYTF 
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The full DNA sequence of the cloned untagged OmpP gene (plasmid pLMM04) is 
given below: 
GGAGACACAT ATACATATGT CTGATTTCTT CGGCCCGGAG AAAATAAGTA 
CAGAGATTAA TTTAGGTACA CTGAGTGGCA AAACAAAAGA ACGGGTTTAT 
GAGCCTGAAG AAGGTGGACG TAAAGTCAGC CAACTGGACT GGAAATACAG 
TAACGCCGCC ATTCTTAAAG GCGCCGTTAA CTGGGAGCTG AATCCATGGT 
TATCTGTTGG TGCAGCTGGC TGGACCACTC TCAATAGTCG GGGGGGGAAT 
ATGGTTGATC AGGACTGGAT GGATTCCGGG ACTCCCGGAA CATGGACAGA 
TGAAAGCAGG CATCCTGATA CACGTCTTAA TTATGCCAAC GAATTTGATT 
TGAACGTTAA AGGCTGGTTT TTAAAAGAAT CTGATTATCG CCTTGCTATT 
ATGGCAGGTT ATCAGGAAAG CCGTTACAGT TTTAATGCTA CAGGAGGAAC 
TTATATTTAT AGTGAGAATG GTGGTTTCCG GAATGAAACG GGAGCGTTAC 
CTGATAAAAT AAAAGTGATT GGTTATAAAC AACATTTTAA AATTCCTTAT 
GTCGGTCTGA CAGGAAACTA CCGTTACGAT AATTTTGAGT TTGGTGGTGC 
ATTTAAATAC AGCGGGTGGG TCAGGGGATC TGATAATGAT GAGCATTATG 
TAAGACAAAC TACATTCCGA AGCAAAGTAA TAAACCAGAA TTACTATTCT 
GTTGCAGTTA ATGCCGGTTA CTATATTACC CCAGAGGCAA AAGTGTACAT 
CGAGGGTGTA TGGAGTCGTC TCACAAATAA AAAAGGGGAT ACATCTCTTT 
ACGACCGTAG TGATAATACT TCGGAGCATA ATAATAACGG GGCTGGAATT 
GAAAATTACA ACTTCATTAC GACGGCCGGT CTGAAGTACA CGTTTTAAGG 
ATCCGCTAAC AAAGCCCGAA AGGA 
 
The start codon (located within the NdeI site) is shown in green and the stop codon is 
shown in red.  The restriction enzyme recognition sites are underlined. 
 
The full protein sequence of untagged OmpP is given below: 
 
MSDFFGPEKI STEINLGTLS GKTKERVYEP EEGGRKVSQL DWKYSNAAIL KGAVNWELNP 
WLSVGAAGWT TLNSRGGNMV DQDWMDSGTP GTWTDESRHP DTRLNYANEF DLNVKGWFLK 
ESDYRLAIMA GYQESRYSFN ATGGTYIYSE NGGFRNETGA LPDKIKVIGY KQHFKIPYVG 
LTGNYRYDNF EFGGAFKYSG WVRGSDNDEH YVRQTTFRSK VINQNYYSVA VNAGYYITPE 
AKVYIEGVWS RLTNKKGDTS LYDRSDNTSE HNNNGAGIEN YNFITTAGLK YTF 
